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General Introduction
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1. Genomics perspectives to host-pathogen interactions
The central dogma in molecular biology posits that, at a very basic level of most known 
living things lies deoxyribonucleic acid (DNA) which consists of sequential segmental 
nucleotide units called genes, interspersed by other nucleotide sequences for structural 
and regulatory purposes. As and exception, the genes of RNA viruses are in ribonucleic 
acid (RNA) as they do not have DNA. Genes are our hereditary material and are also the 
units that encode complex biological products like proteins of the immune system and 
various types of RNA, e.g. microRNAs. We refer to the collection of all genetic material in 
an organism as its genome. The human genome was completely sequenced 10 years 
ago1, 2 and it has since then been used to investigate disease processes in a host-cell at 
a genomic level by, for example, uncovering host genes that are up- or down-regulated 
in expression because of an infection. To study such events more systematically, biologists 
examine biological information at various genomics levels, some of which I shall discuss 
below.
1.1  Transcriptomics
The process of expressing genes from DNA is known as transcription and the protein 
coding precursors of transcribed genes are known as messenger RNAs (mRNAs). In this 
“omics” age, when several genes can be simultaneously investigated using technologies 
like DNA microarrays or RNA-seq to generate the so-called trancriptomics datasets from 
cells, reporting and interpreting huge numbers of genes against the background of 
what is known in the scientific literature is not a simple task. In infection biology for 
example, whole-genome transcriptomics (transcriptome) data, can be generated from 
a host-cell, in order to observe genes or group of genes that are responsive to infectious 
disease agents. Such efforts have yielded good results in several studies. For example, 
using transcriptomics data from high-density oligonucleotide microarrays, Bao and 
colleagues used alveolar epithelial cells (A549 cells) to globally uncover cytokines and 
chemokines that are induced in expression upon human metapneumovirus (HMPV) 
infection of these cells3, 4; thus providing an important resource for HMPV biology which 
I shall use in this thesis, and that will likely inspire other studies on HMPV pathogenesis. 
Another transcriptomics study related to infection concerns the respiratory syncytial 
virus (RSV) infection. Using mouse models, Schuurhof and colleagues examined 
differential host transcription profiles generated during secondary immune responses 
to RSV compared to primary infection to explain the phenomenon of vaccine-enhanced 
disease. They discovered that 5 days after challenge, the chemokine, inflammation and 
interferon response genes were expressed at higher levels during primary immune 
responses, while the immunoglobulin gene expression was higher during secondary 
immune responses. Furthermore, formalin-inactivated RSV vaccination with RSV challenge 
generated vaccine-enhanced disease and resulted in a transcription profile similar to 
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that of a primary immune response instead of a secondary response. In addition, Th2 
gene expression was specifically induced in mice that were vaccinated with formalin-
inactivated RSV. Schuurhof and colleagues concluded that their findings support the 
hypothesis that vaccine-enhanced disease is mediated by prolonged innate immune 
responses and Th2 polarization, in the absence of replication of the virus5. 
1.2  MicroRNAs
Not all genes are protein-encoding. Some genes encode microRNAs (miRNAs) that are 
important in post-transcriptional gene regulation. MiRNAs can stall protein translation 
by binding to the 3’ untranslated region (UTR) of mRNAs of their so-called target genes. 
Furthermore, it has been shown that targeted mRNAs are mainly degraded upon miRNA 
binding; leading to low concentrations of the mRNA targets6-8. MicroRNAs are currently 
being recognized as important regulatory factors in several biological processes such as 
the control of differentiation and maturation of innate-immune cells that are challenged 
with pathogenic material like LPS9-12. 
Identifying miRNAs and their target genes is important in unraveling the gene network 
underpinning immune responses to pathogens. There are a number of bioinformatics-
based algorithms aimed at predicting target genes for miRNAs. These include PicTar13 
and TargetScan14. These prediction programs take genomic factors like the phylogenetic 
conservation of both the miRNA and the target genes amongst multiple animal species 
into account in order to ascertain the reliability of the predictions. In the context of 
evolutionary biology, strong conservation of a miRNA and its target gene suggests a 
functional partnership of the pair.
Experimental identification of miRNA targets is desirable because low degree of com-
plementarity between the miRNA and its target sequence often makes it difficult to 
computationally identify targets. A biochemical method used to assuage this problem 
is based on Argonaute (Ago) proteins which function in multi-protein complexes 
associated with miRNAs15, 16. These protein complexes are guided by miRNAs to partially 
complementary sequences typically located in the 3’ UTR of their target mRNAs leading 
to the inhibition of its translation and/or its destabilization17-19. Based on this principle, 
highly specific monoclonal antibodies against Ago proteins enable the isolation of 
functional Ago-miRNA-mRNA complexes from different cell lines, tissues, or even 
patient samples. Thus enabling isolation and identification of miRNA target mRNAs, as 
has been done in immunoprecipitated human Ago protein complexes20. 
Experimental confirmation of miRNA targets are usually performed after in silico target 
predictions (i.e. after using programs like PicTar) by employing an integrative miRNA- 
mRNA transcriptomics analysis approach. In such an approach, the down-regulated 
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targets of up-regulated miRNAs are deemed to be the likely true targets21-26. For example, 
in infectious disease related miRNA studies, human monocyte derived macrophages 
infected with Mycobacterium avium have been shown to concomitantly up-regulate 
miRNA let-7e and miR-29a  and down-regulate their respective targets  CASP3 and 
CASP726. These observations were further confirmed functionally using Gaussia 
luciferase reporter gene assays26. The miRNA-mRNA integrative approach has also been 
used in studying the development of immune-related cells.  For example, studying the 
differentiation of dendritic cells (antigen-presenting cells of the immune system) from 
their monocyte precursors, Hashimi and colleagues observed that miR-21 and miR-34a 
down-regulated their target genes, JAG1 and WNT1, and the differentiation process was 
stalled when the miRNAs were inhibited or when their targets, WNT1 and JAG1 were 
exogenously added27. Thus making use of the observation that mammalian miRNAs 
reduce levels of their target mRNAs and proteins6 and affect developmental pathways. 
In another example, aimed at investigating the influence of miRNAs on mRNA transcript 
levels, Lim and colleagues discovered that delivering miR-124 into human cells causes 
the down-regulation of about 100 mRNA transcripts. Furthermore, the 3’ untranslated 
regions of these messages had a significant propensity to pair to the 5’ region of the 
miRNA, as expected if many of these mRNA messages are the direct targets of the 
miRNAs8.
1.3  Transcription factor binding sites
Prior to the transcription of genes, proteins known as transcription factors bind in the 
promoter regions of genes to induce their expression. The recognition of transcription 
factor binding sites (TFBSs) in the promoter region of both protein-coding and non- 
protein coding genes is interesting because it can help us to understand the genomic 
architecture underlining gene expression under various circumstances. Furthermore, 
there is increasing evidence that transcription factors work in combination28. Under -
standing the unique combination of transcription factors that are responsible for the 
expression of a group of genes under a given condition, such as during viral infection, 
can enable identification of genes that are likely to be involved in similar biological 
responses. Several techniques have been developed in bioinformatics to enable 
determination of TFBSs in promoter sequences of genes. These include algorithm like 
Clover29  that  is used in searching for sites of well-characterized TFBS-motifs in a group 
of genes that are for example selected based on their similarity in response to a given 
environmental condition. Another algorithm is MEME30, which works by searching for 
repeated, ungapped sequence patterns that occur in a group of DNA sequences, and 
thus can lead to the discovery of novel TFBS motifs common to a group of promoter 
sequences. A number of bioinformatics algorithms have also been developed for 
genome-wide analysis of TFBSs based on data from high-throughput techniques like 
ChIP-Seq (chromatin immunoprecipitation coupled with massively parallel sequencing)31. 
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These include DREME32 and MEME-ChIP33 that are both used for motif-discovery in 
ChiP-Seq data analyses.
  
1.4  Proteomics
Biology is too complex for information retrieved at a transcriptomics level to be wholly 
representative of the cellular conditions, especially because many biological signals are 
orchestrated at the level of proteins. Moreover, proteins are often modified after 
translation from their mRNA precursors. Examining cellular changes during host- 
pathogen interactions at the level of proteins is therefore important. We refer to the 
global repertoire of proteins of an organism or cell as its proteome. Proteomics 
techniques such as 2-D gel electrophoresis followed by mass spectrometry are used to 
generate high-throughput datasets of the proteins present in a cell. Using such 
approaches proteins that become more abundant or less abundant upon infection 
relative to non-infection, can be uncovered. Although important, proteomics data, in 
comparison to transcriptomics data, is relatively expensive to generate and also yields 
far lower number of identifiable proteins34 than the number of cognate genes that can 
be identified using transcriptomics techniques. As such, transcriptomics data are mostly 
used for exploratory genomics work to generate hypotheses that can be readily 
confirmed using detailed biochemical assays at the protein level. Nevertheless, both 
data types are important in understanding host-pathogen interactions. For example, 
protein microarrays  are extensively used to identify pathogen proteins that bind to host 
proteins35. Recent examples include a genome-wide study of Pseudomonas aeruginosa 
outer membrane protein immunogenicity using self-assembling protein microarrays36. 
In that study, as much as 12 P. aeruginosa proteins were identified to trigger an adaptive 
immune response in the patients investigated; providing valuable information about 
which bacterial proteins are actually recognized by the host immune system. 
Another example of immune-related proteomics work is the discovery, using 2-D gel 
electrophoresis and mass spectrometry, of two protein isoforms of PLUNC, a newly 
discovered human gene that is expressed in the upper respiratory tract and is suggested 
to be of importance in host defense against bacteria 37-39.
1.5  Protein-protein interaction networks
Several biological processes are carried out by proteins interacting with each other, 
resulting in biomolecular pathways as those documented in the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) 40. Nevertheless, characterization of all possible biological 
pathways for all biological contexts remains a daunting challenge. As such, the 
documentation of all known protein-protein interactions (PPIs) is important. Such a 
resource can in principle facilitate discovery of PPIs that could be functional in other 
contexts than the one in which the interaction was originally discovered. There are 
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already a number of such PPI resources, including the HPRD41 , BIND42, and BioGRID43 , 
amongst others. 
In general, protein-protein interaction data are usually used in combination with other 
“omics” data (transcriptomics, proteomics, metabolomics), to unveil insights in molecular 
medicine that are not directly eminent from one type of data44, 45. In Figure 1, I depict the 
principle of combining PPI data with transcriptomics data to yield a PPI network that is 
potentially specific to the context of an infection.
Figure 1 - Generation of a potential context-specific protein-protein interaction network.
In the context of virus infection, for example, genes that are induced in expression in 
infected host-cells relative to non-infected cells are earmarked. A general protein- 
protein interaction (PPI) network is then queried for interacting proteins whose genes 
have thus been earmarked in the infection study to yield a context specific PPI network.
18
2. Immune response
In biology, immunity refers to the resistance of an organism against disease, including 
infectious diseases. This is usually conferred by immune defense proteins like interleukins 
and interferons. There is a new bioinformatics discipline called “immunomics”, which 
involves infection-related transcriptomics, genomics, proteomics and immunology 
data analyses46, 47. Immunomics started after the completion of the human genome 
project 10 years ago (Figure 2); and it already epitomizes advancement in vaccine 
research through the use of immunomics protein microarrays as a vaccine discovery 
tool48, 49. Examples of immunomics-related work include the immunomic analysis of the 
repertoire of T-cell specificities for influenza A virus in humans 50. Prior to the latter work, 
relatively few highly conserved epitopes of the virus were known to be relevant in 
humans. Yet, highly conserved epitopes recognized by effector T cells may represent an 
alternative approach for the generation of a more universal influenza virus vaccine. 
Starting from more than 4000 peptides that were selected from a panel of 23 influenza 
A virus strains, Assarsson and colleagues identified 54 nonredundant epitopes with 
high coverage and conservation in the majority of the virus strains analyzed. These were 
also consistently recognized in multiple infected individuals50. Their results provide a 
potential base for the development of a universal influenza vaccine. Similarly, immunomics 
approaches are being used to identify markers that can be employed for vaccine 
development to prevent infectious diseases like malaria51 and Schistosomiasis 48 
amongst others. Nonetheless, several other works, this thesis included, that are related 
to immune response without specifically aiming at vaccine development, still fall in the 
realm of immune-related transcriptomics (Figure 2). 
3. Outline of thesis
This thesis addresses cellular response signals post infection in innate-immune cells 
using genomics data. I shall give a brief outline of the rest of the chapters below.
3.1  Chapter 2
As introduced in section 1 above, signals in biological systems are often propagated 
through proteins interacting with each other. In Chapter 2 of this thesis, we examine 
the dierential protein responses of alveolar epithelial cells (A549 cell model) after 
infection with respiratory syncytial virus (RSV), parainuenza (PIV), human meta-
pneumovirus (HMPV) and measles virus (MV). Using the 2-D gel approach, we show 
that RSV, HMPV, PIV3, and MV induced similar host responses and that the main 
differences were based on time and dosage of host gene response. In addition to 
writing the paper with the co-authors, I performed the molecular network analysis in 
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this chapter. By integrating Gene ontology and protein-protein interaction network 
data, I show that the proteins that become more abundant or less abundant after viral 
infections are signifi cantly enriched in apoptosis. I also provide PPI networks per 
virus-type to highlight the proteins involved. Apoptosis is likely an important innate- 
immune strategy  to combat these viruses. 
3.2  Chapter 3
The concept that proteins interact with each other in molecular pathways has stimulated 
the bioinformatics community to document functional protein-protein interaction (PPI) 
partnerships into general PPI resources available to the public. These resources are 
meant to facilitate the recapitulation of proteins that function together under various 
Figure 2 - Immunomics as a new sub-discipline in bioinformatics.
Over the past 10 years, high-throughput data analysis in infection biology is becoming 
popular, and paving the way to a new area of bioinformatics, immunomics, to focus on 
immunological genomics. The y-axis shows the number of articles in the US library of 
medicine (available at http://www.ncbi.nlm.nih.gov/pubmed) whose title or abstracts 
are associated with immunomics (query terms:  immunome, or immunomics or immunomic); 
and transcriptomics&immunity (query terms: (transcriptome or transcriptomics or 
transcriptomic) and (immune or immunity)) in the last 10 years. (Queries performed at 
Pubmed on June 11, 2011)
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circumstances.  However, before proteins are available to interact with each other in 
various biological pathways, the cognate genes have to be expressed before the 
proteins are translated. The general method used to identify genes that are up- or 
downregulated in expression upon infection is by use of DNA microarray or RNA-seq. 
The ratio of expression of a gene in an infected cell to a non-infected cell of the same 
type is used to select genes that are up-regulated or down-regulated upon infection. 
Using this knowledge, a general approach used in system biology to discover context-
specic protein-protein interaction networks is to overlay the gene response list 
with the general PPI network as demonstrated in Figure 1. Although this approach is 
interesting, general PPI networks are strongly biased towards well studied proteins e.g. 
proteins involved in the immune response. In Chapter 3 of this thesis, I examine genes 
induced in expression after infection of A549 cells with HMPV and other pathogens. 
I describe a novel method called Physical Interaction Enrichment which determines 
the significance of a context-specific PPI network derived from a general PPI network. 
I discovered that in spite of the enrichment of immune-related proteins and their protein 
interactions in general PPI networks, the PPI network of HMPV-induced genes have 
significantly more interactions among them than randomly selected proteins. In 
addition, I show that such networks can be used to predict genes that would be induced 
by HMPV at later time points of infection, thus helping to uncover genes downstream 
pathways activated upon HMPV infection.
3.3  Chapter 4
As most living things, microbial pathogens are in search for shelter and nutritional 
resources; often in detriment to their host. A well known micronutrient that is essential 
for the metabolism of both host-cells and microbes is iron. During infection, invading 
pathogens compete for iron and iron-related resources with the host cells. However, it 
is largely unknown how host innate-immune cells strategize their iron distribution to 
function as immune effectors, yet keeping the iron pools from being used by the 
invading pathogens. In Chapter 4 of this thesis, I describe a new method called Iron 
Squelch which I used to analyse the transcriptomic gene response to infection with 
respect to the response of the same genes to iron-overload or iron-depletion. Using this 
analytical method, I reveal the following: (1) The transcriptomic profiles of host 
innate-immune cells infected with HMPV, RSV, PIV, MV and Chlamydia pneumoniae 
(representing intracellular parasites),  but not Pseudomonas aeruginosa and E. coli 
(representing extracellular pathogens),  resembles that of iron-depleted cells. (2) The 
iron-depletion prole was also triggered by inactivated intracellular pathogens, 
suggesting that it is likely a basic cellular response to the pathogen material. (3)  An 
iron-depletion profile was induced when host innate-immune cells were treated with 
interferon gamma, a common cytokine produced by the host cells upon intracellular 
pathogen infection. This first of all suggests that iron-depletion is a likely phenotype of 
21
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host-cells infected with intracellular pathogens. Secondly, iron-depletion in infected 
innate-immune cells could be interferon-mediated and could be an important innate 
immune strategy of the respiratory tract. I further propose that iron-homeostasis might 
be important in co-infections during which, depending upon the colonized host- 
subcellular compartment, microbes might trigger host-iron redistribution away or into 
their niches, leading to disease amelioration or severity. 
3.4  Chapter 5
MicroRNAs are gene products that are not translated into proteins but may stall protein 
translation by binding to the cognate mRNAs of proteins or degrade the mRNAs. 
In Chapter 5 of this thesis, we identify microRNAs that are over-expressed in dendritic 
cells during their maturation from monocytes. The pathogenic material used in this 
maturation process was LPS which serves in the context of this thesis as a model to 
represent bacteria. Dendritic cells are antigen presenting cells that link innate immunity 
with adaptive immunity. In addition to identifying microRNAs and their target genes 
that could be important in DC dierentiation from their monocyte precursors, I also 
identified binding sites for transcription factors that potentially regulate the expression 
of the identified microRNAs. The results and data presented would serve as an important 
resource to help understand the biology of these important antigen-presenting cells.
3.5  Chapter 6
To combat bacterial infection, neutrophils are the immune cells of choice. In Chapter 6 of 
this thesis, we examine LPS-induced changes in neutrophils extracted from whole 
blood of 4 healthy LPS-infused volunteers. In addition to writing the manuscript with 
the co-authors, I analyzed the post normalized microarray data set. I report genes that 
follow various temporal kinetic patterns. As an example, I reveal CD177, a neutrophil 
specific antigen, as the most persistently up-regulated gene post LPS infusion. I 
performed Gene Ontology analyses on the gene sets and discovered that genes that 
were up-regulated at all 3 time points investigated are mainly enriched in “inflammatory 
response”, “anti-apoptosis” and “defense response”. Meanwhile, genes that were 
down-regulated at all time points after LPS infusion were enriched in “lymphocyte 
activation”. These observations correlate  with the clinical parameters observed in the 
infected volunteers in whom neutrophilia and lymphocytopenia were observed after 
LPS infusion. I also applied the PIE approach to the context-specific networks derived 
from integrating HPRD data with the LPS-induced up- or down-regulated gene sets and 
found them to be physically cohesive. In addition, I provide PPI networks to show the 
temporal interactions between proteins of genes that are up-regulated or down- 
regulated post LPS infusion. We further provide and discuss lists of prioritized genes as 
a resource to help understand temporal changes induced by LPS upon neutrophils and 
likely molecular events underpinning immune responses to bacterial endotoxins.
22
3.6  Chapter 7
I round up in Chapter 7 with a summary discussion of the thesis, a brief discussion of 
events at the interface between host and pathogens, and future directions of 
immunological genomics.
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Abstract
Respiratory virus infections are among the primary causes of morbidity and mortality in
humans. Influenza virus, respiratory syncytial virus (RSV), parainfluenza (PIV) and human 
metapneumovirus (hMPV) are major causes of respiratory illness in humans. Especially 
young children and the elderly are susceptible to infections with these viruses. In this 
study we aim to gain detailed insight into the molecular pathogenesis of respiratory 
virus infections by studying the protein expression profiles of infected lung epithelial 
cells. A549 cells were exposed to a set of respiratory viruses [RSV, hMPV, PIV and Measles 
virus (MV)] using both live and UV-inactivated virus preparations. Cells were harvested 
at different time points after infection and processed for proteomics analysis by 
2-dimensional difference gel electrophoresis. Samples derived from infected cells were 
compared to mock-infected cells to identify proteins that are differentially expressed 
due to infection. We show that RSV, hMPV, PIV3, and MV induced similar core host 
responses and that mainly proteins involved in defense against ER stress and apoptosis 
were affected which points towards an induction of apoptosis upon infection. By 2-D 
DIGE analyses we have gathered information on the induction of apoptosis by 
respiratory viruses in A549 cells.
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1. Introduction
Respiratory viruses are a major cause of lower respiratory tract infections and are among 
the primary causes of morbidity and mortality in humans. These infections are a major 
public health problem. Especially infants and young children as well as the elderly are 
prone to severe and even fatal outcome of infections with respiratory viruses such as 
Influenza virus, RSV, PIV, and human hMPV [1–5]. In young children and infants, RSV is the 
primary etiologic agent of epidemic lower respiratory tract infections being responsible 
for 80% of cases of acute bronchiolitis [6, 7]. For RSV extensive vaccine-related research 
has been performed, but so far no efficient and widely applicable vaccine has been 
developed yet. Also for the recently discovered hMPV [8], which is closely related to RSV, 
no vaccine is currently available. Only for MV an effective vaccine is available and for 
classical Influenza vaccines are available but these need further improvement. 
RSV, hMPV, PIV and MV belong to the Paramyxoviridae family of viruses. These are all 
enveloped viruses and have a linear, non-segmented, single stranded negative sense 
RNA of ~15,000 nucleotides containing 10 genes encoding 10 (RSV) proteins, 13kb 
containing 8 genes (hMPV), ~15,500 nucleotides containing 6 genes (PIV), and 15.9kb 
containing 6 genes (MV), respectively [9]. All these viruses enter the host via the 
respiratory tract by infecting airway epithelial cells that line the nose as well as the large 
and small airways and induce inflammation associated with the disease at the site of 
infection with the exception of MV that disseminates beyond the respiratory tract [9].
Although respiratory cells are the first targets of respiratory virus infection, they are also 
the first line of defense in the innate immune response that is generated upon infection 
[10]. Epithelial cells form a direct physical barrier between the host and the environment, 
the epithelial cells are able to detect invading pathogens and actively participate in the 
innate immune response to invading viruses e.g. by producing acute phase proteins 
and inflammatory cytokines and chemokines [10–12]. Depending on the location in the 
lung, there are different types of epithelial cells that respond to invading pathogens in 
a cell type specific manner due to varying expression of pattern recognition receptors, 
cell-specific protein expression, or to differences in susceptibility to injury. These 
responses can result in killing of the pathogen by recruitment of phagocytes that can 
not only directly kill the invading pathogens but also shape the adaptive immune 
response to viral infection.
However, little is known about the exact mechanisms underlying the induction and 
maturation stages of innate and adaptive anti-viral immune responses. Also the 
interaction between the virus and the host at the molecular level is not well understood. 
A better understanding of these events is required for the development of new 
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strategies for treatment and prevention of these infectious diseases. In this study we 
describe the effect of respiratory virus infection (RSV, hMPV, PIV and MV) on protein 
expression levels in type II alveolar A549 human epithelial cells by 2-D DIGE analyses at 
different time points after infection to gain detailed insight into the interaction between 
the viruses and the host cells and to explore differences in induced protein expression 
changes between different respiratory viruses. A549 cells are frequently used for in vitro 
infection with RSV and all four viruses are capable of infecting these cells making it a 
suitable in vitro model for comparing protein expression profiles between RSV, hMPV, 
PIV, and MV [12–17]. We show that a similar core host response was induced by the 
different viruses that were studied, and that RSV, hMPV, PIV3, and MV mainly affect 
proteins involved in defense against ER stress and apoptosis which points towards an 
induction of apoptosis upon infection.
2. Materials and Methods
2.1  Chemicals and reagents
Fluorescent minimal labeling CyDyes and IPG buffer pH3–10 were purchased from GE 
Healthcare (Roosendaal, The Netherlands). Urea, thiourea, Tris, iodoacetamide, trifluoro-
acetic acid (TFA), phosphoric acid, acetone, glycerol, acetonitrile, ammonium bicarbonate, 
CHAPS, L-lysine, and porcine modified trypsin were all from Merck (Amsterdam, The 
Netherlands), DTT from Sigma-Aldrich (Zwijndrecht, The Netherlands), DHS from Fluka, 
Trizol from Invitrogen (Breda, The Netherlands), TEMED, low melting temperature 
agarose (LMT), ammoniumpersulphate and Coomassie Brilliant Blue R-250 from BHD 
(Amsterdam, The Netherlands), and acrylamide from Nation Diagnostics (Hessle, UK).
2.2  Cells and viruses
The human lung adenocarcinoma epithelial cell line A549 and (American Type Culture 
Collection (ATCC; CCL-185), Manassas, VA, USA) and the Vero-118 cell line (a gift from B.G. 
van den Hoogen) were cultured at 37 °C with 5% CO2 in respectively HAM F12 medium 
(GIBCO) supplemented with 3% heat-inactivated fetal calf serum (FCS, Hyclone) and 
Iscove’s Modified Dulbecco’s Medium (IMDM, GIBCO) supplemented with either 0.02% 
trypsin and 3% bovine albumin fraction Vmedium (for hMPV infection) or 10% FCS (for 
RSV, PIV, and MV infections).All media were also supplemented with penicillin (100 U/ml; 
BioWhittaker), streptomycin (100 μg/ml; BioWhittaker) and L-glutamin (2mM; 
BioWhittaker). High titer stocks from hMPV(NL/1/00, a gift from B.G. van den Hoogen), 
RSV-A2 (ATCC; VR1540), PIV3 (ATCC; VR-93), and MV-Edm (ATCC; VR-24) were grown on 
Vero-118 cells using a serial limiting dilution protocol according to Gupta et al. [18]  and 
used to infect A549 cells. From all virus stocks inactivated virus preparations were 
produced by UV-irradiation using an Uvitec ultraviolet transilluminator (312 nmwavelength).
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2.3  In vitro infection experiments
A549 cells were seeded at a density of 3×105 cells/well in a 6-well plate and were 
allowed to adhere overnight. Live or UV-inactivated virus preparations (same dilution 
from the original high tittered stocks) were added to the cells at a multiplicity of 
infection of 3 to 10. At 60 min after infection the virus-containing serum free medium 
was removed and replaced by a fresh HAM F12 medium (containing 3% FCS) and cells 
were incubated at 37 °C. For the mock-infected cells a medium containing no virus was 
added to the cells. At 6, 12, and 24 h after infection the cells were washed once with 
pre-warmed PBS and the cells were lysed in 1 ml Trizol and stored at −80 °C. These 
infection experiments were performed in duplicate on different days for analysis of 
biological replicates.
2.4  Protein isolation
Proteins were isolated from the remaining interphase and organic phase that remain 
after RNA extraction from Trizol samples. Four volumes of ice-cold (−20 °C) acetone 
were added to these fractions and incubated at −20 °C for 1 h. Precipitated proteins 
were then centrifuged at maximum speed for 5min. The protein pellet was washed 
twice with ice-cold 80% acetone. The pellet was air-dried and suspended in milliQ. 
Protein concentration in each sample was determined using a 96-well plate based BCA 
assay (Pierce) according to the manufacturer’s instructions.
2.5  Protein labeling
A total amount of 25 μg protein was taken from each sample and dried in a vacuum 
concentrator. The protein pellets were dissolved in 10 μl lysis buffer (30 mM Tris, 7 M 
urea, 1 M thiourea, and 4% CHAPS) and were snap frozen five times to completely 
dissolve the protein pellet. Per 25 μg protein 200 pmol fluorescent minimal labeling 
CyDye was added according to the scheme depicted in Table 1 and incubated on ice for 
30 min in the dark. 1 μl 10mM L-lysine was added to each sample and was incubated for 
15 min in the dark to stop the labeling reaction. Labeled samples were stored at −20 ° 
until use.
2.6  2-D gel electrophoresis
Samples to be run on the same gel were combined (Table 1) and used for rehydration 
of 18 cm Immobiline Dry Strips pH4–7 (GE Healthcare). A volume of 310 μl rehydration 
buffer (7 M urea, 2 M thiourea, 4% CHAPS, 1.2% IPG buffer pH3–10, and 2 mg/ml DTT) 
was added to the combined samples and applied to the strips using a rehydration tray. 
After an overnight rehydration the proteins were separated in the first dimension using 
a Multiphor II (3 h 300 V followed by a gradual increase by 300 V every 20 min until a final 
voltage of 2200 was reached). After complete focusing (±30 kVh), the strips were 
equilibrated in 0.5% DTT in equilibration buffer (100 mM Tris pH8.8, 6 M urea, 30% 
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glycerol, and 2% SDS) for 10 min followed by 4.5%  iodoacetamide in equilibration buffer 
for 10 min. The strips were then applied to a 12–20% gradient polyacrylamide gel that 
had been made the day before using low-fluorescent glass plates. The strips were fixed 
using a 1% LMT solution and the proteins were directly separated overnight in the 
second dimension using an Ettan Dalt Six (GE Healthcare) at 10 °C and 2W per gel.
2.7  Scanning and image analysis
Gels were scanned on a Typhoon 9410 (Amersham Biosciences) at excitation wavelengths 
of 488, 532, and 633 nm and 520BP40, 580BP30, and 670BP30 emission filters Cy2, Cy3, 
and Cy5, respectively. For the comparative analyses per time point only those protein 
spots were included that were present in all of the gels to be compared for a certain 
virus or time point. Statistical analysis and quantitative protein expression were done 
using Decyder Analysis BVA software (Amersham Biosciences) and protein spots were 
considered significantly differential at a p-value of <0.01 and a fold change of at least 2.5.
2.8  Mass spectrometry and protein identification
For identification of protein spots a preparative gel containing 500 μg protein was run 
as described in section 2.6 and stained with Coomassie Brilliant Blue R-250. Protein spots 
Table 1 - Experimental setup for 2-D DIGE experimentsa.
 Gel number  Cy3  Cy5  Cy2 
 1–2  Mock t=0  Mock t=6  A549 mock 
 3–4  Mock t=12  Mock t=24  A549 mock 
 5–6  RSV+UV t=6  RSV−UV t=6  A549 mock 
 7–8  RSV+UV t=12  RSV−UV t=12  A549 mock 
 9–10  RSV+UV t=24  RSV−UV t=24  A549 mock 
 11–12  hMPV+UV t=6  hMPV−UV t=6  A549 mock 
 13–14  hMPV+UV t=12  hMPV−UV t=12  A549 mock 
 15–16  hMPV+UV t=24  hMPV−UV t=24  A549 mock 
 17–18  PIV+UV t=6  PIV−UV t=6  A549 mock 
 19–20  PIV+UV t=12  PIV−UV t=12  A549 mock 
 21–22  PIV+UV t=24  PIV−UV t=24  A549 mock 
 23–24  MV+UV t=6  MV−UV t=6  A549 mock 
 25–26  MV+UV t=12  MV−UV t=12  A549 mock 
 27–28  MV+UV t=24  MV−UV t=24  A549 mock 
a 50 μg protein from each sample was labeled with fluorescent CyDyes as indicated.
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of interest were manually excised from the gel and digested with trypsin. Peptides were 
extracted using 2% TFA and were desalted and concentrated using C
18
 StageTips. 
Peptide mixtures were purified and desalted using C
18
 StageTips. Peptide separation 
and sequence determination were performed with a nano-high performance liquid 
chromatography system (Agilent 1100 series, Amstelveen, The Netherlands) connected 
to a 7-T linear quadrupole ion trap-ion cyclotron resonance Fourier transform mass 
spectrometer (Thermo Electron, Breda, The Netherlands). Peptides were separated on a 
15-cm 100-μm inner-diameter PicoTip emitter for online electrospray (New Objective, 
Woburn, MA) packed with 3 μm C
18
 beads (Reprosil, Dr. Maisch GmbH, Ammerbuch-
Entringen, Germany) with a 60-minute linear gradient from 2.4 to 40% acetonitrile in 
0.5% acetic acid at a 300 nl/min flow rate. The four most abundant ions were sequentially 
isolated and fragmented in the linear ion trap by applying collisionally induced 
dissociation. Proteins were identified using the MASCOT search engine (Matrix science, 
London, UK) against the human protein NCBI database using the following search 
criteria: 20 ppm peptide tolerance, a maximum of 2 missed cleavages, a fixed carbami-
domethyl modification of cysteines, and variable oxidation (M) and deamidation (NQ) 
modification.
2.9  Molecular network analyses
The global protein–protein interaction (PPI) network used (herein referred to as galaxy 
6) was built from an accumulation of human-curated PPIs obtained from the 
Biomolecular Interaction Network Database (BIND) (data downloaded in October 2006), 
the Human Protein Reference Database (HPRD) (data of release 6th of January 2007), the 
IntAct database (downloaded in May 2007), the Molecular Interactions Database (MINT) 
(downloaded in May 2007), and the PDZBase database (downloaded in May 2007). All 
PPI networks were drawn using Cytoscape. The Gene Ontology (GO) database used was 
downloaded from NCBI in February 2008. Gene enrichment analyses were done using 
BINGO [19]. Protein enrichment analyses were done using in-house python scripts.
3. Results and Discussion
3.1  2-D DIGE analyses
To study the epithelial responses upon respiratory virus encounter and infection, A549 
cells were exposed to different respiratory viruses (RSV, hMPV, PIV and MV). Both live and 
UV-inactivated virus preparations were used thus allowing distinction between live, 
replicating, virus-induced changes in protein expression and changes induced upon 
contact with or uptake of non-replicating virus particles. At different time points after 
infection, the cells were lysed and used for protein expression analysis by 2-D DIGE and 
quantitative and comparative DeCyder analyses. Approximately 1000 spots were 
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detected in the individual gels. Of these, 325 were present in at least 20 out of 28 gels 
and could be used for statistical and comparative analyses. For the comparative analyses 
per time point only those protein spots were included that were present in all of the 
gels to be compared for a certain virus or time point. Upon infection with either one of 
the respiratory viruses or mock, a total of 70 spots showed differential expression in at 
least one of the time points after infection (Fig. 1A). Differentially expressed spots were 
manually excised from a preparative gel and were analyzed by nano-LC FT-ICR-MS to 
identify the proteins. Of the 70 spots that were picked for analysis we were able to 
identify the corresponding protein in 63 samples. This resulted in the positive 
identification of 55 unique proteins (Table 2). These proteins were shown to be mostly 
involved in cellular structures, stress responses, protein biosynthesis and modification, 
transcription, and trafficking (Fig. 1B).
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Figure 1 -  Preparative gel image (A) and functional classification (B) of protein spots 
that showed differential expression upon respiratory virus infection of 
A549 cells compared to mock at 6, 12 or 24 h after infection.
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Table 2 - Dierentially expressed spots.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
Cytoskeleton/structural proteins 
311 125,000 5.3 O43707 Alpha-actinin 4 ACTN4 26 34.9 1021  −2.65,−3.25 
323 150,500 6.48 P18206 Vinculin VCL 6 5.6 187 −4.39,−2.54
390 115,000 4.53 O43707 Alpha-actinin 4 ACTN4 12 12.5 431 −2.84,– 
396 110,000 4.35 O43707 Alpha-actinin 4 ACTN4 13 14.4 410 −2.81,– –,−6.52 
577 95,000 6.2 P02545 Lamin A/C 
(70 kDa lamin) 
LMNA 20 32.4 828 –,8.46 
578 97,500 6.6 P35241 Radixin RDX 48 75.8 1545 –,11.12 –,−2.14 2.82,– 3.82,– 
615 97,500 6.8 P02545 Lamin A/C 
(70 kDa lamin) 
LMNA 33 51.2 1143 2.41,– 
629 80,000 5.25 P20700 Lamin B1 LMNB1 37 55.5 1313 −4.22,−6.17
841 52,000 5 Q13509 Tubulin beta-3 chain TUBB3 16 40.9 767 3.08,2.38 
844 53,000 4.85 P07437 Tubulin beta-2 chain TUBB 5 14.6 241 4.69,4.70 
Cell cycle  
129 180,000 5.1 Q14978 Nucleolar phosphoprotein 
p130 
NOLC1 3 3.6 95  −3.75,– 
Vesicular trafficking/transport  
182 190,000 5.58 Q15075 Early endosome antigen 1 EEA1 9 5.2 362 −3.69,– 
187 190,000 5.65 Q15075 Early endosome antigen 1 EEA1 2 1.3 72 −5.22,– 2.17,– 
423 125,000 6.6 Q05193 Dynamin-1 DNM1 28 28.6 943  −2.04,– 3.54,– 
674 75,000 5.6 Q96HE7 ERO1-like protein alpha 
(precursor)
ERO1L 11 26.1 378  −7.68,– 
689 77,500 5.08 Q9UNF0 Protein kinase C and 
casein kinase substrate in 
neurons protein 2
PACSIN2 12 23 413  –,−3.78
Mitochondrion  
522 95,000 5.55 P28331 NADH-ubiquinone 
oxidoreductase 75kDa 
subunit
NDUFS1 16 27.6 753   7.06,– 
1157 41,000 5.85 Q9HB07 MYG1 protein C12ORF10 4 12.2 165 2.92,2.50 
Transcription/RNA processing  
197  175,000 5.83 Q00839 Heterogeneous 
ribonucleoprotein U
HNRPU 1 1 36 –,9.11  −2.08,– 
253 150,000 4.88 Q15029 116 kDa U5 small 
ribonucleoprotein 
component 
EFTUD2 5 5.5 188  −2.76,– 
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Table 2 - Continued.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
311 125,000 5.3 P19338 Nucleolin NCL 21 24.1 923  −2.65,−3.25
566 100,000 6.83 Q8TCS8 Polyribonucleotide 
nucleotidyltrans-ferase 1,
PNPT1 43 54 1336  10.85,13.72 
745 70,000 5.13 P61978 Heterogeneous 
ribonucleoprotein K 
HNRPK 10 23.8 412 3.71,–  
DNA repair and maintenance  
482  105,000 5.5 P49959 Double-strand break 
repair protein MRE11A 
MRE11A 5 6.8 219  5.04,5.41 7.06,– 
486 105,000 5.63 P13010 ATP-dependent DNA 
helicase II, 
80 kDa subunit 
XRCC5 6 8.7 258 3.29,3.70  
525  105,000 5.75 P13010 ATP-dependent DNA 
helicase II, 
80 kDa subunit
XRCC5 27 51.6 1061 2.52,2.44   
799 60,000 4.85 P54727 UV excision repair protein 
RAD23 homolog B
RAD23B 14 34 436 4.33,– 
Protein biosynthesis and modification 
425 130,000 6.98 P13639 Elongation factor 2 EEF2 44 46.6 1646 −2.62,– 
428 130,000 6.8 P13639 Elongation factor 2 EEF2 22 25.3 785 −4.37,−4.24
576 80,000 4.08 P41250 Glycyl-tRNA synthetase GARS 2 2.8 86 –,−2.99 
577 95,000 6.2 P41250 Glycyl-tRNA synthetase GARS 27 34.8 885 –,8.46 
707 63,000 4.58 P07237 Protein disulfide-
isomerase precursor
P4HB 2 4.1 85 –,−2.50 2.13,– 2.55,– 
1101 44,500 6 Q9Y570 Protein phosphatase 
methylesterase 1
PPME1 9 26.7 345 –,2.90  
1497 28,500 6.48 O15305 Phosphomannomutase 2 PMM2 13 49.2 442  −2.71,– 
Protein degradation 
311 125,000 5.3 P55072 Transitional endoplasmic 
reticulum ATPase
VCP 20 27.9 710  −2.65,−3.25 
311 125,000 5.3 Q9UBT2 SUMO-activating enzyme 
subunit 2 
SAE2 14 18.4 476  −2.65,−3.25 
692 75,000 5.65 Q9H4A4 Aminopeptidase B RNPEP 19 36.9 689  −3.03,– 
1566 24,500 5.3 P61086 Ubiquitin-conjugating 
enzyme E2-25 kDa
HIP2 6 31.5 187  5.19,– 
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745 70,000 5.13 P61978 Heterogeneous 
ribonucleoprotein K 
HNRPK 10 23.8 412 3.71,–  
DNA repair and maintenance  
482  105,000 5.5 P49959 Double-strand break 
repair protein MRE11A 
MRE11A 5 6.8 219  5.04,5.41 7.06,– 
486 105,000 5.63 P13010 ATP-dependent DNA 
helicase II, 
80 kDa subunit 
XRCC5 6 8.7 258 3.29,3.70  
525  105,000 5.75 P13010 ATP-dependent DNA 
helicase II, 
80 kDa subunit
XRCC5 27 51.6 1061 2.52,2.44   
799 60,000 4.85 P54727 UV excision repair protein 
RAD23 homolog B
RAD23B 14 34 436 4.33,– 
Protein biosynthesis and modification 
425 130,000 6.98 P13639 Elongation factor 2 EEF2 44 46.6 1646 −2.62,– 
428 130,000 6.8 P13639 Elongation factor 2 EEF2 22 25.3 785 −4.37,−4.24
576 80,000 4.08 P41250 Glycyl-tRNA synthetase GARS 2 2.8 86 –,−2.99 
577 95,000 6.2 P41250 Glycyl-tRNA synthetase GARS 27 34.8 885 –,8.46 
707 63,000 4.58 P07237 Protein disulfide-
isomerase precursor
P4HB 2 4.1 85 –,−2.50 2.13,– 2.55,– 
1101 44,500 6 Q9Y570 Protein phosphatase 
methylesterase 1
PPME1 9 26.7 345 –,2.90  
1497 28,500 6.48 O15305 Phosphomannomutase 2 PMM2 13 49.2 442  −2.71,– 
Protein degradation 
311 125,000 5.3 P55072 Transitional endoplasmic 
reticulum ATPase
VCP 20 27.9 710  −2.65,−3.25 
311 125,000 5.3 Q9UBT2 SUMO-activating enzyme 
subunit 2 
SAE2 14 18.4 476  −2.65,−3.25 
692 75,000 5.65 Q9H4A4 Aminopeptidase B RNPEP 19 36.9 689  −3.03,– 
1566 24,500 5.3 P61086 Ubiquitin-conjugating 
enzyme E2-25 kDa
HIP2 6 31.5 187  5.19,– 
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Table 2 - Continued.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
Metabolism  
538 100,000 6.7 Q06210 Glucosamine-
fructose-6-phosphate 
aminotransferase 
GFPT1 12 16.5 376  5.62,4.88 3.48,– 
753 75,000 6.48 P31939 Bifunctional purine 
biosynthesis protein PURH 
ATIC 6 10.3 181  −2.42,−2.74 
898 57,500 6.38 P30838 Aldehyde 
dehydrogenase,dimeric 
NADP-preferrin 
ALDH3A1 9 17.5 308  –,2.13 
1543 27,000 6.7 P60174 Triphosphate isomerase TPI1 2 10 74  3.04,2.70 
Stress response/molecular chaperones 
397  125,000 5.9 P07900 Heat shock protein HSP 
90-alpha
HSP90AA1 26 33.5 1056 4.48,5.95  
519 97,500 5.53 P11142 Heat shock cognate 71 
kDa protein
HSPA8 4 6.3 130  –,5.83 
554 90,000 5.05 P11021 78 kDa glucose-regulated 
protein (precursor)
HSPA5 47 77.5 2001 −2.23,−3.01  
631 80,000 4.95 P11142 Heat shock cognate 71 
kDa protein 
HSPA8 15 25.4 471  –,−2.89
719 77,500 6.35 P49368 T-complex protein 
1,gamma subunit
CCT3 38 69 1292  −2.38,– 
726 63,000 4.3 P49368 T-complex protein 
1,gamma subunit
CCT3 7 9.7 219  −4.32,– 
737 70,000 5.63 P48643 T-complex protein 
1,epsilon subunit
CCT5 38 71 1300 −2.15,−2.46  
767 72,500 6.45 P40227 T-complex protein 1,zeta 
subunit
CCT6A 16 25.6 569  −4.90,−2.91
1809 17,000 6.3 P02763 Alpha-1-acid glycoprotein 
1 (precursor)
ORM1 5 27.4 172  –,6.85 
Apoptosis 
353 135,000 6.3 Q8WUM4 Programmed cell death 
6-interacting protein 
PDCD6IP 31 39.1 1297 −3.42,−2.40 −3.29,–  −2.43,– 
791 17,000 4.88 Q15121 Astrocytic 
phosphoprotein PEA-15
PEA15 2 18.5 81  −2.68,– 
Other/unknown function 
616 74,000 5.33 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 6 11.4 201 –,−3.00 
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Table 2 - Continued.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
Metabolism  
538 100,000 6.7 Q06210 Glucosamine-
fructose-6-phosphate 
aminotransferase 
GFPT1 12 16.5 376  5.62,4.88 3.48,– 
753 75,000 6.48 P31939 Bifunctional purine 
biosynthesis protein PURH 
ATIC 6 10.3 181  −2.42,−2.74 
898 57,500 6.38 P30838 Aldehyde 
dehydrogenase,dimeric 
NADP-preferrin 
ALDH3A1 9 17.5 308  –,2.13 
1543 27,000 6.7 P60174 Triphosphate isomerase TPI1 2 10 74  3.04,2.70 
Stress response/molecular chaperones 
397  125,000 5.9 P07900 Heat shock protein HSP 
90-alpha
HSP90AA1 26 33.5 1056 4.48,5.95  
519 97,500 5.53 P11142 Heat shock cognate 71 
kDa protein
HSPA8 4 6.3 130  –,5.83 
554 90,000 5.05 P11021 78 kDa glucose-regulated 
protein (precursor)
HSPA5 47 77.5 2001 −2.23,−3.01  
631 80,000 4.95 P11142 Heat shock cognate 71 
kDa protein 
HSPA8 15 25.4 471  –,−2.89
719 77,500 6.35 P49368 T-complex protein 
1,gamma subunit
CCT3 38 69 1292  −2.38,– 
726 63,000 4.3 P49368 T-complex protein 
1,gamma subunit
CCT3 7 9.7 219  −4.32,– 
737 70,000 5.63 P48643 T-complex protein 
1,epsilon subunit
CCT5 38 71 1300 −2.15,−2.46  
767 72,500 6.45 P40227 T-complex protein 1,zeta 
subunit
CCT6A 16 25.6 569  −4.90,−2.91
1809 17,000 6.3 P02763 Alpha-1-acid glycoprotein 
1 (precursor)
ORM1 5 27.4 172  –,6.85 
Apoptosis 
353 135,000 6.3 Q8WUM4 Programmed cell death 
6-interacting protein 
PDCD6IP 31 39.1 1297 −3.42,−2.40 −3.29,–  −2.43,– 
791 17,000 4.88 Q15121 Astrocytic 
phosphoprotein PEA-15
PEA15 2 18.5 81  −2.68,– 
Other/unknown function 
616 74,000 5.33 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 6 11.4 201 –,−3.00 
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3.2  Respiratory virus-induced changes in protein expression
Upon infection of A549 cells with the 4 different respiratory viruses, there were 21, 18, 19 
and 17 spots that showed differential expression upon infection with RSV, hMPV, PIV or 
MV, respectively, compared to mock-infected cells at 6, 12 or 24 h after infection (Table 
2). RSV, hMPV, PIV and MV belong to the family of the Paramyxoviridae and are related to 
each other yet inducing distinct disease phenotypes. What became apparent from the 
2-D DIGE analyses is that RSV and hMPV infected cells showed slightly more induced 
changes in protein expression than the PIV and Measles virus-infected cells. Also no 
Table 2 - Continued.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
620 72,000 4.43 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 5 8.7 185 –,−2.96 
627 72,000 4.5 P02765 Alpha-2-HS-glycoprotein 
(precursor)
(Fetuin-A)
AHSG 5 8.7 168 –,−3.56 
641 85,000 6.13 O95671 N-acetylserotonin 
O-methyltrans-ferase-like
ASMTL 13 24.3 456 3.23,3.10 
706 63,000 4.53 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 5 8.7 156 –,−2.66 
784 55,000 4.63 Q9H8Y8 Golgi reassembly stacking 
protein 2 
GORASP4 2 2.8 62  2.81,−5.23 
1174 40,000 5.6 P06748 Nucleophosmin NPM1 5 23.5 158  4.90,3.31 
Unidentified  
120 N/A N/A N/A N/A N/A –,13.75  2.35,– 
174 N/A N/A N/A N/A N/A  –,2.34 
281 N/A N/A N/A N/A N/A  –,2.43 
475 N/A N/A N/A N/A N/A  –,2.63 
630 N/A N/A N/A N/A N/A 2.57,3.14  
1359 N/A N/A N/A N/A N/A 2.99,2.02 
1370 N/A N/A N/A N/A N/A –,6.85 
a,b  Fold changes in protein expression upon infection with live (a) and UV-inactivated (b) virus particles.  
Only significant changes are shown.
–: not significantly changed.
43
Quantitative proteome profiling of respiratory virus-infected lung epithelial cells
2
clear differences were found in direct comparisons between protein samples from live 
and UV-inactivated virus-infected cells, indicative for a predominating general response 
upon virus encounter by A549 cells with no apparent effect of the replication on the 
proteome within the time frame of the experiment. In addition, only proteins with a 
high turn-over rate will show differential expression at earlier time points. An additional 
caveat regarding a non-ambiguous interpretation of the differential protein responses 
measured by 2-D DIGE is an accumulation of virus-induced changes in addition to 
host cellular defense responses upon encounter with the virus particles. Given the 
Table 2 - Continued.
Estimated FT-MS analysis  RSVa,b hMPVa,b PIVa,b MVa,b 
Spot  
nr.
Mass (Da) pI Protein ID Protein 
description 
Gene # Pept. Seq. 
cov. 
(%)
Protein
score
6 12 24 6 12 24 6 12 24 6 12 24
620 72,000 4.43 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 5 8.7 185 –,−2.96 
627 72,000 4.5 P02765 Alpha-2-HS-glycoprotein 
(precursor)
(Fetuin-A)
AHSG 5 8.7 168 –,−3.56 
641 85,000 6.13 O95671 N-acetylserotonin 
O-methyltrans-ferase-like
ASMTL 13 24.3 456 3.23,3.10 
706 63,000 4.53 P02765 Alpha-2-HS-glycoprotein 
(precursor) 
(Fetuin-A)
AHSG 5 8.7 156 –,−2.66 
784 55,000 4.63 Q9H8Y8 Golgi reassembly stacking 
protein 2 
GORASP4 2 2.8 62  2.81,−5.23 
1174 40,000 5.6 P06748 Nucleophosmin NPM1 5 23.5 158  4.90,3.31 
Unidentified  
120 N/A N/A N/A N/A N/A –,13.75  2.35,– 
174 N/A N/A N/A N/A N/A  –,2.34 
281 N/A N/A N/A N/A N/A  –,2.43 
475 N/A N/A N/A N/A N/A  –,2.63 
630 N/A N/A N/A N/A N/A 2.57,3.14  
1359 N/A N/A N/A N/A N/A 2.99,2.02 
1370 N/A N/A N/A N/A N/A –,6.85 
a,b  Fold changes in protein expression upon infection with live (a) and UV-inactivated (b) virus particles.  
Only significant changes are shown.
–: not significantly changed.
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observation that there were not many differences between live and UV-inactivated 
virus particles, the most likely effect is that of the cell upon encounter with the virus 
particles instead of the activity of the live replicating viruses.
Upon infection of A549 cells with RSV, eleven proteins were more abundant, 9 less 
abundant, and 1 more abundant at 6 h while less abundant at 24 h compared to 
mock-infected cells (Table 2). Most of these proteins are known to be involved in protein 
biosynthesis and modification, and cellular structures (Table 2 and Fig. 2A). A total of 18 
protein spots were differentially expressed in A549 cells upon encounter with hMPV, of 
which 7 were more abundant and 11 less abundant (Table 2 and Fig. 2B). A major part of 
the differentially expressed proteins are known to be involved in protein biosynthesis 
and modification, cellular stress responses, transcription or are cytoskeleton- or structural 
proteins. PIV infection showed more abundant expression in 12 protein spots, less 
abundant expression in 6 spots and 1 spot that was more abundant in live virus particles 
infected cells while less abundant in UV-inactivated virus-infected cells (Table 2 and 
Fig. 2C). Finally, MV showed less abundant expression in 8 spots and more abundant 
expression in 9 spots (Table 2 and Fig. 2D).
Figure 2 -  Functional classification of proteins that showed differential expression 
upon infection of A549 cells with respiratory viruses RSV (A), hMPV (B), PIV 
(C), and MV (D).
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In addition to functional annotations, we also used Ingenuity for functional analyses on 
these differentially expressed proteins and identified 34 molecular and cellular functions 
for these proteins. Most functions include cell death, cellular organization and function 
and morphology, posttranslational modifications and folding, and metabolism (Table 3, 
Fig. 1B). These analyses also showed that all 4 viruses affect these cellular processes 
similarly (Table 3).
Table 3  - Molecular and cellular functions of dierentially expressed proteins.
Molecular and cellular functions Number of proteinsa
All RSV hMPV PIV MV 
Cellular organization, morphology, function and proliferation 26 8 12 13 11
Cell death 22 7 14 10 10
Metabolism 11 4 5 6 7
Small molecule biochemistry 14 4 6 4 6
Molecular transport 8 3 5 4 5
Post-translational modification and folding 8 2 5 5 4
Cellular compromise 3 3 5 4 1
DNA replication, recombination, and repair 6 2 5 3 2
Cell-to-cell signaling and interaction 5 3 3 2 2
Gene expression 5 2 3 2
Protein synthesis 4 2 3 1 1
Cellular development 2 2 3
Infection mechanism 3 1 2 2
Cell signaling 1 1 3
Cell-mediated immune response 4 4
Protein Degradation 3 1 3
RNA post-transcriptional 3 1 1 1
modification 
RNA trafficking 1 1 1 1
Inflammatory response 3 1 1
Cellular movement 1 1 1
RNA damage and repair 2 1 1
Cellular response to therapeutics 1 1
Energy production 1 1
Free radical scavenging 1 1
aOnly significant changes are shown.
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3.3  Molecular network analyses
Results from the original GO network analysis (Fig. 3, arrow 1, result 1) show that many of 
the identified proteins (viral perturbed) are involved in apoptosis. To further explore the 
involvement of respiratory virus-induced or repressed proteins in the apoptosis pathway 
we performed a GO enrichment analysis as schematically depicted in Fig. 3A (arrows 2, 2a, 
and 3, result 2). The apoptosis network was extracted from the original GO network and 
was enriched for proteins known to interact with proteins involved in apoptosis resulting 
in the apoptosis N1 protein network (arrow 2b, Fig. 3A). When virus-perturbed proteins 
were analyzed using this database 100% of the proteins were recovered (arrow 4, result 3), 
thus indicating the involvement of these proteins in apoptosis, either directly or indirectly 
by interacting with proteins that are directly involved in apoptosis (Table 4). 
Since cytokines have been shown to be of great importance in respiratory virus infection 
and are known to be involved in apoptosis as well, we generated a new network from the 
apoptosis N1 network and the cytokine network from the original GO database together 
with the virus-perturbed proteins (cytokine and virus-perturbed network) and extracted 
the virus-perturbed N1 network (arrow 6, result 4). Analysis of the virus- perturbed proteins 
in this database revealed that 25–55% of these proteins are either proteins involved in 
apoptosis themselves or cytokines known to interact with these apoptosis proteins (Fig. 3B).
A substantial part of the proteins that were differentially expressed upon infection with 
either one of the different viruses are involved in apoptosis. To check whether this 
observation was not based on coincidence we performed another GO enrichment 
procedure for randomly selected proteins. Table 4 shows that the number of recovered 
proteins was significantly higher in the virus-perturbed than for the randomly selected
proteins, indicating that the proteins that were found differentially expressed are indeed 
mostly involved in apoptosis.
3.4  Functional pathway analyses
Ingenuity functional pathway analyses showed that a total number of 22 differentially 
expressed protein spots is considered to be involved in cell death and 26 in cellular 
organization, function and proliferation (Table 3). Ingenuity function analyses revealed 
that there is a great overlap between these molecular and cellular functions, since 
similar proteins were categorized in these two functional categories. Both categories 
include VCL, RDX, HSPA5, T-complex protein 1, HSPA90AA1,NDUFS1, NCL, PNPT1, 
XRCC5, ALDH3A1, PDCD6IP, and NPM1 and proteins that are cell death associated only 
LMNB1, TUBB3, RAD23B, EEF2, P4HB, VCP, HSPA8, and PEA15 (Table 5). The process of 
virus-induced apoptosis can be divided into 4 processes based on these proteins, namely, 
virus uptake and infection, stress response, disruption of cellular structures and cell death 
by apoptosis.
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Figure 3 -  GO enrichment analysis procedure (A) and protein–protein interactions (B) of 
differentially expressed proteins in respiratory virus-infected A549 cells. 
 The numbers on arrows in figure A represent the order in which the GO enrichment 
procedure was performed. Triangles in figure B represent proteins involved in apoptosis, 
nodes with dark bold borders are cytokines. Green nodes are proteins that were more 
abundant upon infection, while red nodes represent less abundant proteins.
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3.5  Virus uptake and infection
XRCC5 is the 86 kDa subunit of the Ku complex that is abundant in the nucleus and 
binds to DNA [20]. Ku was postulated to have a role in DNA repair or replication as it has 
been shown to bind to the termini of DNA fragments. It was shown previously that Ku86 
has a role in HIV1 and SV40 infection and our data suggest a role for this protein in RSV 
infection of A549 cells as well [21–23].
HSPA8 is a member of the HSP70 family of heat shock proteins and has been shown to 
be virus inducible showing highest expression during the S-phase of cell cycle [24] and 
is necessary for the entry of HTLV-I into its target cells [24, 25]. In hMPV and PIV infected 
A549 cells, HSPA8 is more abundant at 6 and 12 h respectively. This shows that hMPV is 
inducing expression in A549 cells early in infection while this response is somewhat 
slower in PIV infected cells.
3.6  Stress response proteins
Of the set of differentially expressed proteins described above, HSPA5, HSP90AA1, 
TUBB3, P4HB and VCP are all proteins that are involved in cellular stress responses 
preceding apoptosis. All these proteins were shown to be less abundant at 24 h after 
infection except for TUBB3, a member of the tubulin family of microtubule proteins that 
is also known to be involved in adaptation to oxidative stress and cellular survival 
[26–28]. More abundant expression of TUBB3, as observed in hMPV infected cells at 12 h 
suggests an initial mechanism for defense against oxidative stress which might 
eventually fail at 24 h after infection or points towards the blocking of cell cycle 
progression and induction of apoptosis [26,29,30].
Less abundant expression of the other 4 proteins also points towards apoptotic 
processes in A549 cells at 24 h after infection. The molecular chaperones HSPA5 and 
HSP90AA1 are involved in the ER stress response upon accumulation of unfolded 
proteins in the ER [31]. When the unfolded protein response is not correctly activated, 
cells die by apoptosis [32]. In contrast to some other viruses, hMPV induces a less 
abundant expression of HSPA5 protein expression in A549 cells at 24 h after infection 
[33–36], suggesting that the ER stress response is not correctly induced thus resulting in 
the subsequent induction of apoptosis in these cells. 
HSP90AA1 has a very important function in the folding of cell regulatory proteins and 
the refolding of stress-denatured polypeptides [37–39]. In hMPV infected A549 cells we 
observed an initial increase in HSP90AA1 expression at 12 h after infection which 
suggests a cellular response to hMPV-induced ER stress initiated by an increase of 
unfolded or misfolded proteins. Recently, an association between HSP90 protein 
complex and lamin A/C has been observed after oxidative stress [40]. Also in our hMPV 
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and PIV infected A549 cells we observe an increase in HSP90AA1 as well as lamin A/C 
suggesting a damaging oxidative stress response in these cells. The HSP90AA1-associated 
protein lamin A/C has been shown to be involved in viral infections being required for 
repressing HSV replication [41] and more abundant expression in hMPV and PIV infected 
A549 cells supports such a response upon infection.
The other lamin that was found to be differentially expressed upon hMPV infection is 
lamin B1 although in contrast to lamin A/C it was less abundant upon infection. Lamin 
B1 also plays an important role in the cellular response to oxidative stress [42]. As a 
consequence of less abundant expression of lamin B1, hMPV-infected cells might 
become more susceptible to oxidative stress and may result in subsequent cell death.
The molecular structure of P4HB is identical to that of the enzyme protein disulfide 
isomerase (PDI) which is known to protect cells against ER stress and inhibition of the 
protein will result in ER stress and subsequent induction of apoptosis [43–45]. P4HB is 
less abundant at 24 h after infection with RSV suggesting the induction of apoptosis in 
these cells. In hMPV and PIV infected cells this protein is more abundant at 6 h after 
infection suggesting the initiation of a protective response against ER stress.
VCP is involved in many cellular processes such as protein degradation and membrane 
fusion and has chaperone activity. Less abundant expression of VCP expression has 
been shown to cause ER and oxidative stress and thereby induces apoptosis through 
caspase activation while more abundant expression results in anti-apoptotic responses 
[46]. VCP shows less abundant expression at 24 h after infection with hMPV and suggests 
the induction of apoptosis.
3.7  Disruption of cellular structures
CCT3, CCT5, and CCT6 are all part of the T-complex protein 1 that is involved in the 
folding of actin and tubulin as well as many other newly synthesized proteins [47,48]. 
Less abundant expression of CCT5 as observed in the hMPV, PIV and MV infected A549 
cells has also been described for enterovirus 71 infected cells and a role in the disruption 
of the cytoskeletal structure to aid viral replication was suggested [49]. A supportive 
finding for this disruption of cytoskeletal structure is that the F-actin cross-linking 
protein ACTN4 expression is less abundant at 24 h after infection thus facilitating viral 
replication [50]. A similar result was observed for PDCD6IP, a protein that has been 
shown to play a role in infection with enveloped viruses, like human immunodeficiency 
virus type 1 (HIV-1) [51–54]. In addition, PDCD6IP/AIP1 can associate with different 
cytoskeleton elements such as focal adhesion kinase and other cytoskeletal elements 
[55]. Less abundant expression of PDCD6IP as observed at 24 h after infection with RSV, 
hMPV and MV suggests the inhibition of cytoskeleton assembly [56].
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Vinculin (VCL) is a key regulator of focal adhesions that directly interacts with talin and 
actin and controls cell adhesion and migration. Interaction between VCL and the plasma 
membrane is essential for these processes [57]. Several viruses are known to disrupt or 
limit the function of these focal adhesions [58–60]. In glioblastoma cells, less abundant 
VCL expression is associated with induced apoptosis showing that disruption of the 
actin-VCL-cytoskeleton matrix is a major component of induced apoptosis in these cells 
[61]. Decreased expression of VCL by RSV infection in our experiment could suggest that 
the A549 cells have decreased adhesive and increased migratory capacities upon RSV 
infection, but might also suggest that apoptosis is induced in these cells.
Radixin (RDX) forms a complex with ezrin and moesin (ERM complex) that regulate 
membrane protein dynamisms and cytoskeleton rearrangements, are determinants in 
viral susceptibility, and are involved in apoptosis [62–64]. In RSV, PIV and MV infected A549 
cells; expression of RDX was shown to be more abundant at 6 h after infection suggesting 
an initial defense response to the virus. At 24 h after RSV infection, however, RDX expression 
was less abundant suggesting increased apoptosis in RSV infected A549 cells.
Nucleolin (NCL) is an abundant nucleolar protein that has been implicated in chromatin 
structure, rDNA transcription, rRNA maturation, ribosome assembly and nucleo-cyto-
plasmic transport [65]. NCL is also involved in the stabilization of the apoptosis 
suppressor BCL-2. Reduced expression of NCL results in BCL-2 mRNA instability and 
decreased levels of BCL-2 protein resulting in increased apoptosis [66–68]. NCL 
expression is less abundant upon infection with hMPV and thus also points towards 
induction of apoptosis in A549 cells.
Elongation factor 2 (EEF2) is a conserved monomeric GTPase involved in protein 
synthesis and translation elongation. This protein has been shown to have a role in HIV1 
infection as a regulator of apoptosis and host innate cellular responses against viral 
factors as over expression of the protein induces protection against HIV1 induced 
apoptosis. In RSV and hMPV infected A549 cells, EEF2 is strongly less abundant at 24 h 
post-infection suggesting that induced apoptosis is no longer being suppressed by this 
protein [69].
PEA15 is a 15-kDa phosphoprotein that can inhibit proliferation and that regulates the 
ability of BCL-2 to suppress Fas-induced apoptosis in a phosphorylation-dependent 
manner. In addition, PEA15 phosphorylation is mediated by the PTEN/PI3K pathway [70, 
71]. PEA15 is less abundant in MV infected cells at 6 h after infection, which suggests that 
proliferation and BCL-2-mediated suppression of Fas-induced apoptosis is intact and 
proliferation is not suppressed yet.
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4. Conclusions
The respiratory viruses RSV, hMPV, PIV and MV altered the expression of proteins involved 
in cell death that points towards an induction of apoptosis upon infection.  Induction of 
apoptosis in epithelial cells by RSV and hMPV has been described before and our 
findings of induced ER stress, Bcl-2 and p53-dependent apoptosis support these data 
[13–16]. In addition, we newly identified proteins that are altered by the viral infection 
and induce apoptosis in A549 cells. For some of the identified proteins a role in 
virus-induced apoptosis has been previously described for viruses other than the 
respiratory viruses that were used in this experiment. However, several proteins have 
been newly identified, which are considered to be involved in respiratory virus infec-
tion-induced apoptosis. This list of proteins is likely to be further extended by improving 
the 2-D DIGE analysis, i.e. by increasing the number of replicates in the analysis or by 
using a different internal standard. This might allow the analysis of additional proteins 
and might also reliably allow the identification of spots with minor changes in protein 
expression (FC<2.5). In addition, complementary (semi-)quantitative proteomics-based 
techniques such as ICAT, ITRAQ or label-free MS analyses are also expected to confirm 
and are likely to complement our current findings. These proteins are of interest for 
further exploration of respiratory virus-induced apoptosis and might be interesting 
targets for the development of future therapeutics or prevention strategies against 
these severe disease causing viruses.
Acknowledgements
This study was financially supported by the VIRGO consortium, an Innovative Cluster 
approved by the Netherlands Genomics Initiative and partially funded by the Dutch 
Government (BSIK 03012), The Netherlands.
Ta
bl
e 
5 
 - 
 Pr
ot
ei
ns
 in
vo
lv
ed
 in
 c
el
l d
ea
th
.
Sp
ot
 
nr
.
Pr
ot
ei
n 
ID
N
am
e
RS
Va
,b
 
hM
PV
a,
b 
PI
Va
,b
 
M
Va
,b
 
6
12
24
6
12
24
6
12
24
6
12
24
32
3
 P
18
20
6 
 V
CL
 
 
 −
4.
39
/−
2.
54
  
 
 
 
 
 
 
 
57
8
 P
35
24
1 
 R
D
X 
 –
/1
1.1
2 
 –
/−
2.
14
 
 
 
 2
.8
2/
– 
 
 
 3
.8
2/
– 
62
9
 P
20
70
0 
 L
M
N
B1
 
 
 
 
 
 −
4.
22
/−
6.
17
  
 
 
 
 
84
1
 Q
13
50
9 
 T
U
BB
3 
 
 
 
3.
08
/2
.3
8 
 
 
 
 
 
 
52
2
 P
28
33
1 
 N
D
U
FS
1 
 
 
 
 
 
 
 
 
 
 
 7
.0
6/
– 
31
1
 P
19
33
8 
 N
CL
 
 
 
 
 
 −
2.
65
/−
3.
25
  
 
 
 
 
56
6
 Q
8T
C
S8
 
 P
N
PT
1 
 
 
 
 
 
 
 
 1
0.
85
/1
3.
72
 
 
 
48
6
 P
13
01
0 
 X
RC
C
5 
3.
29
/3
.7
0 
 
 
 
 
 
 
 
 
 
 
52
5
 P
13
01
0 
 X
RC
C
5 
2.
52
/2
.4
4 
 
 
 
 
 
 
 
 
 
 
79
9
 P
54
72
7 
 R
A
D
23
B 
 
 
 4
.3
3/
– 
 
 
 
 
 
 
 
42
5
 P
13
63
9 
 E
EF
2 
 
 
 
 
 −
2.
62
/–
 
 
 
 
 
 
42
8
 P
13
63
9 
 E
EF
2 
 
 −
4.
37
/−
4.
24
  
 
 
 
 
 
 
 
70
7
 P
07
23
7 
 P
4H
B 
 
 –
/−
2.
50
 
 2
.13
/–
 
 
 2
.5
5/
– 
 
 
 
 
31
1
 P
55
07
2 
 V
CP
 
 
 
 
 
 −
2.
65
/−
3.
25
  
 
 
 
 
 
89
8
 P
30
83
8 
 A
LD
H
3A
1 
 
 
 
 
 
 
 
 
 
 
 –
/2
.13
 
39
7
 P
07
90
0 
 H
SP
90
A
A1
 
 
 
 
4.
48
/5
.9
5 
 
 
 
 
 
 
 
51
9
 P
11
14
2 
 H
SP
A
8 
 
 
 
 
 
 
 –
/5
.8
3 
 
 
 
 
55
4
 P
11
02
1 
 H
SP
A
5 
 
 
 
 
−2
.2
3/
−3
.0
1 
 
 
 
 
 
 
63
1
 P
11
14
2 
 H
SP
A
8 
 
 
 –
/2
.2
1 
 
 
 
 –
/−
2.
89
 
 
 
 
 
71
9
 P
49
36
8 
 C
C
T3
 
 
 
 
 
 
 
 
 −
2.
38
/–
 
 
 
 
72
6
 P
49
36
8 
 C
C
T3
 
 
 
 
 
 
 
 
 
−
4.
32
/–
 
 
 
73
7
 P
48
64
3 
 C
C
T5
 
 
 
 
 
−2
.15
/−
2.
46
 
 
 
 
 
 
 
76
7
 P
40
22
7 
 C
C
T6
A
 
 
 
 
 
 
 
 
 −
4.
90
/−
2.
91
  
 
 
35
3
 Q
8W
U
M
4 
 P
D
CD
6I
P 
 
 −
3.
42
/−
2.
40
  
 
 −
3.
29
/–
 
 
 
 
 
 
 −
2.
43
/ 
17
91
 Q
15
12
1 
 P
EA
15
 
 
 
 
 
 
 
 
 
−2
.6
8/
– 
 
 
11
74
 P
06
74
8 
 N
PM
1 
 
 
 
 
 
 
 
 4
.9
0/
3.
31
 
 
 
 
a/
b 
 Fo
ld
 c
ha
ng
es
 in
 p
ro
te
in
 e
xp
re
ss
io
n 
up
on
 in
fe
ct
io
n 
w
ith
 li
ve
 (a
) a
nd
 U
V-
in
ac
tiv
at
ed
 (b
) v
iru
s 
p
ar
tic
le
s.
 O
nl
y 
si
gn
ifi
ca
nt
 c
ha
ng
es
 a
re
 s
ho
w
n.
–:
 n
ot
 s
ig
ni
fic
an
tly
 c
ha
ng
ed
.
54
References
 [1]  Curns AT, Holman RC, Sejvar JJ, Owings MF, Schonberger LB. Infectious disease hospitalizations among 
older adults in the United States from 1990 through 2002. Arch Intern Med 2005;165:2514–20.
[2]  Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths 
from acute respiratory infections. Lancet Infect Dis 2002;2:25–32.
[3]  Van Woensel JB, Van Aalderen WM, Kimpen JL. Viral lower respiratory tract infection in infants and young 
children. BMJ 2003;327:36–40.
[4]  Yorita KL, Holman RC, Sejvar JJ, Steiner CA, Schonberger LB. Infectious disease hospitalizations among 
infants in the United States. Pediatrics 2008;121:244–52.
[5]  Lessler J, ReichNG, Brookmeyer R, PerlTM,NelsonKE,Cummings DA. Incubation periods of acute respiratory 
viral infections: a systematic review. Lancet Infect Dis 2009;9:291–300.
[6]  Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007;335:1037–41. [7] Simoes EA. Respiratory syncytial virus 
infection. Lancet 1999;354:847–52.
[8]  Van den Hoogen BG, De Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered 
human pneumovirus isolated from young children with respiratory tract disease.Nat Med 2001;7:719–24.
[9]  Fields, B. N., Knipe, D. M. Field’s Virology, Lippincott Williams & Wilkins; 2001.
[10]  See H, Wark P. Innate immune response to viral infection of the lungs. Paediatr Respir Rev 2008;9:243–50.
[11]  Tsutsumi H, Takeuchi R, Chiba S. Activation of cellular genes in the mucosal epithelium by respiratory 
syncytial virus: implications in disease and immunity. Pediatr Infect Dis J 2001;20:997–1001.
[12]  Tsutsumi H, Takeuchi R, Ohsaki M, Seki K, Chiba S. Respiratory syncytial virus infection of human respiratory 
epithelial cells enhances inducible nitric oxide synthase gene expression. J Leukoc Biol 1999;66:99–104.
[13]  Eckardt-Michel J, Lorek M, Baxmann D, Grunwald T, Keil GM, Zimmer G. The fusion protein of respiratory 
syncytial virus triggers p53-dependent apoptosis. J Virol 2008;82:3236–49.
[14]  Kotelkin A, Prikhod’ko EA, Cohen JI, Collins PL, Bukreyev A. Respiratory syncytial virus infection sensitizes cells 
to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 2003;77:9156–72.
[15]  Bitko V, Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the 
apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 2001;80:441–54.
[16]  Bao X, Sinha M, Liu T, Hong C, Luxon BA, Garofalo RP, et al. Identification of human metapneumovirus-in-
duced gene networks in airway epithelial cells by microarray analysis. Virology 2008;374:114–27.
[17]  Bao X, Liu T, Spetch L, Kolli D, Garofalo RP, Casola A. Airway epithelial cell response to human metapneumo-
virus infection. Virology 2007;368:91–101.
[18]  Gupta CK, Leszczynski J, Gupta RK, Siber GR. Stabilization of respiratory syncytial virus (RSV) against thermal 
inactivation and freeze–thaw cycles for development and control of RSV vaccines and immune globulin. 
Vaccine 1996;14:1417–20.
[19]  Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology 
categories in biological networks. Bioinformatics 2005;21:3448–9.
[20]  Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem 1986;261:10375–9.
[21]  Jeanson L, Subra F, Vaganay S, Hervy M, Marangoni E, Bourhis J, et al. Effect of Ku80 depletion on the 
preintegrative steps of HIV-1 replication in human cells. Virology 2002;300:100–8.
[22]  Jeanson L, Mouscadet JF. Ku represses the HIV-1 transcription: identification of a putative Ku binding site 
homologous to the mouse mammary tumor virus NRE1 sequence in the HIV-1 long terminal repeat. J Biol 
Chem 2002;277:4918–24.
[23]  Quinn JP, Simpson J, Farina AR. The Ku complex is modulated in response to viral infection and other cellular 
changes. Biochim Biophys Acta 1992;1131:181–7.
[24]  Sainis I, Angelidis C, Pagoulatos G, Lazaridis I. The hsc70 gene which is slightly induced by heat is the main 
virus inducible member of the hsp70 gene family. FEBS Lett 1994;355:282–6.
[25]  Fang D, Haraguchi Y, Jinno A, Soda Y, Shimizu N, Hoshino H. Heat shock cognate protein 70 is a cell fusion-
enhancing factor but not an entry factor for human T-cell lymphotropic virus type I. Biochem Biophys Res 
Commun 1999;261:357–63.
[26]  Cicchillitti L, Penci R,DiMM, Filipett F, RotilioD,DonatiMB, et al. Proteomic characterization of cytoskeletal 
and mitochondrial class III beta-tubulin. Mol Cancer Ther 2008;7:2070–9.
55
Quantitative proteome profiling of respiratory virus-infected lung epithelial cells
2
[27]  Akasaka K, Maesawa C, Shibazaki M, Maeda F, Takahashi K, Akasaka T, et al. Loss of class III beta-tubulin 
induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma 
cells. J Invest Dermatol 2009;129:1516–26.
[28]  Ferlini C, Raspaglio G, Cicchillitti L, Mozzetti S, Prislei S, Bartollino S, et al. Looking at drug resistance 
mechanisms for microtubule interacting drugs: does TUBB3 work? Curr Cancer Drug Targets 2007;7:704–12.
[29]  Cicchillitti L, Di MM, Urbani A, Ferlini C, Donat MB, Scambia G, et al. Comparative proteomic analysis of 
paclitaxel sensitive A2780 epithelial ovarian cancer and its resistant counterpart A2780TC1 by 2D-DIGE: the 
role of ERp57. J Proteome Res 2009.
[30]  Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA. Taxol differentially modulates the dynamics of microtubules 
assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry 1997;36:3554–62.
[31]  Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 
2005;115:2656–64.
[32]  Paschen W. Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr 
Neurovasc Res 2004;1:173–81.
[33]  Liberman E, Fong YL, Selby MJ, Choo QL, Cousens L, Houghton M, et al. Activation of the grp78 and grp94 
promoters by hepatitis C virus E2 envelope protein. J Virol 1999;73:3718–22.
[34]  Ciccaglione AR, Costantino A, Tritarelli E, Marcantonio C, Equestre M, Marziliano N, et al. Activation of 
endoplasmic reticulum stress response by hepatitis C virus proteins. Arch Virol 2005;150:1339–56.
[35]  Pavio N, Romano PR, Graczyk TM, Feinstone SM, Taylor DR. Protein synthesis and endoplasmic reticulum 
stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation 
factor 2alpha kinase PERK. J Virol 2003;77:3578–85.
[36]  Cheng G, Feng Z, He B. Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase 
PERK and mediates eIF-2alpha dephosphorylation by the gamma(1) 34.5 protein. J Virol 2005;79:1379–88.
[37]  Chen B, Piel WH, Gui L, Bruford E, Monteiro A. The HSP90 family of genes in the human genome: insights into 
their divergence and evolution. Genomics 2005;86:627–37.
[38]  Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: structure, 
function, and clinical applications. A comprehensive review. Pharmacol Ther 1998;79:129–68.
[39]  Obermann WM, Sondermann H, Russo AA, Pavletich NP, Hartl FU. In vivo function of Hsp90 is dependent on 
ATP binding and ATP hydrolysis. J Cell Biol 1998;143:901–10.
[40]  Nakamura M, Morisawa H, Imajoh-Ohmi S, Takamura C, Fukuda H, Toda T. Proteomic analysis of protein 
complexes in human SH-SY5Y neuroblastoma cells by using blue-native gel electrophoresis: an increase in 
lamin A/C associated with heat shock protein 90 in response to 6-hydroxydopamine-induced oxidative 
stress. Exp Gerontol 2009;44:375–82.
[41]  Mou F,Wills EG, ParkR, Baines JD. Effects of lamin A/C, lamin B1, and viral US3 kinase activity on viral infectivity, 
virion egress, and the targeting of herpes simplex virus U(L)34-encoded protein to the inner nuclear 
membrane. J Virol 2008;82: 8094–104.
[42]  Malhas AN, Lee CF, Vaux DJ. Lamin B1 controls oxidative stress responses via Oct-1. J Cell Biol 2009;12:45–55.
[43]  Noiva R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. 
Semin Cell Dev Biol 1999;10:481–93.
[44]  Puig A, Lyles MM, Noiva R, Gilbert HF. The role of the thiol/disulfide centers and peptide binding site in the 
chaperone and anti-chaperone activities of protein disulfide isomerase. J Biol Chem 1994;269:19128–35.
[45]  Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, et al. Increasing melanoma cell death using 
inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. 
Cancer Res 2008;68:5363–9.
[46]  Braun RJ, Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human 
disease. Biochim Biophys Acta 2008;1783:1418–35.
[47]  Kubota H, Hynes G, Willison K. The chaperonin containing t-complex polypeptide 1 (TCP-1). Multisubunit 
machinery assisting in protein folding and assembly in the eukaryotic cytosol. Eur J Biochem 1995;230:13–6.
[48]  Dekker C, Stirling PC, McCormack EA, Filmore H, Paul A, Brost RL, et al. The interaction network of the 
chaperonin CCT. EMBO J 2008;27:1827–39.
56
[49]  Leong WF, Chow VT. Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential 
cellular gene expression in response to enterovirus 71 infection. Cell Microbiol 2006;8:565–80.
[50]  Honda K, Yamada T, Endo R, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and 
cancer invasion. J Cell Biol 1998;140:1383–93.
[51]  Dussupt V, Javid MP, Bou-Jaoude G, Ino Y, Gotoh M, Brost RL, et al. The nucleocapsid region of HIV-1 Gag 
cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral 
budding. PLoS Pathog 2009;5:e1000339.
[52]  Strack B, Calistri A, Craig S, Popova E, Gottlinger HG. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 
functioning in virus budding. Cell 2003;114:689–99.
[53]  Von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, et al. The protein network of HIV 
budding. Cell 2003;114:701–13.
[54]  Carlton JG, Agromayor M, Martin-Serrano J. Differential requirements for Alix and ESCRT-III in cytokinesis 
and HIV-1 release. Proc Natl Acad Sci USA 2008;105:10541–6.
[55]  Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, Dikik I, et al. Alix/AIP1 antagonizes epidermal growth 
factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol 2004;24:8981–93.
[56]  Pan S, Wang R, Zhou X, He G, Koomen J, Kobayashi R, et al. Involvement of the conserved adaptor protein 
Alix in actin cytoskeleton assembly. J Biol Chem 2006;281:34640–50.
[57]  Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion 
formation by direct interactions with talin and actin. J Cell Biol 2007;179: 1043–57.
[58]  Shoeman RL, Hartig R, Hauses C, Traub P. Organization of focal adhesion plaques is disrupted by action of 
the HIV-1 protease. Cell Biol Int 2002;26:529–39.
[59]  Tan TL, Feng Z, Lu YW, Chan V, Chen WN. Adhesion contact kinetics of HepG2 cells during Hepatitis B virus 
replication: involvement of SH3-binding motif in HBX. Biochim Biophys Acta 2006;1762:755–66.
[60]  Wheeler JG, Winkler LS, Seeds M, Bass D, Abramson JS. Influenza A virus alters structural and biochemical 
functions of the neutrophil cytoskeleton. J Leukoc Biol 1990;47:332–43.
[61]  Magro AM, Magro AD, Cunningham C, Miller MR. Downregulation of vinculin upon MK886-induced 
apoptosis in LN18 glioblastoma cells. Neoplasma 2007;54:517–26.
[62]  Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita S. ERM (ezrin/radixin/moesin)-based molecular 
mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol 1997;139:749–58.
[63]  Kubo Y, Yoshii H, Kamiyama H, Tominaga C, Tanaka Y, Saro H, et al. Ezrin, radixin, and moesin (ERM) proteins 
function as pleiotropic regulators of human immunodeficiency virus type 1 infection. Virology 2008;375:130–40.
[64]  Haedicke J, De Los SK, Goff SP, Naghavi MH. The ezrin–radixin–moesin family member ezrin regulates stable 
microtubule formation and retroviral infection. J Virol 2008;82: 4665–70.
[65]  Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Cell Sci 1999;112:761–72.
[66]  Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer 
AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 2008;68:2358–65.
[67]  Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK. Identification of nucleolin as an AU-rich element 
binding protein involved in bcl-2 mRNA stabilization. J Biol Chem 2004;279:10855–63.
[68]  Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, Pineda-Roman M, et al. Overexpression of nucleolin 
in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007;109:3069–75.
[69]  Zelivianski S, Liang D, Chen M, Mirkin BL, Zhao RY. Suppressive effect of elongation factor 2 on apoptosis 
induced by HIV-1 viral protein R. Apoptosis 2006;11:377–838.
[70]  Peacock JW, Palmer J, Fink D, Ip S, Pietras EM, Mui AL, et al. PTEN loss promotes mitochondrially dependent 
type II Fas-induced apoptosis via PEA-15. Mol Cell Biol 2009;29:1222–34.
[71]  Bartholomeusz C, Rosen D, Wei C, Kazansky A, Yamasaki F, Takahashi T, et al. PEA-15 induces autophagy in 
human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res 2008;68:9302–10.
57
Quantitative proteome profiling of respiratory virus-infected lung epithelial cells
2

Measuring the physical cohesiveness of proteins 
using physical interaction enrichment
Iziah Edwin Sama and Martijn A. Huynen
3
Bioinformatics. 2010 Nov 1;26(21):2737-43
60
Abstract
Motivation: Protein–protein interaction (PPI) networks are a valuable resource for the 
interpretation of genomics data. However, such networks have interaction enrichment 
biases for proteins that are often studied. These biases skew quantitative results from 
comparing PPI networks with genomics data. Here, we introduce an approach named 
physical interaction enrichment (PIE) to eliminate these biases.
Methodology: PIE employs a normalization that ensures equal node degree (edge) 
distribution of a test set and of the random networks it is compared with. It quantifies 
whether a set of proteins have more interactions between themselves than proteins in 
random networks, and can therewith be regarded as physically cohesive.
Results: Among other datasets, we applied PIE to genetic morbid disease (GMD) genes 
and to genes whose expression is induced upon infection with human-metapneumovirus 
(HMPV). Both sets contain proteins that are often studied and that have relatively many 
interactions in the PPI network. Although interactions between proteins of both sets are 
found to be overrepresented in PPI networks, the GMD proteins are not more likely to 
interact with each other than random proteins when this overrepresentation is taken 
into account. In contrast the HMPV-induced genes, representing a biologically more 
coherent set, encode proteins that do tend to interact with each other and can be used 
to predict new HMPV-induced genes. By handling biases in PPI networks, PIE can be a 
valuable tool to quantify the degree to which a set of genes are involved in the same 
biological process.
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1. Introduction
Physical interactions between proteins explain how proteins function together in 
protein complexes or functional modules (Dittrich et al., 2008; Ideker and Sharan, 2008; 
Tucker et al., 2001; Vidal, 2001). Discovery of all protein–protein interactions (PPIs) has 
therefore been a priority in systems biology and there have been several efforts to 
elucidate PPIs both in low- and in high-throughput platforms (Collins et al., 2007; Rual et 
al., 2005; Stelzl et al., 2005), as well as by evolutionary inference (Brown and Jurisica, 2007; 
Huang et al., 2007; Yu et al., 2004).
The resulting PPI networks are invaluable for the interpretation of other genomics data. 
In a number of studies, specific emphasis has been placed on quantifying aspects of 
network topology to identify proteins that are specifically relevant to a biological 
process or for evolution. For instance Wachi and coworkers identified a high network 
centrality for genes that are upregulated during lung cancer as a distinguishing 
topological feature to enable placement of cancer genes into the global and systematic 
context of the cell (Wachi et al., 2005). In a similar study, essential genes in yeast have 
been found to be well connected and globally centered in the PPI network (Jeong et al., 
2001; Wuchty and Almaas, 2005).
Notwithstanding the success of such approaches, there are some experimental biases 
in the determination of PPIs. For instance, the Yeast-2-Hybrid (Y2H) approach is known 
to detect interactions among proteins that may not be likely because the proteins 
naturally do not occur in the same subcellular compartment (von Mering et al., 2002). 
Tandem Affinity Purification followed by mass spectrometry is known to favor highly 
abundant proteins (Bjorklund et al., 2008; von Mering et al., 2002). In addition, evolutionary 
inference of PPIs as ‘interologs’ has placed highly conserved proteins as hubs in general 
PPI networks (Brown and Jurisica, 2007). Even manual curation of PPIs in scientific 
literature has caveats. One main caveat being that the discovery of such interactions is 
driven by existing knowledge and hypotheses (Cusick et al., 2009). The latter has led to 
an overrepresentation of interactions between proteins encoded by disease genes in 
the Human Protein Reference Database (HPRD) (Oti et al., 2006).
Several measures have been developed to improve the reliability of PPI networks 
(Sharan et al., 2007), like the integration of general PPI networks with networks based on 
other data (Karni et al., 2009; Tornow and Mewes, 2003; Yosef et al., 2008). Although such 
comparative genomic approaches increase the reliability of the PPI network, they do 
not specifically remove systematic biases, like the overrepresentation of well-studied 
proteins, from general PPI networks. This is of pertinent concern because function 
information derived from such networks would be skewed towards well-studied genes 
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that are often evolutionarily conserved nodes, immune-related nodes or disease- 
associated nodes in PPI networks. Moreover, such biases can cloud quantitative assessments 
of whether a set of proteins of interest tend to interact with each other, and are therewith 
‘physically cohesive’. For example, when genes that are upregulated under a specific 
condition encode proteins that physically interact with each other, this can be because 
they truly interact more with each other than a random set of proteins, or simply 
because there are just more interactions known for these proteins than for those whose 
genes are not highly expressed (von Mering et al., 2002).
To handle the bias that arises from the overrepresentation of certain proteins (e.g. well- 
studied proteins) in PPI networks, we present an approach called physical interaction 
enrichment (PIE). PIE extracts ‘random’ sets of proteins from a general PPI network that 
have the same node (protein) and edge (interaction) biases in the general PPI network 
as a set of proteins of interest. Secondly, it assesses whether the average degree of 
interaction among the proteins of interest is higher than that among the proteins from 
the random sets and thus quantifies how physically cohesive the proteins are.
To illustrate the usefulness of PIE, we first show how general human PPI networks have 
higher node degrees (i.e. number of interactions) for proteins encoded by morbid 
genetic disease genes. We also reveal biases in these networks for proteins encoded by 
genes that are stimulated by human metapneumovirus (HMPV) infection, a virus 
recently discovered to cause morbidity in very young and elderly people (van den 
Hoogen et al., 2001; van Diepen et al., 2010). The HMPV-induced genes are used here to 
represent a scientifically new and likely more focused context than the morbid genetic 
disease genes. Secondly, we demonstrate how PIE compensates for the enrichment 
biases in both the morbid genetic disease gene set and the sets of HMPV-induced 
genes. Thirdly, we assess physical cohesiveness of genes that are upregulated or 
downregulated to examine the biological coherence in such context. Furthermore, we 
apply PIE to other datasets in which the gene expression response of epithelial cells to 
a cytokine, interferon gamma (INFG) or other airway pathogens like Chlamydia 
pneumoniae, uv-irradiated Pseudomonas aeruginosa, uv-irradiated respiratory syncytial 
virus (RSV) have been measured. Finally, we use PIE to assess whether the propagation 
of interactions through PPI networks is biologically relevant. For the cases where it is 
relevant, we propagate these networks to larger networks and demonstrate the 
predictability of future expressed genes therein, thus showing exploratory potential in 
general PPI networks using PIE.
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2. Methods
2.1  General PPI networks
The PPI network used were built from an accumulation of human-curated PPIs obtained 
from the Biomolecular Interaction Network Database (BIND; Bader et al., 2003) (data 
downloaded in October 2006), the HPRD (Peri et al., 2003) (data of release 6 of January 
2007), the IntAct database (Kerrien et al., 2007) (downloaded in May 2007), the Molecular 
Interactions Database (MINT; Chatr-aryamontri et al., 2007) (downloaded in May 2007) 
and the PDZBase database (Beuming et al., 2005) (downloaded in May 2007). For the 
scope of this study, only direct PPIs within the same species were used. We refer to the 
network composed of all interactions between human proteins as HsapiensPPI. 
Furthermore, interologous PPIs were built using the orthologues datasets from the 
Ensembl genome browser (Hubbard et al., 2007) (Ensembl release 44, downloaded on 
May 2007). These were combined with the HsapiensPPI dataset. We refer to this 
comprehensive dataset as AllspeciesPPI. The HsapiensPPI contains 53 807 interactions 
between 10 826 proteins. The AllspeciesPPI network contains 205 050 interactions 
among 13 920 proteins. Unique to AllspeciesPPI are 151 243 interactions, among 3094 
proteins. The main difference between the HsapiensPPI and AllspeciesPPI is that the 
former has fewer interactions per node than the latter. The high average degree in the 
AllspeciesPPI is in agreement with other studies that posit that preferential conservation 
of proteins with higher degree (hubs) leads to enrichment in protein complexes when 
interactions are transferred between organisms using interologs (Brown and Jurisica, 
2007; Wuchty and Almaas, 2005). All the nodes in the HsapiensPPI and AllspeciesPPI 
networks represent the Entrez gene IDs of interacting proteins, and are not redundant 
in the networks. These PPI networks are large enough for the scope of our study. Unless 
otherwise stated, the HsapiensPPI is used in this article as the general PPI network.
2.2  Disease and immune-related data
All human disease genes were obtained from the Morbid Omim database (downloaded 
February 10, 2009 from ftp://ftp.ncbi.nih.gov/repository/OMIM/morbidmap) (Sayers et 
al., 2009). The HMPV infection data was obtained from (Bao et al., 2008), as deposited 
in the NCBI Gene Expression Omnibus database with reference as GSE8961. Other 
data included that of human lung epithelial cell treatment with the cytokine INFG 
(GSE1815) (Pawliczak et al., 2005). Expression data of bronchial epithelial cells infected 
with respiratory pathogens like Chlamydia pneumonia (GSE7246) (Alvesalo et al., 2008) 
and uv-irradiated airway-pathogens (for P.aeruginosa and RSV; GSE6802; Mayer et al., 
2007).
A geometric average of all probes for a gene was used to represent the fold change (FC) 
of a gene due to infection or treatment. A FC threshold of ≥1.5 was used to select genes 
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induced by the inert pathogens (UV irradiated), and this low threshold was necessary to 
yield adequately testable sample sizes. In all other cases, upregulated or downregulated 
genes used were those that showed a FC ≥3.0 after infection or treatment.
2.3   Enrichment of PPIs for disease genes and immune-related 
genes in general PPI networks
To measure the biased enrichment in interactions for proteins of genetic disease genes 
in general PPI networks, the morbid Omim gene set (n=1996) was used as the genetic 
disease test set. Its enrichment was assessed as follows: the average node degree (nodes 
of degree zero inclusive) in the general PPI network for proteins encoded by the disease 
genes was compared with those of sets of 1996 genes that were randomly selected 
from all human genes (n=36456) that were available in NCBI Entrez gene database in 
2008. The P-value of enrichment in interactions for proteins of disease genes was 
estimated as a fraction of the frequency (out of 1000 simulations) of the sets of random 
genes having an average degree that was equal or greater than that of the disease 
genes. As shown in Figure 1, disease genes have significantly (P<0.001) high node 
degrees in the general PPI networks HsapiensPPI and AllspeciesPPI.
To measure the biased enrichment in interactions for proteins of immune-related genes 
in the general PPI networks, genes that were upregulated at a FC threshold of 3.0 at 
various time points after HMPV infection were used as an example. The enrichment 
procedure for these representative immune-response genes was similar to that carried 
out for the morbid disease geneset. Apart from the gene set at the earliest infection 
time point (6 h), these immune-related sets of genes have significantly (P<0.01) high 
node degrees in general PPI networks (Fig. 1).
Overall, these results indicate that proteins of disease genes and immune-related genes 
have, on average, more interactions in general PPI networks than do proteins of randomly 
chosen genes.
2.4  PIE procedure
Proteins of disease genes or of genes involved in immune response have relatively more 
interactions than random sets of genes in general PPI networks (Fig. 1). This can lead to 
a bias when measuring whether genes whose expression is e.g. triggered by a viral 
infection or involved in genetic disease tend to interact with each other. As such, one 
cannot simply compare the extent to which proteins of these genes interact with each 
other relative to randomly chosen proteins from the PPI network, thus dictating the 
need for appropriate random models (Koyuturk et al., 2007). In order to circumvent 
these biases in the number of proteins that are present in the PPI network and also in 
the number of interactions per protein in the PPI network, the PIE procedure is presented 
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as depicted in Figure 2. PIE measures the physical cohesiveness of interacting proteins 
via the strict randomization procedure described in detail below.
2.4.1   Derivation of test and random PPI networks from a general  
PPI network for PIE
A test PPI network is derived from a set of test genes by selecting all the interactions 
from the general PPI network occurring between proteins encoded by the genes in that 
test set (Equation 1). An example of a test set is a set of genes that are upregulated in 
expression due to a viral infection. Next, for each node in the general PPI network, the 
Figure 1 -  Proteins of disease genes and immune-related genes have higher node degree 
in general PPI networks than do proteins of randomly sampled genes. 
The average node-degree of disease genes (represented by morbid Omim genes) and 
immune-related genes (represented by genes upregulated at least 3-fold in expression 
at various time points after HMPV infection) is observed in the HsapiensPPI (top panel) 
and the AllspeciesPPI (bottom panel) networks to be generally higher than randomly 
sampled genes from the genome. In the top and lower panels, hmpv6, hmpv12, etc. 
refer to gene sets upregulated in expression after 6 and 12 h of HMPV infection. In 
brackets are the P-value estimates of higher node degree (compared with random) of 
disease and immune-related genes in the general PPI networks.
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degree (i.e. number of interactions the node has in the network) is obtained. Thus, a 
degree distribution for the nodes in the general PPI network is derived. We call this the 
global degree distribution. From the global degree distribution, a test degree 
distribution consisting only of the test network nodes (and their associated degree in 
the general PPI network) is extracted. Subsequently, proteins that have the same degree 
as those in the test network are randomly selected from the global degree distribution. 
This is done such that for every degree in the test degree distribution, the number of 
randomly chosen nodes for that degree is the same as that of the test nodes for that 
degree. Moreover, the total number of nodes in the test set is ideally much smaller than 
the total number of nodes in the general PPI network (Equations 2 and 3). As such the 
total number of randomly chosen nodes is the same as that of the test nodes. Thus, 
both random and test have been normalized in the context of the general PPI network.
Essentially, the PIE randomization involves selection of nodes from the general PPI 
network that have the same node degrees as those of the test nodes in the general PPI 
network prior to constructing an induced subgraph by selecting all the interactions 
from the general PPI network that occur between the random nodes.
This randomization procedure presents a caveat regarding saturation of network 
sampling space. In the random sampling procedure, many random protein sets with 
identical degree distribution as the test set are extracted from the global network. 
When the test network becomes large and therewith largely identical to the global 
network, randomly sampled networks will largely overlap with the test network, and it 
will become meaningless to try to measure an increase in the number of interactions in 
the test network relative to the random networks. We measured the overlap of nodes 
between the test and random networks and also the overlap of interactions. In practice, 
the sets of proteins that we tested for physical cohesiveness contained <16% of the 
nodes of the random networks, while the overlap in the number of interactions was 
<13%. Only propagated test networks (see Section 3 below and Supplementary 
Material) contain a substantial fraction of the global network.
2.4.2 Measuring physical cohesiveness
First, the average degree of the test network is calculated as the average number of 
interactions per node (Equation 4). Also, for the random network the average degree is 
calculated by dividing the number of interactions by the number of nodes. Next, the 
ratio of the average degree of the test network relative to the median average degree 
of the corresponding random networks (i.e. those obtained after PIE randomization) is 
calculated (Equation 5). This is the measure of physical cohesiveness or ‘PIE score’ for the 
set of test genes. Finally, the fraction of instances whereby the average degree of the 
random networks is larger or equal to the test network is calculated (Equation 6). This 
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strict empirical value represents the P-value for the physical cohesiveness for the test 
set of genes.
Figure 2 -  Summary of the PIE procedure. In the PIE procedure, a test set of genes of 
interest, e.g. those upregulated by a virus, are used to extract a specific PPI 
network from the general PPI network that consists of proteins encoded by 
genes in that test set. 
The number of interactions of each protein of the test set in the general PPI network (i.e. 
degree) is calculated. A number of proteins equal to the test set and with the same 
degree distribution as the test proteins in the general PPI network are then randomly 
selected from the set of all proteins in the general PPI network. As such the test set and 
the randomly selected set have the same degree distribution in the general PPI network. 
The average degree within the test set itself (i.e. total number of edges divided by total 
number of nodes in the test set) is then obtained and compared with that within the 
randomly selected set. The fraction of cases in which the average degree within a 
randomly selected set surpasses or equalizes that of the test network is recorded as the 
P-value for the physical cohesiveness of proteins of the genes of interest. The PIE score 
is the ratio of the average degree within the test network to the median average degree 
within the random networks.
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2.5  Algorithm
All calculations and graphs were obtained using Python scripting and R. Network 
graphs and Gene Ontology enrichment analyses were obtained using Cytoscape 
(Shannon et al., 2003) and the Cytoscape plugin BINGO version 2.3 (Maere et al., 2005), 
respectively. P-values reported for the gene enrichment analyses were gotten after 
Benjamini and Hochberg false discovery rate correction.
All network P-values indicate how often the average degree of a test network is less 
than that of random networks of equal size and equal global degree distribution as the 
test set.
All calculations of correlations and associated P-values are Pearson moment correlations 
as implemented in the statistical package R. Other specific calculations are as described 
below.
2.5.1 Test PPI network 
Given a general PPI network, G=(V,E) such that V is a set comprising N
V
 vertices (nodes) 
and E is a set comprising N
E 
edges (links, degrees). A PPI network, Gt = (Vt ,Et ) of a given 
test set of genes is constructed such that:
 G t ⊆ G,  induced subgraph (1) 
That is, Vt are the vertices in G that are proteins encoded by the test genes and Et are the 
edges from G that connect all the Vt vertices. For clarity, each gene is represented by 
only one protein node.
2.5.2 Random PPI network for PIE 
The appropriate nodes used to construct the random networks used for comparison 
with the test network are obtained as follows. Let global degree, g be the number of 
edges (interaction partners) a node has in a general PPI network, and α
g
 be a vector of 
all existing g. Given the general network G = (V,E) comprising a set V of N
V  
vertices, with 
a set E of N
E
 edges: we create another vector β
g
 comprising N
g
 number-of-nodes for each 
distinct global node degree g in α
g
.
Next, given a test network G t = (V t ,E t ), we create a vector β
t
 comprising N
gt
 number-of-
nodes from V t such that, G t
 
⊆ G and α
t
 ⊆ α
g
.
Finally, a corresponding (i.e. to the test network) random induced subgraph, G r =(V r ,E r ) 
is deduced from G such that G r ⊆ G and β
r
 =β
t 
and also α
r
 =α
t
 , whereby V r is randomly 
selected from V.
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Resulting in:
 (2)
i.e. total number of nodes of the test network and for a random network is the same, 
and have the same degree distribution.
Furthermore, for adequate sampling space of V r  from V;
  ; such that  (3)
2.5.3 Average Degree of PPI network 
The average degree ω of a network G= (V,E) is the average number of interaction per 
node. This is calculated as follows:
 (4)
Where N
E
 is the total number of edges linking nodes and N
V
 is the total number of 
distinct vertices (nodes) in the PPI network.
2.5.4 Physical cohesiveness 
The score of physical cohesiveness ρ is calculated as follows:
 
(5)
Where ω
t
 and ω
r
 are as derived in (Equation 4) for a test network, and N random networks 
of identical global node-degree distribution (as derived in Equations 2 and 3), 
respectively. The denominator is the median of N random networks. Unless otherwise 
indicated, this N is 1000. To avoid division by zero error, 1 is added to both numerator 
and denominator.
2.5.5 P-value of physical cohesiveness 
The P-value of physical cohesiveness, Pvalueρ, is calculated as follows:
 
; if the numerator =0, Pvalueρ<1/N (6)
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3. RESULTS
3.1   Assessment of enrichment of disease or immune-related protein 
interactions in general PPI networks
As expected, when assessing the presence of genes involved in disease or in the 
immune system we observed a significant overrepresentation of interactions for the 
proteins of these genes. Morbid disease genes have a higher node degree than random 
(P<0.001). Likewise were the proteins of HMPV-induced genes (P<0.01) (Fig. 1).
3.2  Physical cohesiveness of disease and immune-related genes
The PIE approach was tested on morbid genetic disease genes and genes that were 
upregulated in expression due to HMPV infection. The first set of genes represents the 
general context of genes relevant to human health and disease. The second set serves 
as an example of a more focused context and is selected using a more objective 
criterion, i.e. gene expression perturbations upon HMPV infection. Both sets of genes 
encode proteins with overrepresented interactions in general PPI networks (Fig. 1).
3.2.1 Morbid disease genes 
Proteins of morbid disease genes have more interactions with each other than do 
proteins of randomly chosen genes. The average number of interactions between 
morbid disease genes is 2.29 while that of the same number of randomly chosen genes 
is 1.15 (P<0.001). Nevertheless, the PIE procedure indicates that the morbid disease gene 
set has no physical cohesiveness (PIE score = 1), and this is not because the morbid 
disease gene network is quantitatively similar to the general network as it contains only 
11% of the nodes, and 5% of the interactions in the general network. The morbid disease 
gene set has only 15% of its nodes, and 12% of its interactions in common with those of 
the random networks used in the PIE randomization approach.
Thus, the proteins encoded by morbid disease genes are not more likely to interact with 
each other than random proteins with the same degree distribution. Overall, the 
absence of physical cohesiveness for morbid disease genes using PIE might be expected 
because disease genes are involved in many different diseases and likely many different 
processes, and it is encouraging to see that PIE effectively corrects for such biases.
3.2.2 HMPV-induced genes 
Like the morbid disease genes, proteins of genes whose expression are induced after 12 
h of HMPV infection also have a higher number of interaction with each other (average 
degree = 1.148) than the same number of randomly chosen genes (median average 
degree = 1.0). Unlike the case of morbid disease genes, however, the 12 h HMPV-induced 
genes do display significant physical cohesiveness (PIE score = 1.1, P=0.04) when the 
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latter is measured using PIE. The physical cohesiveness of the nodes of the HMPV-induced 
genes therefore does not depend on their overrepresentation in general PPI networks 
(Fig. 1) in which it contains only 0.5% of the general network nodes and 0.12% of the 
interactions. Furthermore, both average degree and physical cohesiveness depend on 
some criteria of severity of HMPV infection. For instance at a gene expression FC 
threshold of 3.0, physical cohesiveness increases with longevity of the infection (Fig. 3). 
In line with the changes in physical cohesiveness, the immune response might become 
more specific in the time course of infection. For example, apoptosis starts to play a 
more prominent role later in infection as reflected by the enrichment of the GO term 
‘apoptosis’ for genes that are upregulated at a FC threshold of 3.0. At various time points 
of infection, the process apoptosis is observed to change in significance as follows: 6 h 
(absent), 12 h (P=2.58e-2), 24 h (P = 1.94e-2), 48 h (P = 2.68e-4) and 72 h (P = 7.39e-4). 
In addition, key apoptosis marker genes like MDA-5 and RIG-1 were found using western 
blotting to increase over time of HMPV infection as seen in the data of Bao and others 
Figure 3 -  Timewise variation in physical cohesiveness of HMPV infection induced genes. 
(A) Changes in average degree for the infection (squares with black line) and random 
(boxplots with grey line). (B) Changes in physical cohesiveness measured as PIE scores 
with P-values of cohesiveness in brackets.
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(i.e. the HMPVdata used in this article) (Bao et al., 2008). In addition to the temporal 
cohesiveness of upregulated genes, it is interesting to examine the cohesiveness of 
infection and immune system related genes in other regulatory contexts.
3.2.3 Other infection related datasets 
The 12 h HMPVperturbed genes were cohesive, not only for upregulated genes (PIE 
score = 1.1, P = 0.04) but also for downregulated genes (PIE score = 1.4, P<0.001), 
indicating the ability of PIE to effectively reveal physical cohesiveness in different 
regulatory settings. We further explored the physical cohesiveness of infection and 
immune system related genes by analyzing the upregulated and downregulated genes 
in a number of relevant datasets: (i) genes that are affected in expression after 24 h 
treatment of bronchial epithelial cells with IFNG (Pawliczak et al., 2005), (ii) genes affected 
by cells infected for 4 h with UV-irradiated RSV or pseudomonas (Mayer et al., 2007) and 
(iii) genes that are affected after 24 h infection by Chlamydia pneumonia (Alvesalo et al., 
2008). Both the IFNG and the UV-irradiated pathogens led to a significant PIE score for 
upregulated genes [PIE score = 1.14, P = 0.02 (IFNG), PIE score = 1.35, P<0.001 (RSV) and 
PIE score = 1.19, P = 0.022 (Pseudomonas)], while only for IFNG did the downregulated 
genes display physical cohesiveness (PIE score = 1.17, P = 0.032). In contrast, PIE indicates 
no physical cohesiveness for genes that were upregulated or downregulated after 
Chlamydia infection of human lung epithelial cells. The absence of physical cohesiveness 
of genes perturbed by Chlamydia might be partly explained by the ability of this 
intracellular parasite to de-modulate host-cell responses, e.g. its abrogation of apoptosis 
in epithelial cells (Airenne et al., 2002; Hacker et al., 2006), thus resulting in PPI networks 
that are less or equally dense as random networks. In this light, the significant physical 
cohesiveness of the upregulated genes after infection with UV-irradiated pathogens is 
particularly interesting, as these cannot be the result of the direct interference of the 
pathogen with the gene regulation, but, in contrast point to the cellular program that 
appears to be triggered by the infection.
3.3   Correlation of physical cohesiveness with prediction of 
downstream pathway genes in propagated networks
We also examined to what extent proteins that interact with the proteins of upregulated 
genes are physically cohesive (Supplementary Material).We observed that a one step 
propagation of networks of genes upregulated in expression by HMPV or IFNG led to 
physically cohesive networks (Supplementary Fig. 1). Nevertheless, the overlap between 
random networks with the same degree distribution and the propagated network 
becomes substantial (25%). At higher levels of propagation, this overlap becomes too 
large to assess a significance value for the PIE score. Comparison between the one step 
propagated networks of genes induced by the HMPV virus at time points 12, 24 and 48 
h and the genes overexpressed at the next time point indicated a significant overlap 
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(P<1.0e-3), showing some predictive capacity of such propagation (Supplementary 
Table 1). Overall, the sensitivity of prediction is 5–41% and the positive predictive value 
is 5–11%. There is a positive, albeit insignificant correlation between the PIE score of 
precursor networks and the predictability of genes in their propagated networks. For 
instance, the correlation between the PIE score and sensitivity of predictions is 0.93 
(P=0.066). These results demonstrate the usefulness of the PIE approach to assess the 
biological coherence of a set of genes and the potential to use general PPI networks in 
an exploratory manner to predict genes of relevance to a process being studied.
4. Discussion
In order to explore PPIs in a quantitative manner, we have developed a method called 
PIE, to circumvent interaction enrichment biases in context-specific networks derived 
from general PPI networks. PIE employs a randomization procedure that appropriately 
considers the global degrees (in a general PPI network) of the extant nodes in a context-
specific test network, prior to assigning physical cohesiveness to the test network.
We have focused on the context of disease and immunity because many proteins have 
been studied in this area. We observe that there are significantly (P<0.01) more 
interactions for proteins of morbid disease genes and HMPV-induced genes than 
random expectation in general PPI networks. This observed enrichment for PPI of 
morbid disease genes and HMPV-induced genes is in agreement with other studies 
indicating that disease-based inquisitional biases have an influence on the topology of 
general PPI networks (Oti et al., 2006; Wachi et al., 2005). The basis for this enrichment 
can be biological, in the sense that disease genes or genes that are triggered upon 
infection are simply more likely to have physical interactions. Nevertheless, it is not 
unlikely that this enrichment is at least partly caused by an experimental bias in research 
efforts. Based on these premises, we investigated the physical cohesiveness of the 
proteins of these sets of genes using the PIE approach.
The PIE approach reveals no physical cohesiveness among the morbid disease genes, 
by taking into account that these genes are significantly enriched in general PPI 
networks. Other studies examining global topological properties of protein encoded by 
disease genes have focused on cancer genes. In this light, greater degrees and 
centralities of cancer genes in comparison to non-cancer genes within the interactome 
have been observed (Jonsson and Bates, 2006; Wachi et al., 2005). In contradiction to the 
previous observation, Goh et al. (2007) have shown that the majority of disease genes 
do not actually show a tendency to code for highly interacting proteins but instead the 
apparent correlation between high degrees and disease genes is entirely due to the 
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~22% overlap between disease genes and essential genes, the latter set of genes being 
mainly hubs (Goh et al., 2007). The methods used by the previous authors were not 
similar to the PIE approach. Nevertheless, PIE further clarifies this discrepancy in the 
literature by indicating that globally, there is no physical cohesiveness between the 
proteins of morbid disease genes, when taking into account their high degrees in PPI 
networks. This suggests that genes that are not associated with similar disorders, even 
if their protein products have many interactions in PPI networks, show negligible 
biological coherence and advocates the existence of distinct, disease-specific functional 
modules.
On the other hand, the PIE approach reveals significant physical cohesiveness for 
HMPV-induced genes. In general, both average degree and the physical cohesiveness 
increased in the time course of infection. The observed increase in physical cohesiveness 
in the course of HMPV infection suggests the existence of biologically coherent 
functional modules, like those for apoptosis (van Diepen et al., 2010), being elicited in 
response to the infection. This observation is in agreement with other interactome–
transcriptome studies that posit that there is a correlation between transcription pattern 
similarities of a pair of genes and there being an interaction between their protein 
products (Ge et al., 2001; Hahn et al., 2005; Wachi et al., 2005).
Moreover, the biologically coherent information observed so far using PIE sets the 
premise to predict genes that might be relevant to HMPV-infection biology but not yet 
expressed at the particular time point of infection being studied. We observe that the 
propagation of a physically cohesive network rapidly leads to a less cohesive network; a 
phenomenon that is likely due to the change in context from which the genes in the 
original network were chosen to the global context of the general PPI network. This 
observation is in agreement with other studies indicating that there is a correlation 
between network distance (distance apart in a PPI network) and functional distance 
(semantic similarity in functional category) between proteins in a PPI network. That is, 
the closer two proteins are in a PPI network, the more similar are their function 
annotations (Sharan et al., 2007). In this light, we could predict 5–41% of the genes that 
would be overexpressed at future time points of the infection. Although the positive 
predictive values for these predictions are low (<11%), mainly due to the rapid growth of 
the propagated networks, they are significant (P ≤0.001, Supplementary Table 1) even 
after randomizations based on networks of the same sizes and degree distributions as 
those of the test networks (i.e. the PIE approach).
PIE is different from general methods designed to derive functional insights from a set 
of genes by integrating gene lists with general PPI networks mainly in the sense that 
most of these methods are aimed at decomposing the network into smaller clusters or 
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functional modules (Sharan et al., 2007). As such it is difficult to directly compare PIE with 
other methods. Notwithstanding, PIE is a very strict and globally unbiased approach. 
Even though PIE scores are in general not very high (the increase in the average number 
of interactions relative to the random networks is about 5–10%) they can nevertheless 
be deemed significant or not (i.e. they are informative). Moreover, the PIE procedure is 
very reliable, in the sense that it mimics the degree distribution of the network that is 
being tested exactly. A disadvantage of this approach is that it limits the number of 
alternative, independent networks that can be extracted from the global network for 
comparison with the network under investigation. An alternative would be to relax this 
constraint slightly by either modeling or binning the degree distribution and extracting 
networks with that modeled or binned distribution. This would also have the advantage 
that the physical cohesiveness of networks with many high degree nodes could be 
assessed (Koyuturk et al., 2007).
Contingencies with respect to the interactions, like inhibition or stimulation, are not 
available at a scale that allows systematic comparisons of networks. Such information 
would of course make the networks more specific, allowing more meaningful 
comparisons with respect to their biological cohesiveness. Nevertheless, regardless of 
the source of experimental or inquisitional bias, PIE circumvents gene enrichment 
biases in a global manner as has been shown here using data of morbid genetic disease 
genes, virus-perturbed genes (HMPV), cytokine-perturbed genes (IFNG), bacteria-per-
turbed genes (C.pneumoniae), and even genes perturbed by inert pathogen material 
(uv-irradiated RSV and P.aeruginosa). PIE can in principle be applied to any given set of 
genes to estimate the overrepresentation of protein interactions as a proxy for their 
biological cohesiveness.
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Abstract
Iron is an essential nutrient for microbes. During infection, invading pathogens compete 
for iron with their host cells. However, it is largely unknown whether host innate-immune 
cells use iron for their own functionality as immune effectors, yet keep it from being 
used by the invading microbes. Herein, we developed a computational method called 
Iron Squelch to investigate iron depletion tendencies by host innate-immune cells after 
challenges with various pathogens. The method compares the transcriptomes of 
infected cells with those of an infection-free iron model. The so-called Iron Squelch 
Indexes of gene sets indicate whether at the transcription level, infection mimics 
iron-depletion or iron-overload or none. Iron Squelch analysis reveals that intracellular 
pathogens (human metapneumovirus, respiratory syncytial virus, measles virus, 
parainfluenza virus, influenza A virus and Chlamydia pneumoniae) lead to an iron- 
depletion profile in infected innate-immune cells. Interestingly, an iron-depletion profile 
is also observed in cells infected with uv-irradiated viruses, suggesting iron-depletion as 
an immediate response of innate-immune cells when ‘sensing’ the presence of 
intracellular pathogens. Our analysis further indicates that interferon-gamma also 
induces an iron-depletion profile, suggesting that the pathway is interferon-mediated. 
Furthermore, using transcription factor binding site analysis, we identified sites for 
interferon inducing transcription factors in the promoter sequences of infection-in-
duced and iron-response genes. This provides further support for the iron-depletion 
profile in infected cells being interferon-mediated. Intriguingly, we observed no 
iron-depletion profile for cells infected with extracellular bacteria (Escherichia coli, 
Pseudomonas aeruginosa), nor with lipopolysacchride (LPS), an antigenic component of 
gram negative extracellular bacteria. These observations suggest that iron restriction is 
an intrinsic cellular response when innate-immune cells sense the presence of 
intracellular pathogens.
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1. Introduction
Iron is an essential micronutrient that is required for proper functioning of both microbes 
and host cells. For instance, it is required as a cofactor in iron-sulfur cluster containing 
proteins that are crucial in energy conversion in the mitochondria, in hemoglobin for 
oxygen transport, and in ribonucleotide reductase for DNA biogenesis 1-3. Previously, 
several studies have shown that iron-depletion ameliorates certain infections while 
iron-overload aggravates the infections 4-8. However, the link between iron-homeostasis 
and infections is controversial, as there are conflicting viewpoints that both iron-overload 
9  and iron-depletion 8, 10 could subdue infections. This discrepancy suggests that the 
mechanisms whereby iron influences the crosstalk between host innate-immune 
response and microbial growth has not been fully elucidated. Furthermore, it is 
unknown whether, and how innate-immune cells would modulate their own iron 
homeostasis state when challenged by intracellular or extracellular pathogens. 
The epithelial cells lining the respiratory tract are the first line of innate-immune defense 
against respiratory pathogens, including viruses and bacteria. These cells have also 
been successfully used to study iron-homeostasis 11. Furthermore, the availability of an 
epithelial cell iron-model 12 makes these cells an elegant model to study the immediate 
interaction between host innate-immune cells and pathogens, e.g. on whether the 
innate-immune cells modulate their iron homeostasis in order to function as immune 
effectors, as well as to reduce the availability of iron to the invading microbes. 
  
Respiratory tract pathogens contribute to morbidity and mortality in the young, elderly 
and immune-compromised individuals 13-17 necessitating further investigations into the 
pathogenesis of these pathogens. Several efforts have been made to understand the 
molecular mechanism underpinning these diseases by identifying genes or proteins or 
pathways that are perturbed in expression in infected cells relative to non-infected cells 16, 
18-23. For example, protein expression profiles of lung epithelial cells (A549 cells) infected 
with respiratory syncytial virus (RSV), human metapneumovirus (HMPV), parainfluenza 
virus (PIV), and measles virus (MV) reveal apoptosis as the principal innate-immune 
response that is mounted after infection with these viruses 18. 
In this study, we compare the cellular transcription profiles of genes that are perturbed 
in expression after iron-depletion or iron-overload with their expression profile in cells 
infected by intracellular or extracellular pathogens of the respiratory tract. We developed 
a novel method called Iron Squelch (Figure 1), to examine the iron-related transcription 
profiles of epithelial cells, following infections with HMPV, RSV, PIV, MV and Pseudomonas, 
amongst others. As reference, we used the gene expression data from an infection-free 
epithelial cell iron study 12 and infer that overall, an iron-depletion transcriptome is an 
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intrinsic response of cells infected with live or uv-irradiated intracellular pathogens, 
unlike extracellular pathogens. An iron-depletion transcription profile was also observed 
in interferon gamma-treated cells; suggesting that the mechanism underpinning iron- 
depletion could be interferon mediated. 
Figure 1 -  Scheme of Iron Squelch principle. 
Summing up the total extent of gene expression fold change of a given set of consistent 
iron-response genes can lead to the following scenarios: (a) down-regulation of the 
expression of a set of genes  during iron-depletion as well as during infection, but 
up-regulation of those genes during iron-overload; (b) up-regulation of gene expression 
during iron-depletion as well as during infection, but an overall down-regulation of 
those genes during iron-overload; (c) down-regulation of gene expression during 
iron-overload as well as during infection, but an  up-regulation of the genes during 
iron-depletion; (d) up-regulation of gene expression during iron-overload as well as 
during infection, but down-regulation of those genes during iron-depletion. In scenarios 
a and b, infection mimics iron-depletion, in scenarios c and d it mimics iron-overload. 
All other scenarios are irrelevant to assess iron-related mimicry for our test set of genes. 
For example, scenarios where the overall extent of gene expression is similar during 
iron-depletion and iron-overload; i.e up-regulated (e, f) or down-regulated (g, h) under 
both conditions, are not informative from the iron-response perspective and are 
therefore not included in our analyses of test set of genes, irrespective of the extent of 
regulation of the genes during infection.
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2. Materials and methods
2.1  Iron Model
We used the microarray data (GSE3573) of Chicault and coworkers 12 as a model for the 
effects of iron overload or iron depletion on the transcriptome. Briefly, we used the 
gene sets that were up-regulated in caco-2 cells treated with hemin for 24 h 
(DMEM-Hemin) relative to their expression in cells treated with the same medium 
without hemin (DMEM-FBS) to assess iron-overload. Likewise, cells cultivated in the 
iron-free medium (SF-0) for 48 h were compared with those treated with iron-free 
medium supplemented with FAC (SF-FAC) to assess iron-depletion.
2.2  Iron Squelch analysis
Firstly, by “Squelch” we mean summing up the log
2
 fold changes of a given set of genes.
When the set of genes is selected based on gene expression signals in the iron model, 
we refer to it as Iron Squelch. In this manuscript, we provide results from two types of 
complementary Iron Squelch analyses: Raw Squelch (our normal Squelch method) and 
Absolute Squelch.
2.2.1 Raw Squelch
In Raw Squelch analysis, (i) we intersect two microarray data (the iron-model data and 
another data set of interest (e.g. infection data)) at the level of common genes, to yield 
a dataset with common genes (Equation 1). (ii) From this common dataset, we select all 
genes that are up-regulated upon iron-overload and down-regulated upon iron- 
depletion (Equation 5) or down-regulated upon iron-overload and up-regulated upon 
iron-depletion (Equation 6) at a fold change (FC) threshold of log
2
(1.5). We call these the 
genes of interest (GOI; Equation 2-7). (iii) We finally squelch the combined data by 
directly summing up their log
2
 transformed relative gene-expression values in the 
dataset of interest (e.g. infection data) to yield an Iron Squelch Index (ISI) for infection 
(Equation 8). Furthermore, to serve as positive or negative controls, we also calculated 
the ISI for iron-overload (Equation 9) and iron-depletion (Equation 10) for the same set 
of genes to compare with the ISI of infection. Since the gene-expression fold changes 
have been log-transformed, the ISI values could be positive or negative numbers. A 
positive ISI indicates overall up-regulation of the genes set while a negative ISI indicates 
overall down-regulation.
(iv) In order to estimate a p-value for the ISI and whether it resembles that of 
iron-depletion or iron-overload, we randomly select (from the complete intersected 
array data, Equation 1), the same number of genes as in the GOI set and calculate their 
Squelch Indexes (SIs; Equation 11-13; using expression values from their corresponding 
microarray datasets. The SI for a random gene set is computed irrespective of the 
iron-response pattern (thus SI and not ISI) of the genes. This process is repeated 1000 
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times, and the p-value is estimated as the fraction of times that the random sets of 
genes (background) has a Squelch Index that is greater than or equal to the ISI of their 
corresponding tests (infection, iron-overload, or iron-depletion); given that the ISI of the 
infection data for iron-depletion is greater than that for iron-overload (Equation 14a); 
otherwise, the reverse comparison is done (Equation 14b). If the ISI for iron-depletion 
and iron-overload were the same, the iron-response genes are deemed not informative, 
and the p-value is assigned as “NA”, not available (Equation 14C). As such, if the p-value 
is close to 1, the expression profile of test data does not mimic that of iron-depletion. If 
it is close to zero, the profile resembles that of iron-depletion. 
The Raw Squelch significance test assesses whether, e.g. upon infection the genes that 
are selected because of their consistent behavior upon iron-depletion and iron-overload 
(i.e. being minimally 1.5 fold up-regulated during iron-depletion but down-regulated 
during iron-overload, or vice versa) show a larger change in gene expression than any 
random set of genes. As positive controls we use the gene expression changes upon 
iron-depletion or iron-overload. Any random set of genes will show a smaller effect on 
gene expression upon iron-depletion than the ones that have been pre-selected for 
consistent behavior under iron-depletion and iron-overload. As such, in a test for 
iron-depletion mimicry, a significant p-value for the ISI of iron-depletion serves as a 
positive-control while a non-significant p-value for the ISI for iron-overload serves as a 
negative-control. 
The ISI calculated using the Raw Squelch approach is best interpreted with its associated 
p-value. Unless otherwise stated, any mention of Iron Squelch Index in the manuscript 
text refers to that calculated from the Raw Squelch approach. Using this principle, we 
are pulling genes from other datasets and assessing the overall extent to which they are 
similarly regulated in the iron-model. 
2.2.2 Absolute Squelch
In the Raw Squelch analysis, we select reliable iron-response genes by using a high fold 
change threshold for iron-depletion and iron-overload. This however can lead to low 
number of iron-response genes because the cellular response to iron is limited. In 
Absolute Squelch analysis we (i) lower the fold change threshold from log
2
(1.5) to 
log
2
(1.2) to yield a set of iron-response genes (i.e. FC=log
2
(1.2) in Equation 5 and 6). 
(ii) From these iron-response genes we select only genes that are regulated in similar 
ways in the infection data of interest as in during iron-depletion (Equation 15) or 
iron-overload (Equation 16). (iii) An Absolute ISI (AISI) is then calculated for the genes 
whose expression profile resembles that of iron-depletion (Equation 17) or iron-overload 
(Equation 18). The term “absolute” is used here because in the calculation of the measure 
of similarity, we take the sum of the overall extent of up-regulation of genes (a positive 
number), and the absolute number (a positive number) of the overall extent of down-
regulation (a negative number) of genes.
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The Absolute Squelch approach results in obtaining the iron-related gene expression 
profile from several genes that respond in similar ways as in the iron-depletion or 
iron-overload models. Thus if the magnitude of AISI for the genes in the infection data 
whose expression were similar to those of genes under iron-depletion is greater than 
that for genes regulated in a similar way during iron-overload, we state that the test set 
of genes mimics iron-depletion. If the AISIs are similar, then the test set of genes are not 
informative. The log
2
(1.2) fold change used here is quite low and can potentially increase 
noise in the data. However, deliberately selecting those genes that respond in similar 
ways (rather than pulling all genes) in the iron-model and infection data, could reduce 
the level of noise generated. Therefore an agreement in the predicted profile using Raw 
and Absolute Squelch analyses emphasizes the usefulness of the squelching principle 
for transcriptomics data. 
2.2.3 Algorithm
The equations used for Iron Squelch analyses are as follows:
 (1)
 (2)
 (3)
 (4)
 (5)
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 (6)
 (7)
 (8)
 (9)
 (10)
 (11)
 (12)
 (13)
 (14a)
 (14b)
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 (14c)
  (15)
 (16)
 (17)
 (18)
2.3  Microarray data
The following microarray data sets were obtained from NCBI gene-expression omnibus 
database (GEO) and used as normalized therein. (i) human metapneumovirus (HMPV) 
infection of airway epithelial cells (A549 cells) at 6, 12, 24, 48, and 72 hours post-infection, 
(data accession number GSE8961) 24 . (ii) Respiratory syncytial virus (RSV) infection of 
human bronchial epithelial cells (BEAS-2B cells) for 4 and 24 hours, (data accession 
number GSE3397, contributed by Huang et al, 2001). (iii) Measles virus (MV) infection of 
monocyte-derived dendritic cells at 3, 6, 12, and 24 hours post-infection (data accession 
number GSE980) 25. (iv) Influenza A infection of mice (accession number of the pulmonary 
cells GSE5289) 26. We translated the mouse influenza-induced expression data to 
homologous human gene-expression using the NCBI HomoloGene homology database 
downloaded in November 2006. (v)  Chlamydia pneumonia infection of  human epithelial 
cell line for  12, 24, 48 and 72 hours (GSE7246) 27. (vi) Probiotic E. coli Nissle 1917 infection 
of caco2-cells (intestinal epithelial cells) for 6 hours (data accession number GSE2232, 
the human dataset was used here) 28. (vii) Pseudomonas aeruginosa infection of airway 
epithelial cells for 90 minutes (data accession number GSE4485) 29. (viii) UV-irradiated 
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airway-pathogens treatment of bronchial epithelial cells for 4 hours, (data accession 
number GSE6802) 20; the pathogens concerned are uv-inactivated Staphylococcus 
aureus, Pseudomonas aeruginosa and Respiratory Syncytial Virus. (ix) Lipopolysaccharide 
(LPS) treatment of airway alveolar epithelial cells for 1 and 4 hours (data accession 
number GSE1541) 30. (x)  Interferon gamma (IFNG) treatment of human bronchial 
epithelial cells for 4 and 24 hours (data accession number GSE1815) 31. (xi) Iron-model 
(data accession number GSE3573) 12  made from infection-free iron-treatments of caco-2 
cells. In-house microarray data were kindly provided by Dr Arno Andeweg at Erasmus 
MC, Rotterdam. For all the microarray datasets, the fold changes of genes were obtained 
by dividing gene response of treated to untreated samples. Geometric means of all fold 
changes (log
2
) were used for all probesets pertaining to a gene. That average value is 
the effective fold change measures used per gene. Unless otherwise stated, we used a 
fold change threshold of ≥1.5 or ≤1/1.5 to determine up-regulation or down-regulation 
respectively. 
2.4  Additional data and Statistics
All “iron” related genes were obtained from NCBI GO database of 2008. There were a 
total of 309 such genes. Chi-squared p-values were obtained using Pearson’s Chi-squared 
test with Yates’ continuity correction as implemented in the statistical package R. The 
P-values for two sampled tests were obtained using Wilcoxon paired test as implemented 
in the statistical package R.
2.5  Transcription factor binding site analysis
For transcription factor binding sites (TFBS) determination, we obtained sequences 
2000 base pairs upstream of the promoter of a given set of genes using the Ensembl 
Genome Browser track of refseq sequences of the March 2006 human genome assembly 
32, 33.  We determined Transcription Factor Binding Sites (TFBS) in these 2000bp upstream 
regions using the Clover (Cis-element over representation) algorithm 34. Briefly, Clover 
screens a given set of DNA sequences against a precompiled library of TFBS motifs and 
reports the motifs that are statistically over-represented or under-represented. As input 
to Clover, we used 263 human TFBS motifs garnered from JASPAR core 2005 35, and 
TRANSFAC 36 version 7.0 as the precompiled library of TFBS motifs. We used sequences 
2000bp upstream of promoters of all human genes as background. All TFBS results 
reported were statistically over-represented TFBS motifs that were obtained at a p-value 
cutoff of <=0.05 against background and the default motif score threshold of >=6. 
Using in-house Python scripts, we further provide graphical displays of the over-repre-
sented TFBSs that were present in the 2kb upstream region of the set of genes being 
examined. 
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3. Results
3.1   Genes perturbed in expression in infected epithelial cells 
include iron-related genes
To determine whether iron-related genes are affected in expression in infected epithelial 
cells, we queried the Gene ontology (GO) database at NCBI (http://www.ncbi.nlm.nih.
gov), and the infection-free iron epithelial cell model of Chicault and colleagues 12 for 
genes that we found to be perturbed in expression (i.e. at least 1.5-fold up-regulated or 
down-regulated) after virus infection of epithelial cells.
We identified 31 out of 277 genes that have “iron” as a keyword in their description in 
GO, to be perturbed ( ≥1.5 fold) in expression in epithelial cells post infection with HMPV, 
RSV, PIV or MV relative to un-infected control cells (Supplemental Figure 1). These 31 (out 
of 1167) virus-perturbed genes, highlight a small but significant crosstalk (chi-squared 
p= 2.94e-02) between cellular response to virus and iron-related processes. 
Furthermore, we identified 52 out of 299 genes that are perturbed either during iron- 
depletion or during iron-overload in the infection-free iron model of Chicault and 
others 12, to be also perturbed in expression post virus infection (Figure 2). These 52 (out 
of 1167) virus-perturbed genes, also indicate a significant crosstalk (chi-square p=3.35e-09) 
of cellular gene expression response to virus and iron. 
3.2   Innate-immune cells that are infected with intracellular 
pathogens show an iron-depletion transcriptome profile
The significant overlap of iron-perturbed and virus-perturbed genes suggests a 
crosstalk between iron homeostasis and innate-immune responses to the viruses 
examined. However, it is not clear whether the gene expression of infected cells mimics 
an iron-depletion or iron-overload situation. To determine this, we measured the 
iron-profile of infected cells using Iron Squelch analysis (details in Methods). Briefly, this 
method compares the overall gene expression response to infection with the expression 
response of the same genes to iron-overload or iron-depletion. The genes examined 
are those that behave consistently during iron-depletion and iron-overload: i.e. they are 
either up-regulated (≥ log
2
(1.5) fold) during iron-depletion and down-regulated during 
iron-overload, or they are down-regulated during iron-depletion and up-regulated 
during iron-overload. Using this set of consistent iron-response genes, we compare the 
sum of their log
2
 gene expression fold change (Iron Squelch Index; Equations 8-10) 
under conditions of (1) iron-depletion relative to control, (2) iron-overload relative to 
control and (3) infection relative to non-infection control. 
Subsequently, we judge using the Iron Squelch Indexes of iron-depletion and of 
iron-overload whether the gene expression profile of infection mimics that of 
iron-depletion or that of iron-overload. To achieve this, we compare the sum of log
2
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gene expression change of random set of genes from a test situation (e.g. infection) 
with that of the consistent iron-depletion/iron-overload selected set of genes. We 
compare this value against that obtained from the condition wherein the set of genes 
changed the most (generally the depletion set of genes) and we check whether the 
Figure 2 -  The 52 virus-perturbed genes that are also perturbed by iron-overload or 
depletion, rsv6 and rsv6uvd refer to data of 6 hours of live and uv-irradiated 
RSV infection Respectively,  RSV, respiratory syncytial virus; HMPV, human meta-
pneumovirus; MV measles virus; PIV, parainfluenza virus;  depletion, iron-
depletion; overload,  iron-overload.  
(Red >=1.5 fold up-regulated; blue >=1.5 fold down-regulated; white not up to 1.5 fold 
perturbed relative to control cells.)
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sum of changes is larger. P-values for these similarities are estimated as the number of 
instances out of 1000, whereby a random set of genes (background) of the same size as 
the test set, has a Squelch Index that is higher than that of the test set of consistent 
iron-response genes.
To serve as controls, we can also do that for random genes affected in the condition of 
iron-depletion or iron-overload, sum their changes, and compare that to the pre- 
selected, consistently behaving iron-response set of genes. The pre-selected genes 
show, one average, lower expression upon iron-overload than do randomly selected 
genes. The pre-selected genes do give a higher change upon iron-depletion than a 
random set of genes, even though some of these genes will actually be down-regulated 
upon iron-depletion.
3.2.1  Iron Squelch analysis reveals that live virus infections mimic iron- 
depletion at the level of gene expression of host cells
First, we applied Iron Squelch, using genes (n=41) that are oppositely perturbed in 
expression in the iron-depletion and iron-overload models, to the expression data of 
A549 cells infected with HMPV, RSV, PIV or MV. The squelch index for iron-overload was 
-3.25 while that for iron-depletion was 13.16. Since iron-depletion is opposite to 
iron-overload, we can use their Squelch Indexes to determine which of the two iron-
conditions is better mimicked by the same set of genes in virus-infected cells. Based on 
these Squelch Indexes, we found that live virus infections mimic iron-depletion at the 
level of gene expression (Figure 3). The iron-depletion profile appears to increase over 
time of infection with live viruses (e.g. for HMPV, Iron Squelch Index= 8.11 (p<0.001), 
12.29(p=0.001) and 13.83(p<0.001) for time points 6, 12 and 24h respectively). 
The iron-depletion profile is also observed in other published data sets, like in HMPV 
infected-A549 cells24, RSV-infected bronchial epithelial cells (Huang et al, 2001), MV–
infected monocyte-derived dendritic cells25 and Influenza–infected lung epithelial 
cells26 (Supplemental Figures 2-5 respectively). 
Using the complementary approach, Absolute Squelch approach, one can also calculate 
whether infection mimics iron-depletion or Iron-overload by comparing the absolute 
sum of expressions of genes that are down-regulated upon infection and also down- 
regulated upon iron-depletion but up-regulated  under iron-overload; or up-regulated 
upon infection and also up-regulated upon iron-depletion but down-regulated upon 
iron-overload. The reverse comparison can also be done. With such stringent rules, a 
low fold threshold of gene expression (log
2
(1.2) ) for infection, iron-depletion and 
iron-overload) is used. We observe using the Absolute Iron Squelch approach, that 
similar to the normal Raw Iron Squelch approach, virus infections mimic an iron-depletion 
profile (Figure 4).
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3.2.2  Iron Squelch analysis reveals that uv-irradiated virus infections mimic 
iron-depletion at the level of gene expression of host cells
Secondly, we applied Iron Squelch analysis to cells infected with dead viruses; i.e. 
uv-irradiated viruses. Interestingly, cells infected with uv-irradiated viruses exhibit a 
profile similar to that of iron-depletion (Figures 3&4). However, as opposed to that of 
their live viral counterparts, the iron-depletion profile for cells infected with uv-irradiated 
viruses decreases over time of infection (e.g. for uv-irradiated HMPV, Iron Squelch Index= 
6.89 (p<0.001), 4.87(p<0.001) and 1.79(p=0.016) for time points 6, 12 and 24h respectively 
(Figure 3). The iron-depletion profile is also observed in a published dataset of which 
bronchial epithelial cells were infected with uv-irradiated RSV20 (Supplemental Figure 6).
Figure 3 -  Profiles from Raw Squelch analysis of genes perturbed in expression in A549 
cells infected with HMPV, RSV, MV and PIV for 6, 12 and 24 hours.
This involves genes that are up-regulated in iron-depletion but down-regulated in 
iron-overload, or vice versa. There are 41 such genes at a fold change threshold (FC) of 
at least 1.5 for up-regulated genes and at most 1/1.5 for down-regulated genes in the 
iron-depletion and overload models. The Squelch index (y-axis) reported is the sum of 
the log
2
 gene-expression fold changes for the  gene set. A low p-value, indicates that 
the infection mimics iron-depletion. (Boxplot : random; grey diamond:test.  Respectively, 
rsv6 and   rsv6uvd refer to data of 6 hours of live and uv-irradiated RSV infection, etc. RSV, 
respiratory syncytial virus; HMPV, human metapneumovirus; MV measles virus; PIV, 
parainfluenza virus;  depletion, iron depletion; overload,  iron-overload.)
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3.2.3  Iron Squelch analysis reveals that intracellular bacteria infections mimic 
iron-depletion at the level of gene expression of host cells
Thirdly, we calculated the Iron Squelch Indices for a non-viral intracellular pathogen of 
the respiratory tract; Chlamydia pneumoniae. Interestingly, the transcription profile of 
human epithelial cells infected with this intracellular bacterium also shows iron-depletion 
profile (Squelch Index=2.98 (p=0.02), 7.11(p<0.001), 8.26(p<0.001) and 7.25(p=0.001) for 
12, 24, 48 and 72h after infection; Supplemental Figure 7). This profile is similar to that of 
the other intracellular pathogens, the viruses. 
Overall, the iron-depletion profile is likely part of an intrinsic host cell response because 
it is elicited by both live and dead viruses, and also by C. pneumoniae. 
Figure 4 -  Profiles from Absolute Squelch analysis of genes perturbed in expression in 
A549 cells infected with HMPV, RSV, MV and PIV for 6, 12 and 24 hours.
This involves genes that are up-regulated in iron-depletion but down-regulated in 
iron-overload, or vice versa, and the expression of the genes in the virus infection data 
is either similar to that of iron-depletion or iron-overload. The Squelch index (y-axis) 
reported is the sum of the absolute sum of the log
2
 gene-expression fold change of 
down-regulated genes and that of up-regulated genes. Overload similar and Depletion 
similar respectively refer to the squelch index of the set of virus-perturbed genes that 
have similar expression (up-regulated or down-regulated at FC 1.2) in the iron-depletion 
or iron-overload model. The magnitude of the y-values signifies the measure of similarity 
of infection-induced gene response to that of iron-overload and iron-depletion. 
(Respectively, rsv6 and rsv6uvd refer to data of 6 hours of live and uv-irradiated RSV 
infection, etc. RSV, respiratory syncytial virus; HMPV, human metapneumovirus; MV 
measles virus; PIV, parainfluenza virus; depletion, iron-depletion; overload, iron-overload.)
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3.3   Innate-immune cells treated with interferon gamma show an 
iron-depletion profile 
Given that both viruses and C. pneumoniae induce the expression of interferon gamma 
(IFNG) in innate-immune cells, as part of the innate-immune response 37, 38, we examined 
the transcription profile of bronchial epithelial cells treated with this cytokine. 
Interestingly, IFNG also induced an iron-depletion profile in cells (Iron Squelch Index=5.33 
(p=0.022), 5.17(p=0.03) after 8 and 24hr of IFNG treatment respectively; Supplemental 
Figure 8). The iron-depletion profile induced by IFNG treatment suggests that the 
iron-depletion profile could be the result of innate-immune strategies induced at least 
via an IFNG pathway. 
3.4   Innate-immune cells infected with extracellular microbes do  
not show an iron-depletion profile 
Having established an iron-depletion profile for IFNG and the intracellular pathogens 
discussed above, we then proceeded to assess the iron profile for extracellular pathogens. 
In epithelial cell cultures infected with extracellular bacteria Pseudomonas aeruginosa 
and Escherichia  coli, we observed no iron-depletion profiles; rather there appears 
even to be a small extent of iron-overload profile when compared to background 
(Supplemental Figures 9-10). In addition, examination of alveolar epithelial cells exposed 
to lipopolysaccharide (LPS), a bacterial surface component, also showed no iron- 
depletion profile (Supplemental Figure 11). Furthermore, examination of uv-irradiated 
airway pathogens in bronchial epithelial cells indicates that the extracellular bacteria 
Staphylococcus aureus and Pseudomonas aeruginosa do not cause an iron-depletion 
profile as strongly as did RSV used in the same study (Supplemental Figure 6).
3.5   Virus-induced and iron-responsive genes highlight a crosstalk 
between iron homeostasis and innate immunity
Having established an iron-depletion profile for the pathogens examined, it is imperative 
to examine the functions of the genes whose expression is affected to understand the 
mechanism underpinning a potential crosstalk between iron homeostasis and infection. 
For brevity, we shall henceforth use the data from virus infection to represent intracellular 
infection. In the Iron Squelch analyses, we selected iron-response genes using the strict 
criterion that the genes had to be expressed in opposite ways under iron-overload and 
iron-depletion at least 1.5 fold relative to control. This yielded 41 genes, 15 of which 
were at least 1.5 fold up-regulated or down-regulated in at least one time point post 
virus-infection. The 15 genes are ADM, BIRC3, FOS, G0S2, INHBB, ISG20, KIF14, LIPH, MT1E, 
MT1H, MT1M, MT2A, NPTX1, S100A3 and TMEM140. In order to have a more comprehensive 
overview of iron-related genes that are affected following infection, we increased the 
number of genes in this list by relaxing this criterion and considered a gene to be iron-
informative if it is at least 1.5 fold up-regulated or down-regulated in expression during 
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iron-depletion or iron-overload relative to their respective controls. Out of 1167 genes 
perturbed (>=1.5 fold relative to control) by either live or uv-irradiated HMPV, RSV, PIV, or 
MV at time points of 6, 12 or 24 hours post infection, 52 are  iron-informative (Figure 2). 
With the exception of HMOX1 which was up-regulated at early infection time points but 
down-regulated later in infection, the remaining 51 genes were consistently down- 
regulated or up-regulated during infection. 
In order to uncover the common theme between immune-response and iron-responses, 
we further classify the 51 consistently expressed genes in Figure 2 into 4 groups (Table 1) 
for a detailed examination of the genes that respond similarly after virus-infection and 
iron treatment. The relation to innate immunity and iron homeostasis for the genes in 
the 4 groups are described below.
The first group consists of genes (n=10) that are up-regulated in iron-replete and 
virus-infected cells (group 1 in Table 1). These genes encode proteins that are related to 
iron-handling and metal detoxification; e.g metallothioneins (MT1E, MT2A, MT1H, MT1F and 
MT1M). Metallothioneins are known to be induced to bind iron during iron toxicity. This 
equally applies to other metals like zinc and copper [29, 30]. Other members in this group 
include the gene encoding G0S2 that modulates cell cycle arrest 39  and is known to 
specifically interact with BCL2 to promote apoptosis by preventing the formation of 
protective BCL2/BAX heterodimers 40. SP110, otherwise known as intracellular parasite 
resistant 1(IPR1) is an interferon inducible gene that has been shown to exert innate immune 
response against viruses and other intracellular parasites like Mycobacterium tuberculosis 
and Listeria monocytogenes by up-regulating apoptosis 41-43. ARNTL2 is a transcription factor 
that has recently been reported to compensate for the dysfunction of its paralog, ARNTL1, 
which is a core component of the circadian clock and controls innate-immune reactions 
involving macrophages 44, 45. Overall, genes encoding both iron-sequestering and immune- 
related proteins are up-regulated in iron-replete and virus-infected cells.
The second group consists of genes (n=28) that are up-regulated in iron-depleted and 
virus-infected cells (group 2 in Table 1). This is the largest of the 4 groups; underlining 
major crosstalk between iron-depletion and viral infection. The genes in this group 
include ISG20, IL32 and BIRC3 amongst others that are known to activate innate immune 
responses against viruses 46-48. Overall, antiviral genes are up-regulated in iron-depleted 
and virus-infected cells.
The third group consists of genes (n=8) that are down-regulated in iron-replete and 
virus-infected cells (group 3 in Table 1).  Amongst these is the gene that encodes TP53I3 
which is involved in p53-mediated cell death 49. In addition, INHBB 50 , FHL2 51 and  CERK 
52, 53  are  known to promote cell growth  and proliferation. Overall, cell proliferation 
genes are down-regulated in iron-replete and virus-infected cells.
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The fourth group consists of genes (n=5) that are down-regulated in iron-depleted and 
virus-infected cells. Amongst these are genes encoding PIR which facilitates DNA 
replication by use of its ferric active site 54 and KIF14 which has been shown using RNA 
interference, to be crucial for cytokinesis progression 55. Overall, cell proliferation genes 
are down-regulated in iron-depleted and virus-infected cells.
3.6   Binding sites for interferon-related transcription factors  
are over- represented in the promoter region of iron-responsive 
genes up-regulated post viral infections
Changes in gene expression such as observed in infections are commonly regulated by 
transcription factors. It is not known whether there are any transcription factors that are 
triggered in expression both during viral infection and during iron-depletion or 
iron-overload. To predict candidate transcription factors involved in regulation of both 
infection-related and iron-related genes, we performed transcription factor binding site 
analysis (see Methods) on the regions 2kb upstream the start sites of these genes. 
The promoter regions of genes that are up-regulated during iron-overload and virus 
infection (group 1 in Table 1) are significantly enriched (p<0.05) in sites for ISRE (interferon- 
Table 1 -  Summary of the 51 genes perturbed in expression by both iron  
and virus.
Group no. Description Genes Overrepresented TFBS
1 relatively up-
regulated in 
iron-replete and 
virus-infected cells
ARNTL2, G0S2,  MT1E, MT1F,
MT1H, MT1M, MT2A, SGK3,  
SP110, ZFP36L2
C/EBP, c-Myc:Max, COUP-TF_
HNF-4, FOXL1, Hox11-CTF1, IRF1, 
ISRE, NF-1, NF-kappaB, NR2F1, 
Oct-1, USF
2 relatively up-
regulated in 
iron-depleted and 
virus-infected cells
ADM, BIRC3, DUSP6, EFNA1, 
EGR1, EMP1, FOS, GADD45A, 
IGFBP3, IL1A, IL32, ISG20, 
KLF6, LAMB3, LAMC2, LDLR, 
LIPH, MMP7, NPTX1, PLAU, 
S100A3, SAT1, SERPINB1, STC2, 
TMEM140, TXNIP, UBD, UGCG
AP-1, C/EBP, c-Rel, FOXD1, 
FOXF2, Freac-2, Freac-3, GATA-1, 
GR, NF-kappaB, Oct-1, Pax-2, 
REL, RELA, SOX9, SRF, STAT1, 
STAT3, STAT4, STAT5A, STAT6
3 relatively down-
regulated in 
iron-replete and 
virus-infected cells
CERK, DDIT4, DEPDC7, FHL2, 
INHBB, MKI67, TACSTD1, TP53I3
E2F, Egr-2, LUN-1, MAZR, NFIL3, 
NF-kappaB, Sp1, STAT5A
4 relatively down-
regulated in 
iron-depleted and 
virus-infected cells
APOH, GCLM, HADH , KIF14, 
PIR
BSAP, MyoD, NF-Y
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stimulated response element), IRF1 (interferon regulatory factor 1), and NF-kappaB amongst 
others (details in Supplemental Table 1 and Supplemental Figure 12). Interestingly, IRF1 is 
up-regulated in both iron-overload and infection. IRF1 activates expression of interferons 
alpha, beta and gamma and represses proliferation of cells 56, 57. This observation 
suggests interferon involvement in regulation of cellular iron-homeostasis and virus 
infection.  
The promoter regions of genes that are up-regulated during iron-depletion and virus 
infection (group 2 in Table 1), are enriched in binding sites for transcription factors like 
NF-kappaB, STAT-1, 3, 4, 5A and 6 amongst others (details in Supplemental Table 2 and 
Supplemental Figure 13). Early cellular responses to human interferons are critically 
dependent on the amount of STAT1 and are essential for the appropriate control of 
intracellular infections 58. The enrichment of binding sites for STAT transcription factors 
in the promoter region of genes that are up-regulated during iron-depletion and virus 
infection suggests induction of interferon-induced genes.
The promoter regions of genes that are down-regulated during iron-overload and virus 
infection (group 3 in Table 1) are enriched in binding sites for factors like Sp1, NF-kappaB, 
and NFIL3 amongst others (details in Supplemental Table 3 and Supplemental Figure 
14). Interestingly, SP1 binding in the promoter of FHL2 have been recently confirmed in 
functional assays at the region -1058 to -1049 nucleotides upstream the gene 59; a region 
we also predicted. MAZR and SP1 are known to facilitate cellular proliferation 59, 60.
The promoter regions of genes that are down-regulated during iron-depletion and 
virus infection (group 4 in Table 1) are enriched in binding sites for NF-Y, BSAP and MyoD 
(Table1, Supplemental Table 4 and Supplemental Figure 15). BSAP is involved in B cell 
development and proliferation 61 , and has been suggested to inhibit apoptosis by 
modulating BCL2 62. In addition, MYOD mRNAs have been observed to be suppressed, 
at a posttranscriptional level,   under inflammatory conditions, such as where cytokines 
like tumor necrosis factor, interferon gamma or NF-kappaB are induced 63.
Overall, for groups 1-4, some of the transcription factors whose binding sites were 
predicted, e.g. IRF1 are expressed in the iron model and/or virus infection (Supplemental 
Table 5). Taken together, the promoter regions of genes that are up-regulated during 
iron-overload and virus-infection have binding sites for interferon regulatory factors. 
Those that are up-regulated during iron-depletion and virus infection are rich in factors 
like STAT1 (signal transducer and activator of transcription 1) which are known to be 
induced by ligands like interferon gamma 64, 65. The observation of interferon related 
transcription factor binding sites in these genes further supports our hypothesis that 
interferon gamma  maybe involved in mediating the iron-depletion profile in cells.
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4. Discussion
Using Iron Squelch analysis on cellular transcriptomics data, we observed, an iron- depletion 
profile for both live and uv-irradiated viruses. We also observed an iron-depletion profile 
for Chlamydia and interferon gamma but not for LPS or for the extra cellular bacteria 
Pseudomonas aeruginosa and Escherichia coli. One possible explanation for these 
observations is that the host cell restricts iron from the niches of the pathogens in the 
cell-infection models, and that the gene expression profile we observe is a secondary 
response to that. Our observations constitute an important contribution to innate 
immunity wherein immune-related iron homeostasis has been evaluated mainly for 
pathogens like Plasmodium7, hepatitis C virus 9, 10, HIV 8  and Chlamydia 66  that mainly 
infect cells of the reticuloendothelial system. Cells in the latter system have rich iron 
stores earmarking them for iron-related investigations.
How do host innate-immune cells project iron-depletion profile? 
Given that iron cannot be secreted from the cell 2, 5  and that the viruses examined here 
are not yet known to utilize iron directly,  we wonder how iron would be sequestrated 
in order to trigger the iron-depletion profile observed. We mined scientific literature for 
iron-related genes, including those not informative in the iron-model 12 used here; and 
that are affected in expression post HMPV24 infection to ensure that they are associated 
with both iron and virus. These genes are summarized in Supplemental Figure 16. We 
suggest 3 possible iron-depletion profile strategies as discussed below.
(1) Iron-depletion mediated by binding of the metal by metalloproteins
Firstly, cellular iron-depletion could result from scavenging of the metal by metallopro-
teins such as metallothioneins, which we observed to be up-regulated in expression in 
the iron-overload model and virus-infected cells (Figure 2 and Supplemental Figure 16). 
Metallothioneins are generally known to  bind and transport metals like zinc,  copper 
and iron and help in protection against metal toxicity 67, 68 . Iron-scavenging during viral 
infection is further supported by an up-regulation of the gene LCN2 (Supplemental 
Figure 16) which is known to sequester iron in a transferin-independent way 69, 70  and 
has been shown to lead to cellular iron-depletion in macrophages infected with the 
intracellular bacteria Salmonella typhimurium 71. 
(2) Iron-depletion mediated by redistribution of iron to the mitochondria
Secondly, cellular iron-depletion could result from iron influx into mitochondria which 
are the main cellular organelles for iron utilization, in processes like haem biosynthesis 
and ATP generation. Among genes that are associated with mitochondrial iron import 
are those encoding the mitoferrins SLC25A28 and SLC25A37 that are up-regulated 
during viral infection (Supplemental Figure 16) and are known to export cytosolic iron 
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to the mitochondria 72. Further supporting iron influx into the mitochondria is the 
down-regulation (in virus-infected cells) of other genes like the mitochondrial nucleoside 
diphosphate kinase (NME4) (Supplemental Figure 16). NME4 converts ATP to GTP 73 ; and 
low levels of mitochondrial GTP have been associated with excessive mitochondrial 
iron-overload mediated by repression of this kinase 74, 75. Furthermore, the virus-induced 
down-regulation (Supplemental Figure 17) of genes encoding ferritin (FTH1 and FTL, 
used for cytosolic iron storage); transferrin receptor C (TFRC, used for cytosolic iron 
import); and cytosolic aconitase (ACO1, used for cytosolic conversion of citrate to 
isocitrate during iron-overload 1, 72), is indicative of persistent cytosolic iron-depletion 
suggesting re-channeling of cytosolic iron into an organelle.
(3) Iron-depletion mediated by interferons and interferon induced genes
Thirdly, iron-depletion could result from interferon production in infected host cells. We 
observed that epithelial cells treated with IFNG (data from 31 ) showed an iron-depletion 
profile (Supplemental Figure 7). Moreover, both HMPV-infected and IFNG-treated 
epithelial cells exhibit a time-wise decrease in ferritin and the iron-import receptor TFRC 
(Supplemental Figure 16). It is important to note that TFRC promotes cellular iron import 
in non-infected cells. However, during HMPV infection and IFNG treatment, TFRC is 
down-regulated in expression (Supplemental Figure 17); suggesting maintenance of a 
persistent iron-depletion status during viral infections.
In addition, the promoter regions of genes that are up-regulated during iron-depletion 
and after viral infections are enriched in binding sites for STAT transcription factors 
which generally induce and are also induced by ligands like interferon gamma 57. Other 
studies corroborate our observation of interferon mediated iron-depletion by showing 
that IFNG is coupled to down-regulation of transferrin receptors culminating in iron-
starvation and depletion 76. Interferon-mediated iron-depletion is particularly interestingly 
because it suggests that the genes that are similarly expressed post virus infection and 
iron-overload; or post virus infection and iron-depletion both point towards an 
iron-depleting profile of infected cells. Reduced-iron import, mediated by interferons, is 
a likely strategy used  by the infected cells to effect an iron-depletion profile.
Why do host innate-immune cells promote an iron-depletion profile during 
viral infection? 
The genes (e.g. ISG20, IL32 and BIRC3 amongst others) that are up-regulated during 
iron-depletion and virus infection are pro-apoptotic 46-48. This is interesting because 
apoptosis promotes innate immunity by indirectly curbing proliferation of intracellular 
pathogens 77. Furthermore in line with iron-depletion being a possible defense strategy 
that is mediated by interferons, recent literature indicates that iron supplementation to 
human endothelial cells which are infected with Chlamydia pneumonia, augments 
chlamydial proliferation and differentiation; while IFNG (promotes iron-depletion profile) 
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had an inhibitory effect on cellular proliferation 66. Cellular iron-depletion is likely important 
in limiting the spread of intracellular infections by at least limiting the number of host cells.
Overall, the crosstalk between iron homeostasis and intracellular infections points towards 
iron-depleting phenotype, activation of innate immunity, apoptosis and repression of 
cellular proliferation. Our observation that live and uv-irradiated intracellular pathogens 
induce an iron-depletion profile while extracellular bacteria did not, urges us to address 
the issue of co-infections during host-pathogen interactions. Co-infections of viruses with 
some bacteria have been shown to cause a pronounced elimination or enhanced 
persistence of both infections. We suggest that the pathogen-dependent pattern of iron-
distribution of innate-immune cells could be compromised during co-infections when 
the immune system redistributes or restricts iron from one microbe’s niche to that of the 
other.  For instance in virus-bacteria co-infection studies, it has been shown that influenza 
virus and Staphylococcus or Pseudomonas, exacerbate respiratory disease 17, 78, 79. 
Conversely, co-infection in the same niche could ameliorate the ramifications of both 
individual infections where iron is synergistically excluded from the colonizing niche as a 
response to both infections. In this regard, there is a relative paucity of virus-virus 
co-infections. Moreover where they occur, such co-infections have not been associated 
with disease severity 80-82 . Such patterns have been seen with different types of viruses. 
For instance RSV and influenza are not associated with more severe signs than their single 
infections in children 83.  Moreover, as reviewed in 84,  attenuation of HIV-1 replication  has 
been observed during co-infection with  viruses like measles virus, HIV-2,  GB virus C,  and 
human T lymphotropic virus types 1 and 2.  Furthermore, co-infection with two obligate 
intracellular pathogens, HIV and the Chlamydia relative Orientia tsutsugamushi, has been 
shown to be detrimental to the virus-bacteria pair 84, 85 . 
In conclusion, we have examined the crosstalk between iron-homeostasis and microbial 
infections. Our observations using Iron Squelch analysis, suggest that iron restriction 
from pathogens might be a general cellular response. Cellular iron-depletion might be 
interferon mediated leading to an iron-depletion profile during intracellular infections. 
These findings may help explain in part the molecular mechanisms underpinning 
disease exacerbations or attenuation from the perspective of iron homeostasis and the 
cellular niche(s) of co-infecting pathogens. We suggest that the synergism or antagonism 
between infections from an iron-homeostasis perspective be experimentally examined.
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Abstract
Background
MicroRNAs (miRNAs) play a fundamental role in the regulation of gene expression by 
translational repression or target mRNA degradation. Regulatory elements in miRNA 
promoters are less well studied, but may reveal a link between their expression and a 
specific cell type.
Results
To explore this link in myeloid cells, miRNA expression profiles were generated from 
monocytes and dendritic cells (DCs). Differences in miRNA expression among 
monocytes, DCs and their stimulated progeny were observed. Furthermore, putative 
promoter regions of miRNAs that are significantly up-regulated in DCs were screened 
for Transcription Factor Binding Sites (TFBSs) based on TFBS motif matching score, the 
degree to which those TFBSs are over-represented in the promoters of the up-regulated 
miRNAs, and the extent of conservation of the TFBSs in mammals.
Conclusions
Analysis of evolutionarily conserved TFBSs in DC promoters revealed preferential 
clustering of sites within 500 bp upstream of the precursor miRNAs and that many 
mRNAs of cognate TFs of the conserved TFBSs were indeed expressed in the DCs. Taken 
together, our data provide evidence that selected miRNAs expressed in DCs have 
evolutionarily conserved TFBSs relevant to DC biology in their promoters.
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1. Background
In recent years, microRNAs (miRNAs) have taken center stage, as they are key regulators 
of gene expression at the post-transcriptional level, and play a fundamental role in a 
wide variety of biological processes, such as cell growth, development and several 
pathological conditions [1-3]. MicroRNAs are small, ~22 nt long, single-stranded 
molecules which, when complexed with an RNA-induced silencing complex (RISC), are 
able to form a complementary double-stranded RNA structure by hybridizing to the 3’ 
untranslated region of target transcripts, and inhibit translation of their cognate mRNA 
and/or promote their degradation [4]. MicroRNAs have an established role in 
hematopoietic development and immunity. For example, forced expression of miR-181 
in hematopoietic progenitors leads to an increase in the number of B cells [5], whereas 
it sets T cell receptor signaling thresholds by targeting negative regulators [6]. 
MicroRNA-146a is up-regulated during toll-like receptor (TLR) signaling and targets TNF 
receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK1) [7], 
thereby serving in a negative feedback loop. Moreover, miR-155 is also up-regulated 
during TLR and TNF signaling [8], and is required for normal immune function [9-14].
Although great strides have been made towards understanding the biogenesis of 
miRNAs [4] and the identification of mRNA targets [15], their own expression is one of 
the least understood aspects. They are transcribed by RNA polymerase II [16] or RNA 
polymerase III [17]. In addition, approximately 80% of miRNAs are located in introns of 
protein coding genes, but at least one third is believed to be transcribed independently 
from their host gene [4, 18-20], whereas recent data suggest that most, if not all, intronic 
miRNAs contain putative promoters independent of their host gene [21]. In fact, it is 
now believed that once physically accessible, a gene is regulated by transcription 
factors that bind to their cognate transcription factor binding site (TFBS) in its promoter. 
Usually, there is more than one TFBS per gene, allowing combinations of transcription 
factors to elicit gene transcription. This phenomenon has been predicted for instance in 
Plasmodium falciparum, a parasite with a dearth of transcription-associated factors 
[22-24] and has been experimentally validated in other eukaryotic promoters [25, 26].
Myeloid dendritic cells (DCs) and monocytes arise from a common monocyte/dendritic 
cell progenitor [27]. In vitro, DCs can be generated from blood-derived monocytes 
when cultured in the presence of the cytokines interleukin 4 (IL4) and granulocyte/
macrophage colony stimulating factor (GM-CSF) [28]. DCs play an important role in innate 
immunity and the initiation of adaptive immune responses. They capture foreign 
antigens in peripheral tissues, migrate to the T-cell areas of secondary lymphoid organs 
and present these antigens to T- and B-cells. Depending on the extracellular signals 
they receive, they either induce tolerance in the steady state (tolerogenic DCs), or an 
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inflammatory response in the presence of pathogen-associated patterns (PAMPs) or 
inflammatory cytokines (activated or mature DCs) [29, 30]. As a consequence, DCs have 
gained considerable interest as vaccine adjuvants and are currently exploited in the 
treatment of cancer after loading with tumor-cell derived antigens [31, 32].
In order to gain insight in miRNAs that may regulate DC development and behaviour, 
expression profiles of 157 miRNAs were obtained from monocytes and DCs under 
inflammatory and tolerizing conditions. We show that DCs express a wide variety of 
miRNAs, some of which are differentially regulated during DC development and 
maturation. We predicted several target genes for these miRNAs, as well as binding sites 
for transcription factors in the putative promoter regions of these miRNAs. Furthermore, 
we show that by also taking evolutionary conservation [33, 34] of the identified TFBSs 
into account, binding sites were found to preferentially cluster within 500 bp upstream 
of the pre-miRNAs. Also, the fraction of conserved TFBSs for which the cognate 
transcription factors are expressed in DCs increases with the number of miRNA 
promoters that contain these TFBSs. Taken together, the data described here provide 
evidence that the promoter regions of the miRNAs expressed in myeloid DCs contain 
binding sites for motifs of transcription factors that are relevant to myeloid cell biology. 
This may help expand the understanding of the molecular mechanisms underlying DC 
biology and development.
2. Methods
2.1  Isolation, culture and characterization of monocytes and DCs
Peripheral blood mononuclear cells (PBMCs) were isolated as previously described [28]. 
Monocytes were isolated from PBMCs using CD14+ selection and the AutoMACS 
technology (Miltenyi Biotec, Bergisch Gladbach, Germany) following the manufacturer’s 
directions. Human monocyte-derived DCs were generated using GM-CSF and IL-4 and 
matured as described previously. Purity and maturation of monocytes and DCs were 
assessed by means of FACS analysis as described previously [28]. Mixed lymphocyte 
reactions were essentially carried out as described elsewhere [35]. Briefly, they were 
co-cultured with peripheral blood lymphocytes in various dilutions for 2 to 4 days. Then 
tritiated thymidine (1 μCi/well; MP Biomedicals) was added to the cell cultures and 
incorporation was measured after 16 hr. Enzyme-linked immunosorbent assays (ELISA) 
were performed to assess the secretion of the inflammatory cytokines TNFα and IL8, using 
BD OptEIA (BD Biosciences, San Jose, CA) kits following the manufacturer’s recommenda-
tions.
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2.2   Isolation of total RNA and microRNA-specific reverse 
transcription and quantitative PCR
Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA), following the manufacturer’s 
recommendation. Quantity and purity were determined spectrophotometrically. For 
each miRNA, 4 ng of total RNA was used as input and miRNAs were converted to cDNA 
using the TaqMan miRNA Reverse Transcription cDNA Synthesis kit and miRNA-specific 
looped primers from the Early Access miRNA Profiling Kit (both from Applied Biosystems, 
Foster City, CA) following the manufacturer’s recommendations. Real-time quantitative 
PCR was performed using miRNA-specific primer/probe pairs from the Early Access 
miRNA Profiling Kit and reactions were carried out as described elsewhere [36]. Actual 
amplification and data collection were performed on the ABI 7700 Sequence Detection 
System (Applied Biosystems, Foster City, CA). After visual inspection, data were exported 
to a text file and further analyzed in Microsoft Excel (Microsoft Corporation, Redmond, 
WA) and various Bioconductor packages [37] in the R statistics environment [38].
2.3  Statistics for miRNAs expression data
Delta Ct values for each miRNA were calculated with hsa-let-7a as a reference, according 
to the manufacturer’s directions. Only miRNAs with a dCt ≤ 12 (where dCt = Ct
target
 – 
Ct
hsa-let-7a
) were considered for further analysis. Data were combined into a convenient 
ExpressionSet (eSet) structure using the Biobase package, and further analyzed by means 
of gene-by-gene one-factor ANOVA using the package LMGene, all in Bioconductor 
and R. Only genes that had a False Discovery Rate-adjusted p-value of < 0.05 were 
considered differentially expressed. These genes were further assessed using non- 
parametric pairwise comparison of the different myeloid cell subsets using Tukey’s 
post-hoc test in the R statistics package. Genes with a p-value < 0.05 were considered 
differentially expressed.
2.4  Determination of TFBSs in microRNA promoters
Putative promoter regions extending 2 kb upstream of the miRNAs were extracted from 
the Genome Browser sno/miRNA track of the UCSC March 2006 human genome 
assembly [39, 40]. The program Clover [41] was used to screen for over-represented 
TFBSs in these sequences using a precompiled library of TFBS motifs. The library 
contained 263 TFBS motifs (position-specific weight matrices) constructed from the 
JASPAR core database (2005) [42] and TRANSFAC version 7.0 [43].
To determine over-represented TFBS motifs, Clover starts for every location in a DNA 
sequence, by calculating a score reflecting the likelihood that a certain TF binds at that 
location. This score is a likelihood ratio, with in the numerator the probability that the 
sequence matches the positional weight matrix of the motif (the product of the 
frequencies of the nucleotides in the weight matrix at the positions corresponding to 
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those in the sequence) and in the denominator the likelihood that the sequence is 
derived from a random sequence (the product of the frequencies of the nucleotides in 
each position in the background sequence). This likelihood ratio is then averaged per 
complete sequence and over all subsets of the set of sequences. Finally a “raw score” 
is derived, by taking the logarithm of the averaged likelihood ratio. A raw score above 
zero thus signifies over-represented motifs and a raw score below zero signifies under- 
represented motifs. The raw score increases when more of the sequences contain good 
motif matches, and also when there are more good matches per sequence. The p-values 
for over-represented motifs are subsequently derived by analyzing, whether random 
sets of promoter sequences from all the genes in the genome are likely to have the 
same, or a higher “raw score”. Clover examines the over-representation of multiple TFBSs 
and takes into account the multiple testing issue for its p-value calculation. Besides the 
raw score, Clover also reports an instance score, which is the logarithm of the likelihood 
ratio mentioned above for any specific TFBS at any specific position in the sequence.
Our inputs to Clover are the miRNA promoter sequences and the 263 TFBS motifs 
mentioned above. For statistical calculations, promoter regions 2 kb upstream of all 
human genes in the genome are included as background. Our thresholds for Clover 
outputs are instance score ≥ 6 for recognizing a specific TFBS, and p-value ≤ 0.05 for 
over-represented motifs (default values in Clover). In addition, any mention of a TF motif 
score in subsequent sections refers to the instance score for the TFBS at a specific 
location in a promoter sequence. Our motivation for including instance scores is to 
enable us to calculate the conservation of the nucleotides at high-scoring TFBSs.
2.5  Calculation of evolutionary conservation score of TFBSs
In order to take into account conservation of TFBSs in the miRNA promoters, the 
PhastCons conservation track from the UCSC Genome Browser of January 2009 (http://
hgdownload.cse.ucsc.edu/goldenPath/hg18/phastCons44way/) was used, which 
represents the conservation of each nucleotide across 44 placental mammals as 
calculated using the PhastCons program [33]. The mammalian conservation track was 
used because we examined the expression of mammalian miRNAs that are generally 
not conserved outside this clade [44, 45]. The base-by-base conservation scores are 
derived from a two-state phylo-HMM and are defined as the posterior probability that 
the corresponding alignment column was generated by the conserved state and not 
the non-conserved state of the phylo-HMM used in the calculation [33]. The score 
ranges from 0 to 1; the higher the value, the more conserved the nucleotide. Using 
in-house Python scripts, we obtained the conservation score for a TFBS as the median 
of the PhastCons scores of the bases in that TFBS.
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2.6  Microarray sample preparation of DCs and microarray analysis
From one donor, 3 different samples (1x107 cells; technical replicate) were generated per 
DC subtype (immature monocyte-derived DCs, maturing DCs, tolerogenic DCs and 
activated tolerogenic DCs) and RNA for microarray analysis was isolated using the 
RNeasy Total RNA Extraction kit (Qiagen, Venlo, the Netherlands). Quality control, 
conversion to labeled RNA, hybridization and scanning were all performed at the 
microarray facility of the Department of Human Genetics (Radboud University Nijmegen 
Medical Centre Nijmegen, Nijmegen, the Netherlands), using Affymetrix technology 
while following the manufacturer’s protocols. The .CEL files were processed using the 
Bioconductor package limma in the R statistics environment and further analyzed with 
the package panp to generate presence/absence calls from the microarray data. In this 
study, intensities above the p-value cut-off of 0.01 indicated presence, p-values between 
0.01 and 0.02 indicated marginal presence, and p-values above 0.02 indicated absence. 
Complete, MIAME-compliant datasets were deposited with the Gene Expression 
Omnibus of the National Center for Biotechnology Information (http://www.ncbi.nlm.
nih.gov/geo/) and can be accessed through GEO Series accession number GSE23371.
2.7  Analysis of miRNA targets
In addition to identifying miRNAs that are expressed in DCs and monocytes, it is 
important to identify some of their target genes. This may help in understanding the 
miRNA-related molecular mechanisms underpinning DC maturation. We used Tar-
getScanHuman version 5.1 [15] to predict the target genes for the miRNAs identified to 
be expressed in DCs and monocytes. The precompiled predictions were downloaded 
from the official TargetScan website (http://www.targetscan.org/) and were further 
filtered for RefSeq transcripts having at least one site that is conserved across placental 
mammals and also had a target score (total context score) of  ≤ -0.4 before further 
analyses. To improve the reliability of the target genes predicted, we used a second 
miRNA target prediction tool, PicTar [46]. The precompiled miRNA target predictions 
were downloaded from the PicTar website at http://pictar.mdc-berlin.de, on January 
2011. We filtered the predictions at a PicTar threshold of ≥0.4. For further analysis we 
used the target genes that were predicted by both TargetScan and PicTar and also by 
each of the algorithms separately. To narrow the scope of the target genes to DCs, we 
used the previously published dataset of Lehtonen and colleagues wherein the relative 
expression levels of gene expression in DCs relative to monocytes are reported [47]. 
Using their data, we selected genes that are at least 2-fold down-regulated in DCs 
relative to monocytes and that we also predicted to be target genes for DC-expressed 
miRNAs. Comparisons between our predicted target genes and genes that were over- 
or under-expressed in DCs relative to monocytes in the Lehtonen dataset were done at 
the level of RefSeq DNA ID to ensure that the correct gene isoforms were being matched. 
(The Lehtonen dataset was based on global gene expression analyses using Affymetrix 
112
HG-U133A Gene Chip oligonucleotide arrays. We used Biomart in Ensembl version 62 
available at http://www.ensembl.org/biomart to obtain the corresponding RefSeq DNA 
IDs for the probesets in the microarray dataset).  The set of genes so selected are likely 
to be important in miRNA regulation of DC maturation from monocytes.
2.8  Gene Ontology analysis
Gene ontology enrichment analyses were done using the Cytoscape [48] plugin BINGO 
version 2.3 [49]. Using this software, we tested for over-representation using the 
hypergeometric test with Benjamini & Hochberg False Discovery Rate (FDR) correction. 
GO processes reported were deemed significant when the corrected p-value was < 0.05. 
Venn diagrams were drawn using the Venny tool of Oliveros, J.C. available at http://
bioinfogp.cnb.csic.es/tools/venny/index.html.
3. Results
3.1   Monocytes and monocyte-derived dendritic cell subtypes 
express distinct microRNAs
Monocytes were isolated to > 90% purity and monocyte-derived dendritic cell subtypes 
were generated and validated as depicted in Additional file 1, Figure S1. A TaqMan-based 
quantitative RT-PCR method was used to profile the expression of miRNAs. Immature 
monocyte-derived DCs (iDCs) were induced to either undergo maturation by LPS 
stimulation for 6 hr (mDCs), to mature into tolerogenic DCs (tDCs) in the presence of 
IL-10 and dexamethasone for 24 hr, or to mature into activated tolerogenic DCs (atDCs; 
previously described by Emmer et al. [50]) in the presence of IL-10 and dexamethasone 
for 24 hr, followed by 6 hr of LPS (Additional file 1, Figure S1A). Phenotypical and 
functional characterization confirmed that mature DCs expressed high levels of CD80 
and CD86 (Additional file 1, Figure S1B), induced strong proliferation of allogeneic T cells 
in a mixed lymphocyte reaction (Additional file 1, Figure S1C) and secreted high levels of 
pro-inflammatory cytokines TNF and IL8 (Additional file 1, Figure S1D). Accordingly, iDCs 
and tDCs did not show up-regulation of CD80 and CD86, induced much less proliferation 
and produced less cytokines. Activated tolerogenic DCs showed a more intermediate 
pattern of activation, indicative of less profound TLR signaling in response to LPS. The 
expression profile of 157 miRNAs in monocytes and the various DC activation stages 
was determined in a primary screen involving total RNA from one donor as shown in 
Additional file 2, Figure S2.
Of the 157 miRNAs screened, 104 were detected and expressed to variable degrees in 
monocytes and/or DCs, whereas 53 miRNAs remained undetected, irrespective of cell 
type or stimulus (Additional file 3, Table S1). Intriguingly, 27 miRNAs appeared to be 
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differentially expressed between monocytes, DCs and stimulated DCs (Table 1). These 
27 miRNAs were selected for additional profiling of multiple donors as described below.
3.2   Identification of miRNAs differentially regulated during  
monocyte-derived DC activation
To validate the expression of the identified 27 miRNAs, their expression was further 
examined in monocytes and DCs of 3 different donors (Additional file 2, Figure S2). 
Statistical analysis revealed that 18 miRNAs were truly differentially expressed 
(gene-by-gene ANOVA, p < 0.05; Table 2). Six miRNAs were up-regulated in monocytes 
versus DCs, and 10 were up-regulated in DCs versus monocytes. Eight miRNAs were not 
differentially expressed and had a high degree of variation in expression levels (data not 
shown). However, hsa-miR-15b and hsa-miR-16 showed remarkably similar expression 
profiles and are expressed at higher levels in monocytes (Figure 1, upper row of charts; 
Pearson correlation = 0.99). Hsa-miR-125a, hsa-miR-221 and hsa-miR-342 are examples of 
miRNAs that are up-regulated in the DC populations relative to monocytes (Figure 1, 
middle row). Furthermore, both hsa-miR-146a and hsa-miR-155 were up-regulated 
during differentiation, and were slightly up-regulated in mDCs and atDCs (Figure 1, two 
left charts in lower row; gene-by-gene ANOVA, p < 0.05, Tukey’s post-hoc test; Pearson 
correlation = 0.90), whereas hsa-miR-210 was primarily up-regulated in atDCs (Figure 1, 
right chart of lower row). Data generated from these analyses indicate that many of the 
selected miRNAs are indeed expressed in monocytes and DCs, and that 3 of these 
miRNAs are differentially regulated during DC development and maturation.
3.3   Identification of TFBSs in promoters of differentially expressed 
miRNAs in monocytes and DCs
In order to link the miRNA expression profiles to a specific TFBS (or groups of TFBSs) of 
the myeloid cell types that were analyzed, sequences 2 kb upstream of the mapped 
pre-miRNAs were chosen for analysis. It should be noted that it is expected that a 
majority of miRNAs contain their own promoters [21], and that in some cases, different 
miRNA genes (such as hsa-miR-16-1 and hsa-miR-16-2) in the genome give rise to an 
identical mature miRNA (such as hsa-miR-16). Therefore 31 promoters could be assigned 
to 27 miRNAs that were profiled in detail (Table 1). Likewise, 167 promoters could be 
assigned to the total of 157 miRNAs analyzed. Analysis of the 31 promoters revealed that 
3 TFBS motifs (Elk-1, RREB-1 and SPIB) were over-represented using the Clover criteria (p 
< 0.05) among all 8 promoter sequences of miRNA genes that are up-regulated in 
monocytes, and to have at least 1 high-scoring TFBS (instance score ≥ 6) in each 
promoter. Selecting TFBSs using these same criteria (over-represented motifs and at 
least 1 high-scoring TFBS per promoter) among the 12 promoters of the miRNAs that are 
up-regulated in DCs relative to monocytes, reveals that they have 13 TFBSs in common 
(Figure 2, Table 3, Additional file 4, Table S2). Furthermore, 4 TFBSs are over-represented 
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5in the promoters in all of the 8 miRNAs that did not show any appreciable difference in 
expression levels (Table 3). The complete set of high-scoring TFBSs found in the 
promoters of the miRNAs that are up-regulated in DCs and monocytes are summarized 
in Figure 3 and Additional file 5, Figure S3 respectively.
Clover detects motifs that are over-represented relative to their expected frequencies 
and calculates p-values based on a comparison with all promoters in the genome. 
Nevertheless such predictions can potentially give rise to false positives, as even random 
sets of miRNA promoters contain some over-represented motifs (Figure 3B). We 
therefore also examined the over-representation of motifs in the promoters of DC and 
monocyte miRNAs relative to those of random sets of miRNAs, selected from the total 
set of 167 miRNA promoters. The 12 miRNAs that are over-expressed in DCs share more 
TFBS motifs than do random sets of 12 miRNA promoters, specifically with respect to T
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Figure 1 -  Expression profiles of various miRNAs that are differentially expressed in 
monocytes and DCs. 
The upper two charts represent miRNAs over-expressed in monocytes, the middle row 
of charts represent 3 of the miRNAs over-expressed in DCs, and the lower row of charts 
represent the 3 miRNAs that are differentially expressed among subsets of DCs. On the 
Y-axis relative expression is depicted, which is normalized to the expression of hsa-let-7a.
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Table 2 -  Assignment of p-values for expressed miRNAs in all cell types 
(monocytes and various DC subsets) and DC subsets alone after 
ANOVA.
Posterior p-values*
miRNA gene All cell types DC subsets
hsa-let-7e 1.9E-05 4.2E-01
hsa-miR-15b 1.2E-04 6.8E-01
hsa-miR-16 2.1E-02 7.8E-01
hsa-miR-27a 3.0E-01 2.5E-01
hsa-miR-27b 8.2E-01 8.2E-01
hsa-miR-34a 3.0E-05 9.6E-01
hsa-miR-99a 2.2E-06 7.2E-01
hsa-miR-100 3.7E-06 7.3E-01
hsa-miR-125a 1.3E-04 8.6E-01
hsa-miR-125b 1.6E-05 7.2E-01
hsa-miR-126 6.1E-01 7.7E-01
hsa-miR-130a 1.6E-03 4.4E-01
**hsa-miR-132 4.0E-02 9.8E-01
hsa-miR-135a 7.1E-10 9.1E-02
hsa-miR-137 3.2E-07 2.1E-01
hsa-miR-140 8.2E-01 7.1E-01
hsa-miR-146a 9.6E-05 1.3E-02
***hsa-miR-150 9.9E-02 7.1E-01
hsa-miR-155 4.7E-06 2.5E-02
hsa-miR-186 7.2E-01 6.9E-01
hsa-miR-199b 5.2E-05 7.1E-01
hsa-miR-199s 8.4E-03 4.4E-01
hsa-miR-210 1.3E-05 4.0E-02
hsa-miR-221 5.6E-06 7.4E-01
hsa-miR-326 7.4E-01 9.7E-01
hsa-miR-340 8.6E-01 7.9E-01
hsa-miR-342 6.1E-06 9.9E-01
*) Posterior p-values < 0.05 indicate differential expression among subsets.
**) Considered not expressed differentially after visual inspection of gene expression data.
***) Considered expressed differentially after visual inspection of the data.
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motifs that are shared by many of the promoters (Figure 3B). When quantifying the 
number of shared motifs as the sum of all occurrences of all Clover detected motifs, 
across all promoters, we observe an enrichment of 1.96 relative to randomly selected 
miRNA promoters (p = 0.001).  Likewise, using random sets of 8 miRNA promoters, we 
Table 3 -  TFBSs that are present in all miRNA promoters in a particular (group of) 
cell type(s).
Cell types Overrepresented TFBS
Monocytes Elk-1, RREB-1, SPIB
DCs* AP-4, E47, MAZR, Myf, MZF1, RREB1, RREB-1, Sp1, SPI1, SPIB, STAT6, 
ZNF42_1-4, ZNF42_5-13
Subset of DCs** AP-1, ARP-1, FOXI1, myogenin/NF-1, Ncx, Oct-1, OCT-x, Sp1, TCF11, 
ZNF42_1-4
All cells*** Oct-1, RP58, SPIB, USF
*) Includes monocyte-derived iDCs, maturing DCs, tolerogenic DCs and activated tolerogenic DCs
**) Includes maturing DCs and/or activated tolerogenic DCs
***) Concerns all cells investigated, and miRNAs did not show appreciable differences in expression level
Figure 2 -  Representation of TFBSs in promoter regions of miRNAs up-regulated in DCs. 
Depicted are the TFBSs at a motif instance score threshold of at least 6 in the miRNA 
promoter regions. The scale of the y-axis ranges from 5 to 15 for each subgraph. The 
legend shows only those TFBSs that are present in all promoter sequences.
118
observed that the 8 miRNAs that are over-expressed in monocytes have a factor of 1.58 
enrichment of TFBS motifs (p = 0.046; Additional file 5, Figure S3B). The p-value here was 
estimated as the number of times, out of 1000, when a randomly chosen set of miRNA 
Figure 3 -  TFBSs shared among the promoter regions of miRNAs up-regulated in DCs.
(A) Shown on the x-axis are the high-scoring TFBSs (i.e. of instance score ≥ 6) that occur 
at least once in the 2 kb promoters of the miRNA up-regulated in DCs. The y-axis shows 
the number of promoters that have the TFBS at least once at this threshold. (B) The 
distribution of the number of common TFBS hits per number of common miRNA 
promoters as in A, for DCs and random sets of miRNA promoters. The values for random 
are the median values from 1000 randomly chosen sets of 12 miRNA promoters. The 
score is the ratio of the sum of all TFBS occurrences across all promoters for the DC set 
relative to that of the random set. The p-value is the fraction of cases wherein this sum 
for random sets of miRNA promoters is greater than or equal to that of the DC set. 
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promoters had at least an equal number of motifs as did the test set of sequences. Given 
the significant over-representation of different sets of TFBSs in the different sets of 
miRNAs, it appears that miRNAs contain multiple, different TFBSs in their promoters that 
specify their expression in certain cell types. This is in agreement with other studies that 
show that transcription factors often work in combinations [25, 26]. 
3.4   Evolutionary conservation and distribution of TFBSs in the 
promoter sequences of myeloid miRNAs 
Assuming that regulation of miRNA expression is conserved among mammals, we used 
the PhastCons evolutionary conservation track that is based on nucleotide conservation 
among placental mammals (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
phastCons44way/) to quantify evolutionary conservation of the predicted TFBSs. We 
compared both the motif instance scores and raw scores of TFBSs, as derived from 
Clover, with the nucleotide conservation score of the TFBSs. Applied to the 2 kb 
upstream sequences of the pre-miRNAs that are up-regulated in DCs, a small but 
significant correlation of 0.12 (p = 6.17 × 10-7) was observed between the conservation 
scores and the TFBS instance scores. Similar results were obtained using the raw score 
(r = 0.22, p = 8.99 × 10-2). An overlay of TFBS instance scores and conservation scores for 
the DC miRNA promoters is depicted in Figure 4A. The positive but weak correlation 
between TFBS motif scores and conservation scores suggests that they are largely 
independent measures and as such, combination of the two as a filtration measure 
would be non-redundant. When filtering predicted sites based both on their 
conservation and on their TFBS instance scores, TFBSs tend to cluster in a region 500 bp 
just upstream of the putative TSS of miRNA genes that are over-expressed in DCs (Figure 4B). 
This result corroborates other findings indicating that TFBSs tend to cluster near the 
transcription start site (TSS) of genes [51-54]. In addition, it suggests that combining the 
motif matching score with the extent of evolutionary conservation of a TFBS would 
likely reveal TFs biologically relevant to the identified set of miRNA promoters.  
In further support of the conservation of the binding motifs that are over-represented 
in the promoters of the DC-expressed miRNAs, we created a set of random sequence 
blocks of the same length-distribution as the predicted TFBSs from the same promoters 
as the test set. From these two data sets, we observed that the predicted TFBSs are 
significantly (p = 1.49 × 10-3, Wilcoxon rank sum test) more conserved than randomly 
chosen sequences. The conservation score assigned to a TFBS is the median of the 
PhastCons scores of the bases in that TFBS segment. We observed that the median of 
the conservation scores of the test TFBSs is more than 2 fold higher than that of the 
random sequences (Figure 4C). The complete set of conserved high-scoring TFBSs 
found in the promoters of the miRNAs up-regulated in DCs and monocytes are 
summarized in Figure 5 and Additional file 6, Figure S4 respectively. Furthermore, we 
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Figure 4 -  Distribution and evolutionary conservation of TFBSs in promoter regions of 
DC-expressed miRNAs.
(A) The TFBS motif scores (in blue, y-axis range from 0 to 15 per subgraph) as calculated 
using Clover and the extent of evolutionary conservation as PhastCons score (in grey, 
y-axis on the right). (B) Distribution pattern of TFBSs, selected based on various motif score 
and evolutionary score thresholds, in the promoter region of miRNAs up-regulated in DCs. 
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observed at the threshold of 10th percentile of median TFBS conservation, that the 
miRNAs that are over-expressed in DCs share more (fold = 3.51, p < 0.001) sites for TF 
motifs than did 1000 random sets of promoters of equal size, length and at the same 
conservation threshold (Figure 5B).  A similar result (fold = 3.48, p= 0.003) was obtained 
for the miRNAs that were over-expressed in monocytes (Additional file 6, Figure S4B). 
These results show that evolutionary conserved TFBSs are more common in the 
promoters of miRNAs over-expressed in DCs and monocytes than in randomly chosen 
miRNA promoters.
3.5   Integrating the motif-matching and evolutionary conservation 
scores of TFBSs and further validation of cognate TFs in 
microarray data from DCs
Without taking evolutionary information into account, 13 TFBSs were found to occur at 
least once in all the promoters of miRNAs preferentially expressed in DCs (Figure 2). 
Filtering TFBSs at 10th percentile threshold of the TFBS conservation scores not 
surprisingly identifies TFBSs that are common to far less miRNAs promoters (Figure 5). 
Among these, the TFBS of MZF1 was the most conserved at the thresholds used. To 
validate the expression of the cognate transcription factors whose binding site was 
identified, a transcriptome was generated of DCs from one donor using microarrays. 
The resulting data were screened for the presence or absence of transcription factors 
(TFs) whose binding sites were predicted in promoters of miRNAs up-regulated in DCs. 
For 10 out of the 17 TFBSs that are over-represented among the DC promoters (Additional 
file 4, Table S2B) and that contained at least one TFBS with an instance score of at least 
6.0 and a conservation threshold score of 0.968 (i.e. the 10th percentile of the median 
conservation scores of all TFBSs predicted in the set of miRNA promoters) as shown in 
Figure 5, the mRNA encoding their cognate TF was expressed in DCs. Expression of this 
58.8% of the predicted over-represented TFs is slightly higher than that for all the TFs 
that were examined with the microarrays (54% expressed, 46 % not expressed, 
Additional file 7, Table S3). Nevertheless, we found a high correlation (r = 0.91, p = 1.17 x 
10-2) when the number of motifs of expressed TFs was correlated with the number of 
miRNA promoters in which the motifs of these TFs were detected (Additional file 8, 
Figure S5A). An insignificant correlation (r=-0.72, p= 4.88 x 10-1) was observed when a 
random set of miRNA promoters was used (Additional file 8, Figure S5B). 
(C) Comparison of the median conservation scores of the bases in the predicted TFBSs in 
the promoters of miRNAs that are over-expressed in DCs, with those of randomly chosen 
sequences of the same length from the same promoters. Boxplots represent the median 
and interquartile range of the median PhastCons conservation scores. The fold shown is 
the ratio of the median of the DC conservation scores and the median of the conservation 
scores of the random sets (n=number of TFBS instances concerned).
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Figure 5 -  TFBSs shared among the promoter regions of miRNAs up-regulated in DCs.
(A) Degree to which conserved TFBSs in promoter regions of miRNAs up-regulated in 
DCs are shared among their promoters. Shown on the x-axis are high-scoring TFBSs 
filtered at a motif instance score threshold of at least 6 and at a 10th percentile 
evolutionary conservation score that occur at least once in the promoters of miRNAs 
up-regulated in DCs. The y-axis shows the number of promoters that have the TFBS at 
least once at these thresholds. (B) The distribution of the number of common TFBS hits 
per number of common miRNA promoters as in A, for test and random sets of miRNA 
promoters. The values for random are the median values from 1000 random sets of 
miRNA promoters of the same size and length as those in the DC set. The score is the 
ratio of the sum of all occurrences of conserved TFBS for the DC set relative to that of the 
random sets. The p-value is estimated from the number of instances wherein this sum 
for 1000 random sets of miRNA promoters is greater than or equal to that of the DC set. 
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Gene Ontology of the expressed TFs highlighted immune-related processes like 
“interspecies interaction between organisms” (p=4.49 x 10-5) and “regulation of T-helper 
2 type immune response” (p=1.19 x 10-2, Additional file 9, Table S4A). This is in line with 
the expected functions of DCs in immune response. Meanwhile, Gene Ontology of the 
TFs that were not expressed highlighted development-related processes like “cell 
development” (p=1.88 x 10-3) and “cell fate commitment” (p=7.54 x 10-3, Additional file 9, 
Table S4B), with little relevance to immune-related processes. Taken together, these 
data provide evidence that many expressed miRNAs in DCs have evolutionarily 
conserved TFBSs that may be relevant to DC biology in their promoters.
3.6   Target prediction and Gene Ontology analysis of microRNAs 
enriched in monocytes and DCs
To extend the regulatory pathways in which the miRNAs participate downstream, we 
predicted miRNA targets, using TargetScanHuman version 5.1 [15] and PicTar [46]. Both 
datasets were based on conservation in mammals. We obtained the precompiled 
dataset from their official websites. At a TargetScan context score threshold of at most 
-0.4, we obtained 421 distinct target genes (Additional file 10, Table S5; counting in 
RefSeq DNA IDs) for the miRNAs that are over-expressed in DCs. Meanwhile at a PicTar 
score threshold of at least 0.4, we obtained 2300 distinct target genes (Additional file 11, 
Table S6) for the miRNAs over-expressed in DCs. Likewise, we predicted 282 (Additional 
file 12, Table S7) and 1591 (Additional file 13, Table S8) distinct genes using TargetScan 
and PicTar respectively, to be targets for the miRNAs that are over-expressed in 
monocytes. For both DC-over-expressed miRNAs and monocyte-over-expressed 
miRNAs, the overlap of targets predicted by both TargetScan and PicTar is less than 50% 
of their respective total predictions (Additional file 14, Figure S6) suggesting that we still 
need to examine their independent predictions. Interestingly, only 7 identical targets 
were predicted for both monocyte-over-expressed miRNAs and DC-over-expressed 
miRNAs at the TargetScan threshold of ≤-0.4 and PicTar threshold of ≥0.4. The numbers 
of target genes predicted are summarized in Additional file 14, Figure S6. 
The number of target genes predicted using TargetScan and PicTar are very large even 
at the stringent thresholds used. Furthermore, Gene Ontology (GO) analyses of the 
gene sets did not yield conclusive results. To increase the relevance of the predicted 
targets to DCs we further filtered them based on their differential expression in DCs 
relative to monocytes during DC differentiation using previously published data by 
Lehtonen et al (2007) [47]. At a gene expression fold change threshold of 2, we identified 
34 unique genes corresponding to the DC-associated targets predicted using PicTar to 
be down-regulated at all time points in DCs relative to monocytes (Additional file 15, 
Table S9A). Amongst this filtered set of genes is IL10, which interestingly is involved in 
the process of “negative regulation of myeloid dendritic cell activation” (p=2.64 x 10-2, 
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from GO analysis of the 34 down-regulated genes). Correspondingly, 10 unique genes 
were associated with the down-regulated genes of the TargetScan-predicted targets of 
miRNAs that were over-expressed in DCs relative to monocytes (Additional file 15, Table 
S9B). In total, 6 of these down-regulated genes (SIK1, PELI2, MYLIP, RNF138, CCNG2 and 
FOXO1; in order of increasing down-regulation of their RNA transcripts at time point 24 
hr) were also predicted using PicTar (Additional file 15, Table S9). Of these, SIK1, PELI2 and 
one transcript of CCNG2 were increasingly down-regulated in DCs relative to monocytes 
in the time course of DC differentiation from monocytes; suggesting their involvement 
in mechanisms of DC differentiation. 
In addition to the DC dataset, we also examined the expression of the predicted target 
genes of the miRNAs that are over-expressed in monocytes relative to DCs. We found 35 
unique genes associated with the PicTar-predicted targets of miRNAs over-expressed in 
monocytes relative to DCs that were down-regulated in monocytes relative to DCs 
(Additional file 16, Table S10A). Correspondingly, transcripts of 9 unique genes associated 
with the TargetScan-predicted targets of miRNA over-expressed in monocytes relative 
to DCs were also down-regulated at all time points in monocytes relative to DCs (Table 
S10B). Among these is DICER1 which is involved in RNA interference and is up-regulated 
in DCs. Furthermore, there was an overlap of 2 genes (ACVR2A and MAP3K4) between 
the PicTar and TargetScan target gene sets (Additional file 14, Figure S6 and Additional 
file 17, Table S11). One transcript of ACVR2A was increasingly down-regulated (Additional 
file 16, Table S10). Moreover, there was no overlap in expressed genes that were targets 
to both DC- and monocyte-over-expressed miRNAs, suggesting congruency in our 
data. These results suggest that miRNA target genes can be either up-regulated or 
down-regulated in myeloid cells to regulate differentiation of the myeloid cells.
4. Discussion
As little is known about the expression and regulation of miRNAs in monocytes, DCs 
and their stimulated progeny, part of the miRNA transcriptome of these cells was 
generated and analyzed. Out of 157 miRNAs profiled, 104 appeared to be expressed in 
myeloid cells to a varying degree. Since the database miRBase 13.0 (March 2009) reveals 
the existence of at least 706 human miRNAs, it is conceivable that a much higher 
number of miRNAs is expressed in human monocytes and DCs. Six miRNAs appear 
up-regulated in monocytes, 10 are up-regulated in DCs and 3 are differentially expressed 
among different DC populations in response to LPS. Also, some miRNAs showed similar 
changes in expression levels among DC subsets.
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Amongst the 10 miRNAs that were over-expressed in DCs as compared to the monocytes 
from which they were derived, hsa-miR-34a, hsa-miR-125a, hsa-miR-342 and hsa-let-7e 
have been shown to be up-regulated in the course of DC differentiation from monocytes 
in culture [55, 56]. The up-regulation of hsa-miR-342 in monocyte-derived DCs as 
compared to monocytes is likely the result of culture conditions, as hsa-miR-342 is 
expressed at a much lower level in freshly isolated blood-derived myeloid DCs than in 
DCs generated in vitro (data not shown). Of the remaining miRNAs, 6 show an upward 
trend in expression level in blood-derived DCs, but the levels in cultured DCs are higher. 
Intriguingly, hsa-miR-146a and hsa-miR-155 appear to respond to LPS, but much less so 
than in monocytes and macrophages [7, 8]. Recently, it was demonstrated that 
LPS-mediated activation of protein kinase Akt1 results in up-regulation of miRNA let-7e 
in primary macrophages, while at the same time repressing miR-155 expression [57]. Our 
data show that both hsa-let-7e and hsa-miR-155 are up-regulated in DCs compared to 
monocytes, but that only hsa-miR-155 is slightly up-regulated by LPS. Taken together, 
these data imply that intrinsic differences between DCs and macrophages exist in 
response to the TLR4 ligand LPS. 
With regard to the targets of the miRNAs screened herein, recent literature indicates 
that inhibition of hsa-miR-34a or addition of one of its target genes, JAG1, have been 
observed to functionally stall the differentiation of monocyte-derived dendritic cells 
[55]. This supports our identification of hsa-miR-34a as an over-expressed miRNA in DCs 
relative to monocytes and JAG1 as its target gene (NM_000214 in Additional file 11, 
Table S6). In addition, we provide a list of predicted DC targets that are down-regulated 
in expression in DCs relative to monocytes (Additional file 15, Table S9). In this list, one of 
the targets of the DC-expressed miRNA, hsa-let-7e, is IL10, which is involved in negative 
regulation of myeloid dendritic cell activation. Taken together, these data highlight 
miRNAs, and their target genes, that can potentially modulate DC differentiation.  
Extensive miRNA promoter analysis revealed that 13 TFBSs are over-represented and 
commonly shared by the 12 promoter sequences of the 10 miRNAs that are up-regulated 
in DCs. These include signal transducer and activator of transcription 6 (STAT6), which is 
known to be involved in IL4 signaling and DC differentiation and maturation [58], spleen 
focus forming virus (SFFV) proviral integration oncogene spi1 (SPI1, also known as PU.1), 
which is indispensable for normal myeloid and lymphoid development [59] and 
specificity protein 1 (SP1), which is involved in the expression of dendritic cell-specific 
ICAM-3 grabbing non-integrin (DC-SIGN) [60].
Although the TSSs in these promoter regions are not known, TFBSs did cluster, especially 
when taking evolutionary conservation into account, within the 500 bp upstream 
region of the annotated pre-miRNAs, coinciding with the region in miRNA promoters at 
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which TSS have been discovered experimentally [19, 61]. Amongst the TFBSs predicted 
in the DC miRNAs, the sites for myeloid zinc finger (MZF1) is best conserved of all, even 
though the role of its cognate TF in DCs remains elusive. Nevertheless, MZF1 is thought 
to be a bi-functional transcriptional regulator, repressing transcription in non-hemato-
poietic cells, activating transcription in cells of hematopoietic origins and controlling 
cell proliferation and tumorigenesis [62, 63]. In addition, one of the conserved TFBSs for 
which the cognate TF was not expressed in monocyte-derived DCs appears to be Spi-B 
transcription factor (SPIB), which has been implicated in plasmacytoid DC (pDC) 
development, a non-myeloid cell type [64, 65]. It should be noted, however, that many 
of the miRNAs expressed in myeloid monocyte-derived DCs are also expressed in pDCs 
(data not shown).
When taking all predicted and well-conserved TFBSs in the promoters of miRNAs that 
are up-regulated in DCs into account, the number of TFs expressed increases with the 
degree at which their TFBS motifs are shared between the promoter sequences. Gene 
Ontology analysis indicates that the type of expressed TFs enriched in these data are 
relevant to the immune system process and are in line with the known function of DCs, 
whereas those that were not expressed are relevant to cell development (Additional file 
9, Table S4). Importantly, libraries of TFBS motifs used do not represent all possible TFBSs 
and as such not all possible TFBSs for expressed miRNAs have been identified in this 
study. Moreover, for consistency, we have used TFBS motifs, and not TFs, in making 
comparisons of TFBSs because the databases used have redundant motif names for the 
same TFs. It should be noted that predicted target genes were not uniformly down-
regulated, as we found evidence in DCs whereby predicted target genes were 
up-regulated in the cells or were also targets for the miRNAs that were over-expressed 
in monocytes. This may be due to limitations of the target prediction algorithms, or the 
targets might still be down-regulated at the protein level. Nevertheless, none of the 
down-regulated DC-miRNA targets was a predicted target for the monocyte-miRNAs. 
Furthermore, there is evidence that in a minority of cases, target genes are actually 
up-regulated by miRNAs [66, 67]. The up-regulation of DICER1 in DCs relative to 
monocytes is of special interest, as it is known that innate immune signaling is tightly 
controlled by miRNAs [7, 8]. Furthermore, there is also evidence that one type of DC, the 
Langerhans cell, requires proper functioning of DICER1 to induce CD4 T cell function 
[68]. Together with the fact that there are more up-regulated miRNAs in DCs than 
monocytes in our data set, it is tempting to speculate that DICER1 up-regulation is 
required for proper DC function. 
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5. Conclusions
The data provide evidence that, among the many expressed miRNAs in DCs, evolutionarily 
conserved TFBSs relevant to DC biology are present in their promoters. Furthermore, 
the identified miRNAs, their associated TFs and predicted target genes could help 
improve our understanding of the molecular pathways that underpin DC differentiation 
and maturation.
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Abstract
Polymorphonuclear cells (neutrophils) play an important role in systemic inflammatory 
response syndrome and the development of sepsis. These cells are essential for the 
defense against microorganisms, but may also cause tissue damage. Therefore, 
neutrophil numbers and activity are considered to be tightly regulated. In previous 
studies, gene transcription during experimental endotoxemia in whole blood and 
peripheral blood mononuclear cells have been investigated. However, the gene 
transcription response of the circulating pool of neutrophils to systemic inflammatory 
stimulation in vivo is currently unclear. We herein examine neutrophil gene transcription 
kinetics in healthy human subjects (n=4) who were administered a single dose of 
endotoxin (LPS, 2 ng/kg iv). In addition, freshly isolated neutrophils were stimulated ex 
vivo with LPS, TNFα, G-CSF and GM-CSF to identify stimulus-specific gene transcription 
responses. Whole transcriptome microarray analysis of circulating neutrophils at 2, 4 
and 6 hours after LPS infusion revealed activation of inflammatory networks which are 
involved in signaling of TNFα , IL-1α and IL-1β. The transcriptome profile of inflammatory 
activated neutrophils in vivo reflects extended survival and regulation of inflammatory 
responses. We show that these changes in neutrophil transcriptome are most likely due 
to a combination of early activation of circulating neutrophils by TNFα and G-CSF and a 
mobilization of young neutrophils from the bone marrow.
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1. Introduction
Sepsis is the most frequent cause of death at non-cardiac intensive care units1, 2. It is 
characterized by a systemic inflammatory response, and associated with marked 
cardiovascular changes, capillary leakage, tissue damage and multiple organ failure. The 
most common form of sepsis is caused by bacterial infection, and involves a severe host 
immune response. The inflammatory responses induced by bacteria are mediated by 
the expression of pathogen-associated molecular patterns (PAMPs) which are 
recognized by the host cells via pattern recognition receptors (PRRs) such as Toll-like 
receptors (TLRs)3. For example, stimulation of TLR4 by lipopolysaccharide (LPS) of 
Gram-negative bacteria results in activation of inflammatory signaling pathways and 
induction of cytokine secretion by endothelium and circulating leukocytes4. In blood, 
systemic inflammation is classically reflected by a change in leukocyte count with a 
prominent increase in neutrophils. During the course of systemic inflammation, 
neutrophil numbers remain elevated5. Besides their anti-microbial activity, neutrophils 
also exert regulatory functions during inflammation by secretion of their granular 
content and direct cell-cell interaction with mononuclear cells and endothelium6, 7. It 
has been shown that the pool of circulating neutrophils during systemic inflammation 
is characterized by a diversity of neutrophil phenotypes8. 
The human endotoxemia model is a valuable tool to study early inflammatory 
mechanisms9. Transcriptome analysis of this in vivo response to LPS has been shown to 
reflect the trancriptome profiles of septic or injured patients10-12. These studies focused 
on whole blood and PBMC analysis, showing an early acute response followed by a 
recovery phase in gene expression. However, up till now, it is unclear what part of this 
acute systemic inflammatory regulation can be attributed to circulating neutrophils. In 
the current study, we present for the first time the transcriptional response of circulating 
neutrophils to LPS administration in vivo. We use novel analysis methods based on 
physical protein interaction to control for interaction enrichment bias. Hereby, we aim 
to identify the role of circulating neutrophils in controlling systemic inflammation by 
evaluation of their gene expression kinetics and immunomodulatory properties during 
early inflammatory responses, increased granulopoiesis and neutrophilia.
2. Methods
2.1  Subjects
Neutrophil gene expression was studied in 4 healthy male volunteers who participated 
in a human endotoxemia trial (Clinical Trial Register number NCT00783068, placebo 
group). The study protocol was approved by the Ethics Committee of the Radboud 
University Nijmegen Medical Centre and complies with the Declaration of Helsinki 
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including current revisions and the Good Clinical Practice guidelines. Written informed 
consent was obtained from all study participants. Physical examinations, electrocardi-
ography, and routine laboratory studies on all the volunteers before the start of the 
experiment showed normal results. Volunteers were not taking any prescription 
medications, and tested negative for hepatitis B surface antigen and human immuno-
deficiency virus infection.
2.2  Human endotoxemia model
Subjects refrained from food 12 hours before the start of the experiment, and caffeine 
or alcohol containing substances 24 hours before the start of the experiment. The 
experiments were performed according to a strict clinical protocol as described 
previously13. U.S. Reference E. coli endotoxin (Escherichia coli O:113, Clinical Center 
Reference Endotoxin, National Institute of Health (NIH), Bethesda, MD) was used. Ec-5 
endotoxin, supplied as a lyophilized powder, was reconstituted in 5 ml saline 0.9% for 
injection and vortex-mixed for at least 10 minutes after reconstitution. The endotoxin 
solution was administered as an intravenous bolus injection at a dose of 2 ng/kg of 
body weight.
2.3  Plasma cytokine and growth factor measurements
During human endotoxemia experiments, EDTA anticoagulated blood was collected 
from the arterial line and immediately centrifuged at 2000g for 10 minutes at 4 oC to 
obtain plasma. Concentrations of IL-1β, TNF-α, IL-6, IL-10, IL-1RA and MCP-1 in plasma and 
whole blood stimulation supernatants were measured using a simultaneous Luminex 
Assay according to the manufacturer’s instructions (Bio-plex cytokine assay, BioRad, 
Hercules, CA, USA). IL-8 was measured in plasma by ELISA (Pelipair, Sanquin, Amsterdam, 
the Netherlands) following manufacturer’s protocol and plasma G-CSF and GM-CSF 
concentrations were measured by cytrometric bead array (BD, Franklin Lakes, USA) on 
the FACScalibur flow cytometer.
2.4  Neutrophil isolation
Blood samples were drawn at 0, 2, 4 and 6 hours after LPS administration in 10 ml 
sodium heparin blood tubes (BD). Total leukocytes were determined by Tuerk’s solution 
(Merck staining). Blood was diluted 1:1 with PBS and placed on lymphoprep (Axis shield) 
and centrifuged. The 1:1 diluted blood plasma was stored at -80°C until further use. The 
lowest compartment containing the polymorphonuclear cell fraction was taken 
containing neutrophils (purity >95%) mostly contaminated by eosinophils and minor 
PBMCs. Shock buffer containing 0.155 M NH4Cl, 0.0001 M Na2EDTA and 0.01 M KHCO3 
was used to lyse the red blood cells. After washing, the granulocytes were counted on 
a hemocytometer and cell viability (>99%) was determined using 0.4% trypan blue 
solution. Granulocytes were suspended at a concentration of 10x106 cells/ml in Qiagen 
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RLT buffer (Qiagen, Venlo, the Netherlands) containing 1% B-mercaptoethanol and 
stored at -80°C until RNA isolation. For ex vivo neutrophil stimulation, after obtaining 
written informed consent, EDTA coagulated blood was drawn from healthy volunteers 
(N=4). Neutrophils were isolated according to the same protocol. After isolation and 
washing, cells were allowed to recover for 30 minutes at 37°C.
2.5  RNA isolation and Microarray analysis
RNA was isolated by Qiagen RNAeasy RNA isolation kit according to the manufacturer‘s 
protocol. DNA contamination was removed by on column DNase treatment (Qiagen, 
Venlo, the Netherlands). Total RNA yield was determined on the nanodrop ND-1000 
(Isogen life sciences, and Total RNA quality was assessed at Agilent 2100 bioanalyzer 
with RNA 6000 Nano chips (Agilent, Santa Clara, USA). Neutrophil gene expression was 
measured on Affymetrix Human ST 1.0 exon arrays. RNA material was first amplified, 
transformed to cDNA and labeled using ambion WT expression kit and the affymetrix 
terminal labeling kit (Ambion, Life Technologies, Carlsbad, USA). Labeled cDNA was 
then hybridized for 17 hours to a Human ST 1.0 exon array, washed and stained according 
to manufacturers’ instructions and scanned on a Genechip ® scanner 3000 (Affymetrix, 
Santa Clara, USA).
2.6  Transcriptomics data analysis
Affymetrix® CEL-files from microarray scans were used for quality control and first Robust 
Multiarray Averaging (RMA) analysis for normalization was performed with Partek® 
genomics suiteTM. In order to assess the extent of gene expression fold changes after LPS 
infusion in a subject, the normalized log2 intensity value at time 0 was subtracted from 
those of 2, 4 and 6h, to yield the relative expression fold change per probeset identity. 
The mean fold changes of all probeset identities pertaining to a gene were used to 
represent the effective fold change of the gene for that infused subject. The mean fold 
change for a gene in all 4 subjects was finally used as its overall fold change in expression 
after LPS infusion. Genes that were over- or underexpressed at least 2 fold relative to 
time 0 of LPS infusion were used for subsequent analyses. That is, a gene is considered 
upregulated in expression if its log2 fold change value is ≥ 1; or downregulated if its 
log2 fold change value is ≤ -1. At this fold change threshold, we examined temporal 
gene response to LPS. We queried for sets of genes that are up- or down-regulated in 
expression at any time point (i.e. major overall perturbed gene set); at each time point; 
at all time points; only at certain time points; those that are increasingly upregulated or 
downregulated in the course of infusion; and finally those that showed wavy expression 
patterns by being upregulated at one point but downregulated at another. We 
performed gene ontology analysis on each of these sets of genes to elucidate the 
temporal transcription program elicited upon LPS stimulation in neutrophils.
138
2.7  Gene ontology and protein-protein interaction network analyses
All gene ontology annotations were done using the BINGO14 plugin in cytoscape15. 
Using this algorithm, we assessed for gene set overrepresentation using the 
hypergeometric test with the multiple correction method of Benjamini & Hochberg 
False Discovery Rate (FDR) correction. Our gene sets were tested against whole GO 
annotation. Unless otherwise stated, all biological processes mentioned were 
significantly (corrected p-value<0.01) overrepresented by the set of genes up- or 
downregulated at any time after 0h of LPS infusion. All protein-protein Interaction (PPI) 
data were obtained from HPRD16, release 9. Significance of a PPI network was tested 
using the Physical Interaction Enrichment approach 17. By proper node-degree 
normalization of random networks being used in comparison with a test network, this 
approach circumvents biases that might arise, during network analyses, due to the over-
representation of certain proteins in global PPI networks.
2.8   Q-PCR for microarray validation and in vitro neutrophil gene 
expression
From every sample, 250 ng RNA was reverse transcribed to cDNA with superscript III 
(Invitrogen, Paisley, UK). Gene specific Taqman gene expression assays (Life Technologies, 
Carlsbad, USA) were used in q-PCR to determine sample gene expression. GAPDH and 
18S were used as reference genes. Q-PCR was performed at the applied biosystems 
7500 fast q-PCR machine using standard procedures.
2.9  In vitro neutrophil stimulation
Neutrophils (5x106 cells/ml) in RPMI supplemented with 0.5% Human Serum Albumin 
(Sanquin, Amsterdam. The Netherlands) were stimulated at t=0 with LPS (10 ng/ml; 
Escherichia coli serotype 055:B5, Sigma Aldrich, purified as described previously18), TNFα 
(10 ng/ml; Abcan, Cambridge, UK), G-CSF (50 ng/ml; R&D Systems, Minneapolis, USA) 
and GM-CSF (50 ng/ml; Cellgenix, Freiburg, Germany). After 2 hours, 800 µl cell 
suspension was taken and washed with PBS. Subsequently cells were resuspended in 
350 µl RLT with 1% Beta mercapthoethanol and stored at -20°C. After 7 hours, 200 µl cell 
suspension was used for apoptosis assay. 
2.10  Cell survival and apoptosis measurements
Survival and apoptosis were determined on the FACScalibur by Annexin V apoptosis 
detection kit (BD, Franklin Lakes, USA) according to the manufacturers’ instructions. Cell 
survival statistics were performed with repeated measures ANOVA, and Tukey’s multiple 
comparison post-hoc test. P values ≤0.05 were considered statistically significant.
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3. Results
3.1   Clinical and inflammatory parameters induced by LPS infusion 
in healthy volunteers
Infusion of LPS in healthy volunteers induced clinical symptoms that reflected systemic 
inflammatory response (increased heart rate, increased body temperature) (data not 
shown). Total leukocyte counts increased 1-2 hours after infusion of LPS and remained 
elevated during the whole experiment (12 hours) (Figure 1A). Leukocyte counts showed 
a depletion of monocytes and lymphocytes 1 hour after LPS infusion with gradual 
recovery afterwards. In contrast, the neutrophil fraction after a short drop in numbers 
(50%), increased 1 hour after LPS infusion and remained elevated during the entire 
experiment (Figure 1A). Plasma levels of pro-inflammatory cytokines TNFα and IL-6 
levels were maximal 1.5 hours after infusion of LPS and returned to baseline after 6 
hours, whereas circulating IL-1β remained below the detection limit. The anti-inflammatory 
cytokines IL-1RA and IL-10 reached maximal plasma levels 3 hours after LPS infusion. The 
chemokines IL-8 and MCP-1 peaked at 2 and 3 hours after LPS infusion, respectively 
(Figure 1B). The colony stimulating factor G-CSF peaked at 4 hours after LPS infusion, 
whereas plasma levels of GM-CSF remained below detection limit (Figure 1C).
3.2   Microarray transcriptome analysis of circulating neutrophils 
after LPS infusion reveals a time specific expression pattern
To investigate the in vivo neutrophil transcription response after LPS infusion, a total of 
17393 genes was analyzed on microarray. Principal component analysis of expression in 
time indicates a separation of time t=2 from time t=4 and t=6 for all four subjects (Figure 2). 
Figure 1 -  Clinical parameters in time after LPS infusion. 
(A) Leukocyte count with total leukocytes, Polymorphonuclear cell fraction and 
mononuclear cell fraction. Error bars represent SEM (N=4). (B) Plasma cytokines at 
different time points measured by luminex or ELISA (IL8). Error bars represent SEM (N=4). 
(C) Plasma GM-CSF and G-CSF measured by cytometric bead array. Error bars represent 
SEM (N=4).
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From the total of 17393 genes examined, 2248 genes (≈13%) were differentially expressed 
relative to time 0h at a fold change threshold of 2 (data too large to be included in this 
thesis but shall be provided as Supplemental Table in the published article ). Out of these, 
233 genes were upregulated and 307 genes were downregulated at all 3 time points 
following LPS infusion. However, at early time points, more genes are upregulated, 
meanwhile at later time points more genes are downregulated (Figure 2); revealing a 
time specific expression pattern in which gene response at T=2 is different from that of 
T=4 and T6. Furthermore, out of the 2248 differentially expressed genes, 37 were 
increasingly upregulated and 79 genes were increasingly downregulated over time. 
Meanwhile, 49 genes showed a ‘wavy’ behaviour in time, being either first upregulated 
at t=2 and downregulated at t=4 and t=6 or vice versa (Figure 3).
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Figure 2 -  Time specific expression pattern post LPS infusion. 
(A) Principal component analysis of temporal gene expression response to LPS reveals a 
separation of neutrophil gene expression at T=2, from those of T=4 and T=6h after 
infusion of LPS in 4 volunteers. (B) PCA of time post LPS infusion. 2h, red ; 4h, blue; 6h, 
magenta. Differentiating codes for volunteers : BUR12, HEX1, TUN5 and DOR8. Volunteer 
code suffix _Tx denotes time after LPS infusion (C) Overview of number of temporally 
differentially expressed genes in neutrophils after systemic LPS infusion.
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3.3   Validation of microarray by q-PCR
The top 5 persistently upregulated and the top 5 persistently downregulated genes 
were selected for q-PCR validation of the microarray, as well as 5 relevant inflammatory 
genes with wavy behaviour (Table 1). Q-PCR gene expression analysis was similar with 
the expression data from the microarray (Figure 4). Strongly downregulated IL7R and 
CD3G confirm minor PBMC contamination in isolated neutrophil fractions.
3.4   A temporally stable neutrophil transcriptome reveals 
“inflammatory response” and “anti-apoptosis” for upregulated 
genes, and “lymphocyte activation” for downregulated genes
In order to unravel the biological processes of the genes that are stably upregulated in 
neutrophils  after systemic LPS infusion, we performed a Gene Ontology (GO) analysis 
using the  233 genes that are upregulated at T=2h, 4h, and T=6h relative to 0h in the four 
volunteers examined. GO analysis revealed several biological processes to be significant 
Figure 3 -  Persistent changes in gene expression. 
(A) Genes which are persistently upregulated in time. (B) Genes which are persistently 
downregulated in time. (C) Genes which are regulated in opposite direction between 
t=2h and t=4h/t=6h after LPS infusion (wavy genes). (D) Heat map with fold change of 
genes relative to t=0. Green represents downregulation and red upregulation.
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(p<0.05) for the set of upregulated genes and indicates “inflammatory response” and 
“anti-apoptosis” as the principal biological processes (Figure 5). Likewise, GO analysis 
was carried out for the 307 genes that are downregulated in expression at T=2h, T=4h, 
and T=6h after LPS infusion. This set of stably downregulated genes are also significantly 
(p<0.05) enriched in several processes, including “lymphocyte activation” as the main 
biological process (Figure 5). The enrichment of downregulated genes in the process of 
“lymphocyte activation” is interestingly coherent with the low levels of circulating 
lymphocytes (PBMC population, Figure 1A) post LPS infusion. Meanwhile, the enrichment of 
the upregulated genes in the processes of “inflammatory response” and “anti-apoptosis” 
is in line with the observed circulatory neutrophilia (PMN population, Figure 1A). 
Table 1 -  Selection of top 5 persistently upregulated, persistently 
downregulated, and relevant wavy genes from microarray data for 
q-PCR validation.
Gene 
symbol
2h 4h 6h Description
Persistently 
upregulated
CD177 3.48 4.5 4.64 CD177 molecule
HGF 2.39 4.43 5.04 hepatocyte growth factor (hepapoietin A; 
scatter factor)
HP 2.48 3.9 4.22 haptoglobin
TRPS1 2.22 3.89 4.03 trichorhinophalangeal syndrome I
IL18R1 2.4 3.12 3.33 interleukin 18 receptor 1
Persistently 
downregulated
P2RY10 -3.67 -4.27 -4.53 purinergic receptor P2Y, G-protein 
coupled, 10
IL7R -3.19 -3.48 -3.69 interleukin 7 receptor
FAIM3 -2.87 -3.17 -3.75 Fas apoptotic inhibitory molecule 3
ITGA4 -2.91 -3.14 -3.15 integrin, alpha 4 (antigen CD49D, alpha 4 
subunit of VLA-4 receptor)
CD3G -3 -3.06 -3.81 CD3g molecule, gamma (CD3-TCR 
complex)
Wavy behaviour FCGR1A -1.56 2.34 2.89 Fc fragment of IgG, high affinity Ia, 
receptor (CD64)
STAT5A -1.03 1.27 1.28 signal transducer and activator of 
transcription 5A
JAK3 -1.31 1.16 1.35 Janus kinase 3
IL1RAP -3.4 1.06 1.41 interleukin 1 receptor accessory protein
KCNAB2 1.29 -0.38 -1.3 potassium voltage-gated channel, shaker-
related subfamily, beta member 2
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GO analysis of all the genes that are perturbed in expression respectively at 2h, 4h and 
6h after LPS infusion, reveal biological processes that are not much different from, but 
further support, those of the stable responses. For example, “induction of apoptosis” is 
significant (p<0.05) for genes that are downregulated at T=2h and is supportive of 
“negative regulation of apoptosis”, which is a process wherein genes that are upregulated 
at all time points are significantly (p<0.05) enriched.
3.5   Genes that are consistently up- or downregulated in 
neutrophils after LPS infusion show physical interaction 
enrichment between their encoded proteins
The higher the number of protein-protein interactions within a set of proteins, the more 
functionally cohesive one expects the set to be. The overrepresentation of interactions 
among a set of proteins, relative to a random set of proteins with the same number of 
interactions in the complete set of known protein-protein interactions, can be expressed 
with a Physical Interaction Enrichment (PIE) score17. The PIE score for randomly chosen 
genes is expected to be 1.0; P-values are obtained by randomly sampling sets of genes. 
To identify relevant networks involved in the neutrophil kinetics after LPS infusion, we 
analyzed the genes that were consistently upregulated (233) or downregulated (307). 
Both the consistently upregulated and the consistently downregulated genes show a 
high number of protein-protein interactions among them (PIE score 1.139, p=0.053 for 
the upregulated genes and PIE score 1.274, p=0.002 for the downregulated genes), 
indicating that they are functionally cohesive. As mentioned in the section above, the 
upregulated genes are enriched in the process of inflammation, while the downregulated 
genes are enriched in the process of lymphocyte activation. Based on integration of 
Figure 4 - Validation of array results by taqman gene expression assay q-PCR. 
(A) Gene expression in time relative to t=0 for 16 target genes. (B) Corresponding q-pcr 
results for same geneset in time relative to t=0.
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corr p >0.05; <=0.05; <=0.01; <=0.001 respectively
Figure 5 -  Overview of biological processes of genes that are expressed in similar 
ways at all time points after LPS infusion. 
“DownregAllTimes”, “UpregAllTimes” respectively refer to the down- or upregulated 
genes at T=2, 4 and 6h after LPS infusion. “OverallPerturbed” refers to the complete set 
of 2248 genes that are perturbed upon LPS infusion.
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gene expression data with protein-protein interaction data we constructed networks of 
their interacting proteins at various time points post LPS infusion (Figure 6). For the 
scope of this manuscript, we focus on the upregulated genes since we are interested in 
LPS-induced inflammation. We also depict interacting proteins of the wavy genes on 
this network of upregulated genes. The protein-protein interaction network of 
upregulated genes contains interacting proteins involved in signaling of TNFα and IL-1, 
regulators of transcription (NFκB family), apoptosis and ligand-receptor interaction 
(Figure 6).
3.6   TNF-signaling, inflammatory networks and apoptosis networks 
are significantly influenced by LPS infusion
Most of the upregulated genes that are involved in inflammatory pathways and genes 
of the TNFα signaling pathway were affected early after LPS infusion. In general, 
transcription factor expression for inflammatory genes was observed as represented 
by the upregulation of NFκB-family genes NFKB1, NFKB2, NFKBIA, NFKBID and NFKBIE 
(Figure 7A). 
Figure 6 -  PPI network of LPS-perturbed genes. Red node, upregulated gene. 
Blue node, downregulated  gene. Grey node, default node colour (i.e. gene not up- or 
down-regulated at the fold change threshold of 2).
T=2h
T=4h
T=6h
Network properties
PIE score= 1.139, p=0.035
Legend
edge: protein-protein interaction
red nodes: upregulated genes
blue nodes: downregulated genes
large nodes: persistently upregulated genes
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Since TNFα plasma levels increased early following LPS infusion in parallel with 
circulating neutrophils, we investigated the activation of neutrophils by TNFα. TNFα 
inducible proteins 3 and 6 were strongly upregulated at all time points with peaks at t=2 
hours. TNFAIP3 was also validated by q-PCR because of its important role in TNFα 
signaling (Figure 4). Furthermore, TRAF genes were induced and TNF receptor gene 
expression was differentially regulated (Figure 7B). TNFα gene expression was 
upregulated at t=2 hours, but not at t=4 hours and t=6 hours. These data suggest that 
Figure 7 -  Kinetic behaviour of inflammatory genes. 
(A) TNF related genes and genes from TNF receptor family. Fold change in time relative 
to t=0. (B) Genes of the NFκB family. Fold change in time relative to t=0. (C) Apoptosis 
mediating genes. Fold change in time relative to t=0.
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circulating neutrophils after LPS infusion are activated by circulating TNFα.
Apoptosis of neutrophils is inhibited by G-CSF and interestingly, apoptosis of circulating 
neutrophils is decreased during sepsis19. Early after LPS infusion in healthy volunteers, 
plasma levels of G-CSF increased (Figure 1C). Apoptosis pathway genes were differentially 
regulated, with among them a pronounced upregulation of anti-apoptotic genes BIRC3 
and TNFRSF10D (Figure 7C).
3.7   Specific ex vivo stimulation of neutrophils results in stimulus 
specific gene expression patterns
The induction of the increasingly upregulated genes and TNF/anti-apoptosis pathways 
could be initiated by multiple ligands. To investigate ligand specific gene expression 
regulation detected in the experimental endotoxemia model, freshly isolated neutrophils 
were stimulated in vitro with LPS, rTNFα, rG-CSF and rGM-CSF. Figure 8 shows neutrophil 
gene expression at 2 hours after stimulation. The neutrophil specific protein CD177 was 
mainly induced by G-CSF (15 fold increase) and TNFα induced TNFAIP3 expression (12 
fold increase) as well as NFKBIA (8 fold increase). Other genes investigated were not 
mediated by these specific ligands. 
In addition, the ex vivo survival of neutrophils was assessed. Neutrophils incubated with 
LPS and G-CSF for 7 hours showed 10% more viable cells compared with RPMI control, 
and GM-CSF stimulated cells (Figure 9). TNFα stimulated neutrophils exhibited 10% 
lower viable cells compared with RPMI. These results confirm that the activation, reflected 
by gene-expression patterns of circulating neutrophils, can be partially induced by the 
early secreted cytokines, growth factors, and direct stimulation with LPS.
Figure 8 - Gene expression in in vitro stimulated neutrophils. 
Cells were stimulated with 10 ng LPS, 10 ng rTNFα, 50 ng rG-CSF or 50 ng rGM-CSF. At 
t=2h after stimulation RNA was isolated and q-pcr was performed with taqman probes. 
Fold change relative to unstimulated. Error bars represent SEM (N=4)
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4. Discussion
In our study, we characterized the transcriptome profiles of circulating neutrophils, in 
the human experimental endotoxemia model. We showed an abundant upregulation 
of inflammatory pathways and regulation of apoptosis pathways involving G-CSF, TNFα 
IL-1α and IL-1β. 
Microarray analysis revealed direct neutrophil responses to a diverse pool of activators 
present in high concentrations in circulation after LPS infusion. Clear distinction can be 
made between early (2 hours after LPS) and late (4 hours and 6 hours after LPS) response 
transcriptome profiles with highest activation at 2 hours after LPS.  In contrast, Calvano 
and colleagues showed a time dependent activation of inflammatory pathways with 
peak activation at 4 hours in whole blood10. Interestingly, the profile at 2 hours is highly 
similar with our current findings as reflected by e.g. early elevated expression of IL1A, 
IL1B, TNF, TNFAIP3, PTX3 and different chemokines.  This suggests that the reported 
change in whole blood inflammatory gene transcription at 2 hours after LPS 
administration can be mainly attributed to circulating neutrophils. Furthermore, others 
have shown previously in this model of systemic inflammation that after LPS 
administration, a population of CD16dim neutrophils with a banded nuclear morphology 
appears in blood circulation, most likely released from the bone marrow8. This 
Figure 9 -  In vitro neutrophil survival after stimulation with 10 ng LPS, 10 ng rTNFα, 
50 ng rG-CSF or 50 ng rGM-CSF. 
Cell viability was determined in ≥ 1x105 cells with Annexin V apoptosis detection kit at 7 
hours after stimulation. Dots represent the percentage of viable (Annexin V negative 
and 7 AAD negative) cells. N=4 *p<0.05.
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population comprises up to 40% of the total amount of circulating neutrophils at 6 
hours after LPS administration. In this respect, it is very likely that changes in gene 
expression at 4 hours and 6 hours after LPS are partially due to an increase of these 
young CD16dim neutrophils in the circulation.
The novel analysis method based on physical protein interaction, enabled us to identify 
networks of upregulated genes linked with inflammatory activation and apoptosis of 
neutrophils. By restricting to the protein interaction network with high cohesiveness, 
we identified potential relevant protein interactions for neutrophils in early inflammatory 
response. The current analysis revealed a network of eleven different protein interactions 
that may account for the inflammatory regulation of circulating neutrophils. Since 
multiple upregulated genes such as Matrix Metalloproteinase 9 (MMP9), Lipocalin 
2(LCN2), Hepatocyte growth factor (HGF) and Haptoglobin (HP), are known as granule 
proteins, the network of upregulated genes we found, is suggesting a change in granule 
content following activation by pro-inflammatory factors. Interestingly, the expression 
of these proteins is increased in bone marrow neutrophils and their precursors20-22 . 
Since HGF and HP are poorly upregulated in expression by specific ex vivo stimulation 
(Figure 9), it is plausible to ascribe the observed increases in expression to the release of 
bone marrow neutrophils into the circulation. This is supported by our findings that 
upregulation of CD177 is even higher at 4 hours and 6 hours after LPS compared with  2 
hours after infusion. In contrast with this, we show that G-CSF induced upregulation of 
CD177 expression ex-vivo. This is confirmed by Passamonti and colleagues, who showed 
that neutrophils isolated from the bone marrow, or from peripheral blood following 
G-CSF administration showed both increased CD177 expression compared with 
circulating granulocytes on steady state23. Taken together, this implies that direct 
stimulation of circulating neutrophils and influx of bone marrow neutrophils both 
contribute to changes in gene expression kinetics.
During systemic inflammation, the pool of circulating neutrophils is maintained by 
stimulation of pro-inflammatory pathways (TNF, LPS) and pro-survival routes (G-CSF, 
GM-CSF). High concentrations of circulating cytokines and growth factors can cause 
this neutrophilia by induction of neutrophil release from the bone marrow24, 25. In 
addition to the release from the bone marrow, delayed neutrophil apoptosis may also 
contribute to high circulating neutrophil numbers. During sepsis, a delayed apoptosis 
can result in neutrophilia and subsequent tissue damage26. It has been demonstrated 
already that under steady state conditions, in vivo neutrophil lifespan is about 5.4 days27. 
We showed under early inflammatory conditions that apoptosis pathways are regulated 
at the gene expression level. Gene expression profiles indicated delayed neutrophil 
apoptosis by either early induced expression of anti-apoptotic routes like the TNFα 
pathway but also G-CSF driven inhibition of pro-apoptotic routes via Calpain and XAF128. 
On the other hand, ex vivo stimulation of neutrophils with G-CSF, did reduce apoptosis 
but stimulation with TNFα even increased apoptotic cell death. This implies that 
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although the TNFα survival pathway was upregulated, TNFα has no anti-apoptotic 
effect early after stimulation. As described recently, IL-1β inhibits IKKβ-NF-κB and thereby 
contributes to neutrophilia29. The protein interaction network of upregulated genes 
after LPS infusion suggests increased IL-1 signaling although circulating IL-1β was not 
detectable. Since IL-1α expression was strongly increased (6 fold) in neutrophils at 2 
hours after LPS infusion it may indicate an important role of IL-1α in the observed 
neutrophilia and activated IL-1 signaling pathway. This supports our hypothesis that in 
addition to neutrophils infiltrating from the bone marrow, part of the neutrophilia is 
caused by cytokine and growth factor that increase survival of circulating neutrophils. 
In neutrophils, the role of IL-1α could be superior in comparison to that of TNFα. The 
contribution of IL-1 in the mediation of survival in neutrophilia should therefore be 
further investigated. 
We hereby directly demonstrate early pro-inflammatory activation of neutrophils 
reflected by induced pathway expression. Since LPS is cleared from blood circulation 
very rapidly, high numbers of circulating inflammatory cytokines, released by, e.g. tissue 
macrophages13 and endothelium, are likely to account for the major part of this activation 
of neutrophils.
TLR pathways are induced in macrophages and endothelial cells directly after infusion 
of LPS30, 31. We found no persistent upregulation of these pathways in circulating 
neutrophils.
We did, however, show that NFκB family genes were induced and TNF signaling routes 
were activated. Interestingly, LPS was able to slightly increase neutrophil survival ex vivo. 
Since neutrophils do express TLR432 , it is plausible that LPS can activate these pathways, 
however this activation is not reflected at the gene expression level.
This is the first full genome gene transcription analysis that has been performed in 
circulating neutrophils during human experimental endotoxemia. We herewith include 
the complex environment of circulation after systemic activation. By combining this 
analysis with specific ex vivo neutrophil stimulation we underlined the complexity of 
neutrophil kinetics during early systemic inflammation. We showed that gene 
transcription profiles of inflammatory activated neutrophils reflects extended survival 
and regulation of inflammatory responses. These changes in neutrophil transcriptome 
are most likely due to a combination of early activation of circulating neutrophils and a 
mobilization of young neutrophils from the bone marrow.
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1. Summary of findings
Deciphering cellular responses to pathogens using genomics data is an important 
endeavour in bioinformatics and biomedical sciences which can potentially uncover 
leads to disease therapy. In this thesis, we have used bioinformatics approaches to 
analyse data that were obtained from innate-immune cells after infection with some 
pathogens that contribute to respiratory infectious diseases. Among these pathogens 
are viruses such as the human metapneumovirus (HMPV), the respiratory syncytial virus 
(RSV), the parainfluenza virus (PIV) and the measles virus (MV).
1.1  Context-specific protein-protein interaction
In chapter 2, we show using 2-d gel and context-specific protein-protein interaction 
(PPI) network analyses that respiratory viral pathogens are capable of affecting the 
host-cell proteome. The proteins concerned are involved in defense against ER stress 
and apoptosis. This information contributes to our understanding of the biology of 
respiratory viral infections. In chapter 3, we describe Physical Interaction Enrichment 
(PIE); a novel bioinformatics method in PPI network analysis. This method was developed 
because we noticed that general PPI networks are enriched in certain types of proteins, 
e.g. immune-related proteins which have been extensively studied. To mitigate the 
skewing of quantitative inferences made from general PPI networks PIE employs a 
normalization that ensures equal node degree (edge) distribution of a test set and of 
the random networks (background) it is compared with. As such we can assign networks 
derived from proteins that are triggered to increase or decrease in quantity in infected, 
relative to non-infected host-cells whether they are physically cohesive (biologically 
coherent) or not; irrespective of their over- or under-representation in general PPI 
networks. PIE is a valuable tool (e.g. to the biomedical community) that can be used to 
quantify the extent to which genes (or their cognate proteins) are involved with each 
other in the same biological pathway. 
1.2  Iron depletion profile
In chapter 4, we describe Iron Squelch, a new bioinformatics method that is aimed at 
comparing genomics data obtained from two biological contexts: iron-homeostasis 
and infection. Iron Squelch interrogates, from a computational point of view, the 
crosstalk between infection and iron-homeostasis. Using Iron Squelch we observe that 
cells infected with intracellular (e.g. HMPV), but not extracellular (e.g. E. coli) pathogens 
mimic the profile of iron-depleted cells. Importantly, the iron-depletion profile was also 
triggered by non-live viruses and by interferon gamma, a cytokine induced by host cells 
upon intracellular infections. We posit based on Iron Squelch analysis that an 
iron-depletion profile is likely to be a cellular response because both live and non-live 
viruses could induce such a profile. Understanding iron redistribution strategies and 
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the effects on innate-immune cells during extracellular and/or intracellular pathogen 
infections could improve our understanding of respiratory infectious diseases.
1.3  Transcription factor binding sites in DC-expressed miRNAs
In chapter 5, we identify transcription factor binding sites (TFBS) in microRNAs (miRNAs) 
that are over-expressed in monocyte-derived dendritic cells (DCs). DCs are professional 
antigen presenting cells that get mature upon infection (e.g. exposure to bacterial 
endotoxin, LPS) by differentiating from circulating monocytes. MicroRNAs, to 
recapitulate, regulate gene expression by translational repression or target mRNA 
degradation. Our analysis pipeline reveal miRNAs that are triggered in expression in DCs 
and indicate that evolutionarily conserved TFBSs cluster preferentially within 500 bp 
upstream the promoter region of precursor miRNAs. We also find that many mRNAs of 
the cognate TFs of the conserved TFBSs were expressed in the DCs. These miRNAs and 
their target genes may facilitate future research aimed at understanding mechanisms in 
DC differentiation from monocytes.
1.4  Neutrophil transcriptome
In chapter 6, we examine transcriptomics data generated from neutrophils of 4 
LPS-induced volunteers. Neutrophils participate in systemic inflammatory response 
syndrome and the development of sepsis due to bacterial infections; including those 
that infect the airways. We investigated the in vivo neutrophil transcriptional responses 
after LPS infusion. Principal component analysis of gene expression reveals a distinctive 
temporal pattern in which gene expression at time t=2 hours after LPS infusion, was 
different from time t=4 hours and t=6 hours. Using PIE, we found that PPI networks of 
genes affected in expression after LPS infusion were physically cohesive. Gene Ontology 
analysis indicates that the up-regulated genes are involved in the processes of 
inflammatory response while the down-regulated genes are involved in lymphocyte 
activation. We also observed an increase in neutrophil number and provide candidate 
genes to further interpretation of LPS-induced neutrophilia and the gene response 
kinetics at a molecular level in neutrophils.
2. Future perspectives
2.1  Bioinformatics, immunomics and hypothesis generation
This thesis addresses cellular response signals post infection in innate-immune cells 
using genomics data. The study of immune responses using genomics, proteomics or 
immunomics approaches in general, can foster our understanding of immunity by 
raising testable hypotheses based on bioinformatics-discerned patterns in biomedical 
data. This means that the collaboration between wet-lab and dry-lab work is essential in 
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biomedical research; predictions need to be validated and validated results can be used 
to improve further predictions. Moreover, while we need more experimental data to 
improve on the power of our hypotheses, we also need specific biochemical 
confirmations of the results, and this is usually tedious and not high-throughput. The 
challenge therefore lies in data integration for option-reduction so as to provide the 
biochemist or immunologist with a doable number of confirmatory experiments. We 
herein examine this promise in the realm of innate immune responses to pathogens; 
and we also look at the latest and/or upcoming relevant technologies.
2.1.1 Pathway exploration using PPI networks
In chapter 3, we presented PIE which could be used to measure the physical coherence 
of a set of genes. In that chapter, we also showed that a good measure of coherence of 
a set of genes correlates positively with the prediction of more genes in downstream 
pathways following the same stimulant (e.g. HMPV infection). This finding can be 
applied to the following archetype of hypotheses: “In my study of gene responses to 
RSV infection, I already have a physically cohesive PPI network of genes that were 
up-regulated after 3 hours of infection. However, without having to perform further 
large-scale experiments, what other genes would likely be induced later in infection?” A 
physically cohesive propagated-network would give us a confident list of the new 
genes that would be likely induced later in the infection.
2.1.2 Optimizing protein-protein Interaction networks
General PPI networks for human proteins will likely become more comprehensive to 
enable a complete proteome-level analysis using methods like PIE. This can be achieved 
by means of additional independent datasets, e.g. the subcellular localization of proteins 
(i.e. the “subcellulome” data if much is known), their various isoforms (the “isoformome”, 
if much is known) and their tissue specificity in the organism concerned. If these “omics” 
data are complete or near completion for humans, it would undoubtedly help in the 
characterization of functional protein interactions that are important in cellular immune 
response against specific infections. This might even lead to the construction of a 
reference immune-response chip of context-specific PPI networks that might be used 
to diagnose, and troubleshoot a patient’s response to a particular infection. To this end, 
protein chips have already been invented. For example the NAPPA (nucleic acid 
programmable protein array) approach which produces proteins just-in-time for 
functional assays1. Self-assembling protein microarrays have been used to detect 
humoral immunity to known and novel self-antigens, cancer antigens, autoimmune 
antigens, as well as pathogen-derived antigens in the immunome 2. Other examples 
include the use of protein chips to differentiate antibodies induced by various avian 
viruses 3, and the identification of several antibody-binding antigens from the outer 
membrane proteins of Pseudomonas aeruginosa 4. While the above examples are mainly 
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applicable in diagnosing disease agents, a reference context-specific-PPI network on a 
chip would help unravel the subnetworks of different respondents to the infection in 
question. For example, which interacting proteins can be used to explain why young 
adults are not as vulnerable to HMPV infection as do infants?
 
2.1.3 Co-infections and cellular iron homeostasis
In chapter 4, we showed that intracellular respiratory tract pathogens induce an 
iron-depletion gene expression profile in cells; an effect that is likely to be cellular 
because it was promoted by both live and dead viruses. Furthermore, this effect was 
not promoted by extracellular pathogens; suggesting an iron-restriction behavior from 
the niches of the pathogens. We also highlighted that Iron restriction from pathogens is 
interesting in the interplay between co-infections and disease severity in its host 
because certain respiratory co-infections are rare, and where they occur, the disease 
caused is less severe than during single-infections5-8 . Understanding the role of iron-
homeostasis in such instances could help unravel pathogenesis during respiratory tract 
(co)-infections in particular and infections in general. We suggest that these observations 
should be experimentally investigated by measuring cytoplasmic iron concentrations in 
infected cells.
2.1.4 MicroRNAs, LPS and dendritic cells
In chapter 5 we investigated miRNA and their targets that are involved in DC differentia-
tion from monocytes using LPS in addition to other factors. We found miRNAs like 
hsa-miR-34a and its target JAG1 that has been independently observed by others to be 
crucial in promoting DC differentiation from monocytes. In other words, repression of 
hsa-miR-34a or addition of its target, JAG1, stalls DC differentiation from monocytes 9. 
This positive example makes the rest of our predictions interestingly open for further 
investigations.
2.2   The interface of host-pathogen interactions: a further call for 
bioinformatics
In this thesis we have examined host-cell responses to infections mainly from the 
perspective of the host-cell and generated hypotheses for wet-lab confirmation. 
Nonetheless, past, current and further work examining the impact (during host invasion) 
on a pathogens’ genome, the interactions between host-proteins with pathogen 
proteins, host RNA with pathogen RNA or DNA-protein interactions, would be essential 
in advancing our understanding of host-pathogen interactions. Several high-through-
put technologies are being developed to advance this area, and bioinformatics is 
indispensable to unravel the huge amount of data generated.
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2.2.1 MicroRNAs
Host miRNAs have been implicated in antiviral defense when they bind viral mRNAs 
leading to its degradation and eventual stalling of protein translation. For instance, 
miR-323, miR-491, and miR-654 have recently been shown to inhibit replication of the 
H1N1 influenza A virus through binding to the PB1 gene of the virus leading to down-
regulation of PB1 expression through mRNA degradation10. Identifying host miRNAs and 
their targets in the genome of the respiratory tract pathogens examined here could be 
useful in improving our knowledge on their mechanisms of pathogenesis.
Aside from host miRNAs, viral miRNAs have also been reported to offset host-cell 
immune defenses11. For example, down-modulation of LMP2A (the Epstein-Barr virus 
latent membrane protein 2A) expression by the viral miRNA, miR-BART22, has been 
suggested to permit escape of Epstein-Barr-infected cells from host immune 
surveillance12. Furthermore, virally encoded miRNAs have been shown to target host 
genes and subvert antiviral immune responses. For example Stern-Ginossar and 
colleagues bioinformatically predicted targets for cytomegalovirus miRNAs, resulting in 
the identification of the human MICB (the major histocompatibility complex class 
I-related chain B) gene as a top candidate target of the viral miRNA, hcmv-miR-UL112. 
MICB is a stress-induced ligand of the natural killer (NK) cell activating receptor, NKG2D, 
and is critical for the NK cell killing of virus-infected cells and tumor cells13. Stern-Ginossar 
and colleagues showed that hcmv-miR-UL112 specifically down-regulates MICB 
expression during viral infection, leading to decreased binding of NKG2D and reduced 
killing by NK cells; thus revealing a miRNA-based immunoevasion mechanism that 
appears to be exploited by human cytomegalovirus14 . MiRNA data for the pathogens 
examined in this thesis are not available for similar investigations. However, this could 
be pioneered by bioinformatics predictions of the pathogen miRNAs, and subsequently 
followed by predictions and experimental validation of the target genes of the host.
As mentioned above, viral miRNAs can regulate both cellular and viral gene expression. 
However, target gene identification has been a difficult and cumbersome task. Some 
methodologies have been developed to overhaul this problem. For example, RIP-Chip 
(the immunoprecipitation of Argonaute-protein containing RNA-induced silencing 
complexes (RISC) followed by microarray analysis), is a technology that enables the 
identification of miRNA-targetomes at whole transcriptome level 15, 16. While RIP-Chip 
yields a plethora of high-confidence miRNA targets and provides a quantitative estimate 
of miRNA function, additional bioinformatic analyses are required to identify individual 
miRNA binding sites. These types of data are lacking for the respiratory tract pathogens 
examined in this thesis, yet they could help to unravel the networks of regulation 
exerted by both pathogen and cellular miRNAs, thereby providing the basis for 
functional studies on miRNA-mediated regulation of gene expression in respiratory 
tract infections.
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2.2.2 Pathogen proteins
Apart of subverting host immune responses via miRNA related mechanisms, pathogens 
may also use their proteins to counteract host immunity. For example, in DC biology, 
infection of immature DCs with HMPV, RSV or PIV3 has been shown to yield low to 
moderate levels of DC maturation for all three viruses17. Meanwhile, the immature DCs 
were responsive to a secondary treatment with LPS; indicating that their intrinsic ability 
to mature was not impaired. A more recent study using HMPV, demonstrates that the 
LPS-induced effects can be dampened by the G-protein of the virus18. It was found that 
TLR4 (a canonical LPS ligand) plays a major role in HMPV-induced activation of mono-
cyte-derived DCs, as down-regulation of its expression by small interfering RNA 
significantly blocked HMPV-induced chemokine and type I IFN expression 18. The latter 
authors also assert that the G-protein of the virus affects TLR4-dependent signaling. 
This assertion was based on the observation that infection of DCs with recombinant 
HMPV lacking G-protein inhibited LPS-induced production of cytokine and chemokines 
significantly less than did wild-type virus. Furthermore, treatment of DCs with the 
purified viral G-protein resulted in a similar inhibition of LPS-dependent signaling. This 
recapitulates the question of consequences on host immune responses when a patho-
gen-protein interacts with a host-protein. Fortunately, protein microarrays that contain 
the protein repertoire of a pathogen are being developed to enable identification of 
host proteins that interact with those of the pathogen. For example, using a protein 
microarray, Margarit and colleagues identified known and novel interactions between 
surface proteins of two pathogenenic bacteria (Streptococcus pyogenes and Streptococcus 
agalactiae), with three human ligands (fibronectin, fibrinogen, and C4 binding protein) 
that are known to play an important role in streptococcal pathogenesis 19. This 
technology, together with follow-up bioinformatics analyses, could lead to the 
identification of host-pathogen protein that might abate immune responses. Similar 
analysis could be performed for the respiratory tract pathogens examined in this thesis 
to yield undoubtedly useful insights as to their mechanisms of pathogenesis.
2.2.3 Distorted host protein phosphorylation by pathogens
Pathogen proteins have also been observed to distort post translational modifications 
like the phosphorylation of proteins that are important in host immune response. 
Protein phosphorylation is important to trap proteins in subcellular locations and is 
ubiquitous in intracellular signaling transduction cascades wherein proteins get 
activated upon phosphorylation. Viral proteins have been observed to distort host 
protein phosphorylation, resulting in improper localization and eventual abatement of 
defense. For example, the non-structural proteins (NS1 and NS2) of RSV have been 
associated with degradation of STAT2 in epithelial cells and subvert host interferon 
alpha and beta responses 20-22. In a more recent study Jie and colleagues showed that 
RSV infection increases the total cellular levels of STAT1 and STAT2 in DCs, but impaired 
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the IFN-beta-dependent phosphorylation and nuclear localization of the STAT proteins. 
Interestingly, these inhibitory effects of RSV on STAT1 and STAT2 phosphorylation and 
translocation were abolished by UV inactivation23 ; indicating that it is not a basic cellular 
response against the virus but rather a virus-imposed effect against its host. These 
examples demonstrate the complexity of elucidating innate immune responses. Not-
withstanding, recent advancement in protein microarray technologies have been made 
to enable deciphering of the phosphoproteome of cells24-26, including virus-infected 
host cells27 , possible. For example, using a high-throughput reverse-phase phospho-
proteome analysis of airway epithelial cells infected with Rift valley fever virus, Popova 
and colleagues observed that the virus infection down-regulated phosphorylation of a 
major anti-apoptotic regulator of survival pathways, AKT, along with phosphorylation of 
FOX 01/03, which controls cell cycle arrest downstream from AKT. Consistent with this, 
the level of apoptosis inhibitor XIAP was also decreased27.  These observations 
demonstrate the use of this technology in unraveling intracellular pathways and also 
highlight phosphoproteins as potential points of pharmacological interventions. 
Moreover, the bioinformatics community is already designing tools to facilitate analysis 
of such data. For example, ProteoConnections28 is a platform recently designed to 
enable integration of quantitative proteomics data to determine the changes in protein 
phosphorylation under different cell stimulation conditions or kinase inhibitors.
2.2.4 Pathogen-host PPI networks
In addition to the above mentioned examples, integration of a PPI network of an 
infectious disease agent with that of its host and the known host-pathogen interacting 
proteins could help interpret events at the interface between a pathogen and its host. 
For example, glucocorticoids - a family of anti-inflammatory drugs - have been shown 
to be ineffective in the treatment of RSV-induced bronchiolitis and wheezing. This 
situation has been ascribed to the repression of glucocorticoid receptor (GR)-mediated 
gene activation by the live virus; unlike the uv-irradiated virus 29.  As recently shown by 
Hinzey and colleagues, RSV infection inhibited dexamethasone induction of three 
GR-regulated genes (glucocorticoid-inducible leucine zipper, FK506 binding protein, 
and MAPK phosphatase 1) in epithelial cells. However, RSV infection did not alter GR 
protein levels or GR nuclear translocation, but does reduce GR binding to the promoters 
of the glucocorticoid responsive genes analyzed 29. Identifying the mechanisms through 
which this suppression occurs (competitive transcription factor binding or perturbed 
PPI?) is a question to which a solution may lead to the development of novel therapeutics. 
A PPI network that is comprehensive and optimized to RSV and its host may help find 
the interaction, if present, that is causative to the ineffectiveness of glucocorticoids 
against RSV-induced bronchiolitis.
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3. Conclusion
The constant collaboration between bioinformatics and immunology is essential to our 
understanding of disease pathogenesis. High-throughput technologies aimed at 
characterizing the interactome, phosphoproteome, subcellulome, miRNA-targetome, 
transcriptome, and proteome of a host and/or its pathogens would continue to provide 
data whose integration can help us understand the cellular mechanisms underpinning 
infectious disease in greater detail than is currently feasible. As such bioinformatics-
based hypotheses that can be readily tested using biochemistry could be generated 
from large scale datasets to ascertain the inferences we make on cellular processes. 
These approaches can be applied not only to understand respiratory infectious diseases, 
but all diseases, including genetic disorders.
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Summary
Summary
This thesis presents and describes results from bioinformatics analyses of transcrip-
tomics data that were generated from innate-immune cells after infection with some 
pathogens (or inactive pathogen material) that contribute to respiratory infectious 
diseases. Among these pathogens are viruses such as the human metapneumovirus 
(HMPV), the respiratory syncytial virus (RSV), the parainfluenza virus (PIV) and the 
measles virus (MV). These viruses belong to the family paramyxoviridae. Worldwide, 
these respiratory tract viruses cause morbidity and contribute to mortality particularly 
in infants, the elderly, and in patients having a repressed immune system. Conceptually, 
the thesis is divided into a method development section (chapters 3, 4 and 5) and an 
application section (chapters 2 and 6). Chapter 1 is the General Introduction. Chapter 7 
is the General Discussion.
In chapter 2, we use the concept of context-specific protein-protein interaction (PPI) 
networks. A PPI network is a graphical representation in which a node represents a 
protein and the edges linking a node to other nodes represent a physical interaction. As 
such, a given node in such a network has at least one interaction partner. PPI networks 
are important because in biological systems, many processes are carried out by means 
of proteins interacting with each other. A context-specific PPI network, as the name 
implies, is a PPI network in which interacting proteins or their cognate genes were 
found to be regulated in a given context, e.g. due to viral infection. 
We applied this concept to our investigations which were aimed at gaining detailed 
insight into the molecular pathogenesis of respiratory virus infections in infected lung 
epithelial cells; A549 cells. These cells were exposed to a set of live and uv-irradiated 
respiratory viruses: RSV, HMPV, PIV or MV. Cells were harvested at different time points 
after infection and processed for proteomics analysis by 2-dimensional difference gel 
electrophoresis (2-d gel). Samples derived from infected cells were compared to 
mock-infected cells to identify proteins that are differentially expressed due to infection. 
By 2-d gel and PPI network analyses we show that RSV, HMPV, PIV3, and MV induced 
similar host-cell responses and that mainly proteins involved in defense against ER stress 
and apoptosis are affected. This information contributes to our understanding of the 
biology of respiratory viral infections.
In chapter 3, we describe a new bioinformatics method in PPI network analysis called 
Physical Interaction Enrichment (PIE). In that chapter, we start by showing that in general, 
PPI networks have an enrichment bias for proteins that are related to both genetic 
morbid diseases and to infectious diseases. This situation could skew quantitative 
inferences made from PPI networks that are derived from general PPI networks; thus 
necessitating proper randomization to ascertain the reliability of context-specific networks. 
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PIE employs a normalization that ensures equal node degree (edge) distribution of a 
test set and of the random networks (background) it is compared with. It measures 
whether proteins of a given set of genes have more interactions between themselves 
than proteins in random networks, and can therewith be regarded as physically cohesive. 
We applied PIE to a couple of immune-related datasets. Firstly, we discovered that the 
PPI network of genetic morbid disease genes was not physically cohesive, despite their 
enrichment in general PPI networks. Secondly, we observed that genes that are 
up-regulated in expression in alveolar epithelial cells after HMPV infection are physically 
cohesive. The PPI network of the down-regulated genes was also physically cohesive. 
Furthermore, we observe physical cohesiveness for genes induced upon interferon 
gamma treatment, and for uv-irradiated RSV or Pseudomonas; demonstrating the ability 
of PIE to measure physical cohesiveness in various circumstances. Physical cohesiveness 
of the up-regulated genes after infection with uv-irradiated pathogens is particularly 
interesting, as this cannot be the result of the direct interference of the pathogen with 
the host cells’ gene regulation, but points to the innate cellular program that appears to 
be triggered by the infection. We further demonstrate another useful aspect of PIE that 
entails prediction of genes in pathways downstream infection response. Using 
HMPV-induced genes, we observed a positive correlation between the PIE score of the 
PPI network of these genes and the sensitivity of prediction of genes downstream 
HMPV-induced pathways. This positive correlation indicates that PIE is a valuable tool to 
quantify the extent to which genes are involved with each other in the same biological 
pathway. 
In chapter 4, we describe another new bioinformatics method called Iron Squelch that 
is aimed at interpreting genomics data in relation to iron-homeostasis and infection. 
Iron is essential for the metabolism of microbes and their hosts. During infection, 
pathogens compete for iron with their host cells. It is however, unclear whether host 
innate-immune cells could redistribute iron for their (the immune cells) own functionality 
as immune effectors while keeping the iron pools from being used by the invading 
pathogens. 
Our novel computational methodology compares the transcriptomics profiles of infected 
cells with those of an infection-free iron experiment. Precisely, Iron Squelch measures 
the total extent of gene expression fold change of iron-response genes under conditions 
of iron-overload, iron-depletion and infection. It further assesses, using the so-called 
Iron Squelch Indexes, whether the transcription profile (of the same set of genes) during 
infection mimics that of iron-depletion or iron-overload or none.
We applied Iron Squelch to microarray data from cells that were challenged with the 
following: HMPV, PIV, RSV, MV, LPS, Chlamydia pneumoniae, Escherichia coli, or Pseudomonas 
aeruginosa. We observe that cells infected with the intracellular (i.e. C. pneumoniae and 
the viruses), but not extracellular (E. coli, P. aeruginosa and LPS) pathogens mimic the 
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profile of iron-depleted cells. Importantly, the iron-depletion profile was also triggered 
by inactivated viruses (uv-irradiated HMPV, RSV, PIV and MV) and by interferon gamma, 
a cytokine induced by host cells upon intracellular infections. The iron-depletion profile 
observed is likely to be a cellular response because the inactivated viruses could also 
induce such a profile. 
In addition to uncovering the infection-induced iron restriction profiles of innate immune 
cells, our observations also open an avenue to investigate iron-dependent synergy or 
mitigation of disease during (co)-infections. Understanding iron redistribution strategies 
and effects on the hosts during extracellular and/or intracellular pathogen infections 
could improve our understanding of respiratory infectious diseases.
In chapter 5, we develop and apply an analysis pipeline to uncover transcription factor 
binding sites (TFBS) in microRNAs (miRNAs) that are over-expressed in monocyte-de-
rived dendritic cells (DCs). DCs are professional antigen presenting cells and are 
important in circumventing both viral and bacterial infections; respiratory infections 
inclusive. They are triggered upon infection (e.g. exposure to bacterial endotoxin, LPS) 
to differentiate from circulating monocytes. MicroRNAs, meanwhile, play a fundamental 
role in the regulation of gene expression by translational repression or target mRNA 
degradation. Despite the importance of miRNAs in regulation of cellular processes, 
regulatory elements in miRNA promoters are less well studied. Yet, such elements may 
reveal a link between miRNA expression and a specific cell type. 
To explore this link in myeloid cells (a group of cells that includes DC precursors), miRNA 
expression profiles were generated from monocytes and DCs. Differences in miRNA 
expression among monocytes, DCs and their stimulated progeny were observed. 
Furthermore, putative promoter regions of miRNAs that are significantly up-regulated in 
DCs were screened for TFBSs based on TFBS motif matching score, the degree to which 
those TFBSs are over-represented in the promoters of the up-regulated miRNAs, and the 
extent of conservation of the TFBSs in mammals. 
Analysis of evolutionarily conserved TFBSs in DC promoters revealed preferential 
clustering of sites within 500 bp upstream of the precursor miRNAs, and that many 
mRNAs of cognate TFs of the conserved TFBSs were actually expressed in the DCs. 
We also predicted target genes for the over-expressed miRNAs, some of which have 
been observed to be down-regulated in DCs during its differentiation from monocytes. 
Taken together, our data provide evidence that selected miRNAs expressed in DCs 
differentiated from monocytes using LPS as an infection model, have evolutionarily 
conserved TFBSs relevant to DC biology in their promoters. These miRNAs and their 
target genes may facilitate future research aimed at understanding mechanisms in DC 
differentiation from monocytes.
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In chapter 6, we applied PIE to transcriptomics data generated from neutrophils of 4 
LPS-induced volunteers. Neutrophils are white blood cells that play an important role in 
systemic inflammatory response syndrome and the development of sepsis following 
bacterial infections; including those that infect the airways. Neutrophils are essential for 
a proper defense against microorganisms but may also cause tissue damage. To 
investigate the in vivo neutrophil transcriptional responses after LPS infusion, a total of 
17393 distinct genes were analyzed on microarray using samples from the infected 
volunteers. Principal component analysis of gene expression in time indicates a 
separation of time t=2 hours after LPS infusion, from time t=4 hours and t=6 hours for 
the 4 LPS-induced volunteers examined. From this set of genes, 2248 genes (≈13%) were 
differentially expressed relative to time 0h at a fold change threshold of 2. Out of this set, 
233 genes were up-regulated and 307 genes were down-regulated at all 3 time points 
following LPS infusion.  PPI networks of the former and latter gene-sets, especially the 
down-regulated genes, were physically cohesive. Based on Gene Ontology analysis, the 
up-regulated genes are involved in the processes of inflammatory response while the 
down-regulated genes are involved in lymphocyte activation. Further independent 
hematological measurements revealed neutrophilia and lymphopenia in the whole blood 
post LPS administration in the 4 volunteers. The congruency of the transcriptomics 
responses with the hematological parameters to LPS infusion are likely due to both 
direct activation of circulating neutrophils and mobilization of neutrophils from 
the bone marrow. We provide candidate genes as a resource to further interpretation 
of LPS-induced neutrophilia and the gene response kinetics at a molecular level in 
neutrophils.
In Chapter 7, we recapitulate the work described in this thesis, with a look into the 
future of bioinformatics-based analysis of immune response to respiratory tract 
pathogens. The constant collaboration between bioinformatics and immunology is 
essential to our understanding of disease pathogenesis. High-throughput technologies 
aimed at characterizing the interacteome, phosphoproteome, subcellulome, miRNA-
targetome, transcriptome, and proteome of a host and/or its pathogens would continue 
to provide data whose integration can help us understand the cellular mechanisms 
underpinning infectious disease in greater detail than is currently feasible. 
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Dit proefschrift presenteert en beschrijft de resultaten van bioinformatica analyses van 
transcriptoomdata, die gegenereerd werden uit cellen van het aangeboren immuun -
systeem nadat ze geïnfecteerd werden met pathogenen (of inactief pathogeenmateriaal), 
die bijdragen aan infectieziektes van de luchtwegen. Onder deze pathogenen zijn virussen 
zoals het menselijke metapneumovirus (HMPV), het luchtweg syncytiële virus (RSV), het 
parainfluenzavirus (PIV) en het mazelenvirus (MV). Deze virussen horen bij de familie 
paramyxoviridae. Wereldwijd veroorzaken ze leed en sterfte vooral bij kleine kinderen, 
ouderen en mensen met een verzwakt afweersysteem. Inhoudelijk is dit proefschrift 
onderverdeeld in twee secties, één sectie gaat over ontwikkeling van methodiek 
(hoofdstukken 3, 4 en 5) en één die over de toepassing ervan gaat (hoofdstukken 2 en 6). 
Hoofdstuk 1 is de algemene introductie. Hoofdstuk 7 is de algemene discussie.
In hoofdstuk 2, maken wij gebruik van het concept van context-specifieke netwerken 
van eiwit-eiwit interacties (protein-protein interactions in het Engels, oftewel PPIs). 
Een PPI netwerk is een grafische weergave waarbij een knooppunt (‘node’ in het Engels) 
een eiwit voorstelt terwijl de lijnen tussen knooppunten (‘edges’ in het Engels) fysieke 
interacties voorstellen. Elk knooppunt heeft dus één of meer interactiepartners. Ze zijn 
belangrijk omdat veel biologische processen via interacties tussen eiwitten bewerkstelligd 
worden. Een context-specifiek PPI netwerk is, zoals de naam al aangeeft, een netwerk 
waarin interacterende eiwitten of hun bijbehorende genen in een bepaald verband 
gereguleerd worden, bijvoorbeeld vanwege een virale infectie.
We pasten dit concept toe in ons onderzoek om dieper inzicht te krijgen in de 
moleculaire pathogenese van luchtweg virusinfecties in geïnfecteerde longepitheel-
cellen; de A549 cellen. Deze cellen werden blootgesteld aan een aantal levende en 
uv-bestraalde virussen: RSV, HMPV, PIV of MV. De cellen werden geoogst op verschillende 
tijdstippen na infectie en verwerkt voor proteoomanalyse met 2-dimensionele 
difference gel electrophorese (2-d gel). Monsters afkomstig van geïnfecteerde cellen 
werden met schijn-geïnfecteerde cellen vergeleken om eiwitten te identificeren wiens 
expressie door de infectie anders werd. Door 2-d gel en PPI netwerkanalyses laten wij 
zien dat RSV, HMPV, PIV3 en MV soortgelijke gast-cel reacties teweeg brengen en dat het 
vooral eiwitten betreft die betrokken zijn bij bescherming tegen ER-stress en apoptose. 
Deze informatie draagt bij aan onze kennis van de biologie van virale luchtweg infecties.
In hoofdstuk 3, beschrijven wij een nieuwe methode in PPI netwerkanalyse genaamd 
fysieke interactieverrijking (physical interaction enrichment in het Engels, oftewel PIE). 
In dit hoofdstuk beginnen wij met het aantonen dat PPI netwerken over het algemeen 
verrijkt zijn bij zowel genetische als bij infectieziekten. Dit kan kwantitatieve conclusies 
die gebaseerd zijn op algemene PPI netwerken systematisch beïnvloeden, waardoor 
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een goede randomisatie nodig is om de betrouwbaarheid van context-specifieke net - 
werken te beoordelen. 
PIE maakt gebruik van een normalisatietechniek die een gelijke verdeling van het aantal 
lijnen per knooppunt (node degree) tussen test en bijbehorende random PPI datasets 
waarborgt. Het kwantificeert in hoeverre eiwitten in een netwerk meer met elkaar 
interacteren dan bij soortgelijke random netwerken, en dus als fysiek cohesief kunnen 
worden beschouwd. 
We hebben PIE toegepast op een paar immuun-gerelateerde datasets. Ten eerste 
ontdekten wij dat de PPI netwerken van genetische ziektes niet fysiek cohesief zijn, 
ondanks hun verrijking in algemene PPI netwerken. Ten tweede ontdekten wij dat 
genen wiens expressie omhoog gereguleerd worden in alveolare cellen na HMPV 
infectie wel fysiek cohesief zijn. Ook het PPI netwerk van de omlaag gereguleerde 
genen was fysiek cohesief. Bovendien waren genen die geïnduceerd werden door 
behandeling met interferon gamma, uv-bestraald RSV of Pseudomonas ook cohesief. 
Dit laat zien dat PIE de fysieke cohesiviteit kan meten in verschillende omstandigheden. 
De fysieke cohesiviteit van de genen die omhoog gereguleerd werden na infectie met 
uv-bestraalde pathogenen is bijzonder interessant omdat dit niet door een directe 
inmenging van het pathogeen in de genregulatie kan zijn, maar eerder een ingebouwde 
cellulair programma lijkt te zijn dat op de infectie reageert. Daarnaast laten we zien dat 
PIE ook nuttig is voor het voorspellen van genen in cellulaire processen die volgen op 
infectie. Bij de genen die door HMPV geïnduceerd werden, zien wij een positieve 
correlatie tussen de PIE score van hun PPI netwerk en de mate waarin genen die 
reageren op HMPV infectie voorspeld kunnen worden. Deze positieve correlatie geeft 
aan dat PIE een waardevol hulpmiddel kan zijn om de mate waarin een set van genen 
in hetzelfde biologische proces betrokken is te kwantificeren.
In hoofdstuk 4, beschrijven wij een andere nieuwe bioinformatica methode genaamd 
Iron Squelch die gericht is op het interpreteren van genoomdata in relatie tot ijzer- 
homeostase en infectie. IJzer is essentieel voor het metabolisme van zowel microben 
als hun gastheren. Tijdens infecties concureren microben en gastheercellen om ijzer. 
Het is echter onduidelijk of de cellen van het aangeboren immunsysteem het ijzer 
kunnen herverdelen om het voor eigen gebruik te behouden en tegelijkertijd de 
 beschikbaarheid ervan voor de pathogenen te ontnemen.
In onze nieuwe methodiek worden transcriptoomprofielen van geïnfecteerde cellen 
vergeleken met die van een ijzerbehandeling zonder infectie. Iron Squelch meet de 
totale mate van verandering in genexpressie van genen die op ijzer reageren bij ijzer-
overbelasting, ijzer-tekort en infectie. Door gebruik te maken van de zogenaamde iron 
squelch index wordt verder gekeken of het transcriptieprofiel van dezelfde set genen 
meer lijkt op die van ijzer-tekort, ijzer-overbelasting, of geen van beide.
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We pasten deze methodiek toe op data van cellen die geïnfecteerd werden met HMPV, 
PIV, RSV, MV, LPS, Chlamydia pneumoniae, Escherichia coli of Pseudomonas aeruginos. We 
vonden dat cellen die met intracellulaire (C. pneumoniae en de virusen) maar niet extra-
cellulaire (E. coli, P. aeruginosa en LPS) pathogenen geïnfecteerd werden soortgelijke 
profielen vertoonden als bij ijzer-tekort. Belangrijk hierbij is het feit dat dit ijzer-tekort 
profiel ook veroorzaakt werd door niet-actieve virussen (uv-bestraalde HMPV, RSV, PIV 
en MV) en interferon gamma, een cytokine die omhoog-gereguleerd wordt bij intracel-
lulaire infecties. Dit duidt erop dat dit ijzer-tekort profiel een cellulaire reactie is omdat 
de inactieve virussen een soortgelijk profiel induceren.
Naast het blootleggen van door infectie veroorzaakte ijzer-profielen maken onze 
observaties het ook mogelijk om ijzer-afhankelijke synergie of ziektevermindering te 
bestuderen tijdens (co)-infecties. Het begrijpen van ijzer herverdelingsstrategieën en 
hun effect op extra- en/of intracellulaire infecties kan onze kennis over luchtweginfec-
tieziektes vergroten.
In hoofdstuk 5, ontwikkelen en passen wij een aanpak toe  om transcriptiefactor bin-
dingsposities (transcription factor binding sites in het Engels, oftewel TFBS) in microRNAs 
(miRNAs) die tot over-expressie komen in van monocyten afkomstige dendritische 
cellen (DCs). DCs zijn professionele antigeen-presenterende cellen die belangrijk zijn bij 
afweer van zowel virale als bacteriële infecties, waaronder ook luchtweginfecties. Ze 
worden aangezet om circulerende monocyten te vormen na infectie (bv LPS 
blootstelling). MicroRNAs daarentegen spelen een fundamentele rol in de regulatie van 
genexpressie door repressie van translatie of degradatie van doelwit mRNAs. Ondanks 
het belang van miRNAs voor cellulaire processen zijn de regulatoire elementen in hun 
promotors minder goed bestudeerd. Toch kunnen zulke elementen verbanden aan het 
licht brengen tussen miRNA expressie en bepaalde celtypen.
Om dit verband in myeloide cellen (een groep cellen die DC voorlopers omvat) te 
bestuderen werden miRNA expressieprofielen gegenereerd voor zowel monocyten als 
DCs. Verschillen in miRNA expressie tussen monocyten, DCs en hun gestimuleerde 
nageslacht werden waargenomen. Daarnaast werden de vermoedelijke promotor-regi-
onen van miRNAs die significant omhoog-gereguleerd werden in DCs onderzocht op 
TFBSs, gebaseerd op TFBS motief score, mate van over-representatie van die motieven 
in de promotors van omhoog-gereguleerde miRNAs en evolutionaire conservering van 
die TFBSs bij zoogdieren.
Analyse van evolutionair geconserveerde TFBSs in DC promotors toonde een neiging 
aan om binnen 500bp voor het begin van de voorloper miRNAs te clusteren en 
bovendien dat veel mRNAs die door bijbehorende TFs gereguleerd worden ook tot 
expressie kwamen in DCs. Daarnaast voorspelden wij ook doelwit mRNAs voor de over-
vertegenwoordigde miRNAs waarvan sommige omlaag-regeruleerd worden in DCs 
tijdens de differentiatie van monocyten. Samengevat laat onze data zien dat bepaalde 
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miRNAs, die tot expressie komen in DCs die uit monocyten gedifferentiëerd worden 
door middel van LPS als infectie-model, evolutionair geconserveerde TFBSs in hun 
promotors hebben die relevant zijn voor DC-biologie. Deze miRNAs en hun doelwitgenen 
kunnen toekomstig onderzoek naar DC differentiatie uit monocyten bevorderen.
In hoofdstuk 6, hebben wij PIE toegepast op transcriptoomdata gegenereerd uit 
neutrofielen van vier vrijwilligers die LPS kregen toegediend. Neutrofielen zijn witte 
bloedcellen die een belangrijke rol spelen bij het systemische inflammatie syndroom en 
bij het ontstaan van sepsis na bacteriële infecties, waaronder die van luchtwegen. 
Neutrofielen  zijn essentieel voor een goede weerstand tegen micro-organismen, maar 
ze kunnen ook weefselschade veroorzaken. Om de in vivo transcriptieresponsen van 
neutrofielen te bestuderen na LPS infusie werden in totaal 17393 afzonderlijke genen 
geanalyseerd op microarrays, gebruik makend van monsters van de geïnfecteerde 
vrijwilligers. Principiële componentanalyse van de genexpressie in de tijd laat een 
scheiding zien van tijdstip t=2 uur na LPS infusie ten opzichte van tijdstippen t=4 en t=6 
bij de vier vrijwilligers die LPS kregen toegediend. Uit deze set van genen kwamen 2248 
genen (≈13%) tenminste een factor twee anders tot expressie dan op tijdstip t=0. Van 
deze set waren 233 omhoog-gereguleerd en 307 omlaag-gereguleerd voor alle 3 
tijdstippen na LPS infusie. PPIs van deze genensets, vooral van de omlaag-gereguleerde 
genen, waren fysiek cohesief. Gen Ontologie analyse liet zien dat de omhoog-geregu-
leerde genen betrokken zijn bij inflammatie terwijl de omlaag-gereguleerde genen bij 
lymphocyte activatie betrokken zijn. Verdere onafhankelijke hematologische metingen 
toonden neutrofilie en lymphopenie aan in het bloed van de vier vrijwilligers na 
toediening van LPS. De overeenkomstige transcriptomische reacties en hematologische 
parameters na LPS infusie komen waarschijnlijk als gevolg van zowel directe activatie 
van circulerende neutrofielen alsmede  van de mobilisatie van neutrofielen uit het 
beenmerg. Wij stellen kandidaatgen voorspellingen beschikbaar om de interpretatie 
van door LPS veroorzaakte neutrofilie te bevorderen, alsmede ook het begrip op 
moleculair niveau van de kinetiek van het genrespons in neutrofielen.
In hoofdstuk 7, beschouwen wij het werk dat in dit proefschrift beschreven wordt met 
een blik op de toekomst van bioinformatische analyse van het immuunrespons op 
luchtwegpathogenen. Een doorlopende samenwerking tussen bioinformatica en 
immunologie is nodig om ziekteprocessen te kunnen doorgronden. Grootschalige 
technologieën gericht op het karakteriseren van interacteoom, phosphoproteoom, 
subcelluloom, miRNA-doelwitoom, transcriptoom en proteoom van een gastheer en/of 
zijn pathogenen zullen data beschikbaar moeten blijven stellen die na integratie ons 
kunnen helpen de onderliggende cellulaire mechanismen van infectieziektes in meer 
detail te begrijpen dan nu mogelijk is.
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Appendix 1: 
Supplementary material to Chapter 3
Measuring the physical cohesiveness of proteins using Physical 
Interaction Enrichment
Iziah Edwin Sama and Martijn A. Huynen
1. Test PPI Network Propagation
1.1   Precepts of propagation of test PPI networks derived from 
general PPI networks
Having a PPI network that is physically cohesive is interesting because it indicates that 
the genes used to construct this network are functionally related to each other, 
suggesting some sort of biological coherence. In addition, interesting information can 
be garnered from a cohesive PPI network by testing the limit of its cohesiveness. For 
instance, one can assess to what extent proteins that interact with those in an original 
test network, but that are not part of it, are biologically relevant to the process one is 
studying.
To achieve this, a test PPI network is propagated and the cohesiveness of the resultant 
networks is examined using the PIE randomization procedure. Propagation of a test 
network based on a given gene list involves inclusion of interactions not only between 
proteins encoded by genes in that original gene list (N0 propagations, Equation 1), but 
also those in the general PPI network known to interact directly with those that are 
present in the original gene list (N1 propagation, Equation 2) and interactions with the 
latter (N2 propagations, Equation 3) and so forth (Figure 1A). This enables us to observe 
the change in physical cohesiveness from the original context of the test proteins (N0) 
to what is likely a less specific context as we propagate through the entire general PPI 
network. The propagated networks that are physically cohesive constitute an interesting 
resource from which additional genes that are relevant to the process being studied 
can be obtained.
1.1.1 Network propagation
A PPI network G 1 = (V 1, E 1) containing a set  V 1 with N
V
 vertices, and a set E 1 with N
E 
edges 
is propagated using a general network G  = (V , E ) such that:
Level 0, (N0) =  N0G 1 ⊆ G (1)
Level 1, (N1) =  N1G 1 ⊆ G (2)
Level 2, (N2) = N2G 1 ⊆ G ; practically, N2G 1 ≈ G (3)
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Etc., where N0G 1, N1G 1 and N2G 1 are induced subgraphs of G; and respectively consists 
of the original V 1 nodes and the captured V nodes in G at distance 0, 1 and 2 from V 1. 
1.2  Results of propagation of test PPI networks
It is interesting to assess to what extent proteins that are in a general PPI network, but 
absent in an original set of test proteins, interact with the test proteins. 
1.2.1 Propagation of derived PPI networks of HMPV-induced genes
Using HMPV-induced genes that are up-regulated at a fold change threshold of 3.0 after 
12 hours of infection indicates that the physical cohesiveness increases from N0 (PIE 
score=1.1, p=0.04) to N1 (PIE score=1.4, p<0.01) propagation (Figure 1B). This increase is 
due to the rise of average degree for the test networks which is notably also in line with 
those of their corresponding random networks (Figure 1B). Although the average 
degree increases for both test and random networks, the PIE score, which is a strict 
relative value, is observed to drop drastically at higher levels of propagation than 1 (data 
not shown). This drastic drop occurs because the propagated network grows and 
almost completely overlaps with the general PPI network.  Moreover, examination of 
the average node overlap between test network with random networks for the N0, N1 
and N2 networks respectively, revealed an increasing overlap (3%, 24%, and 81% 
respectively) of the nodes in the test networks with their random counterparts. Likewise, 
we observed an increasing overlap (3%, 25% and 68 respectively) of the test network 
interactions with those of their random equivalents. These overlaps are large, partially 
because of the imposed PIE randomization constraints. Overall, at higher levels of 
propagation (>1), one cannot obtain independent samples from the complete network 
to assess the statistical significance. Although at a single iteration (N1) the propagated 
network already contains 6% of the nodes in the general network and 25% of the nodes 
with the randomized networks, the significant overlap with the biological network at 
that point (see below) suggests that the N1 network derived from the original network 
of up-regulated genes is likely to be biologically relevant to HMPV infection.
1.2.2 Propagation of derived PPI networks of IFNG induced genes
Using IFNG-induced genes that are up-regulated at a fold change threshold of 3.0, the 
physical cohesiveness is observed to increase from N0 (PIE score = 1.14, p=0.03) to N1 
(PIE score=1.23, p<0.01) network propagation. As was the case of HMPV-induced genes, 
this pattern is a consequence of the rise in average degree upon propagation of the 
networks which increased for both test and random networks (Figure 1C). 
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Figure 1 -  Propagation of context derived networks. (A) Scheme of propagation of  
PPI networks. 
The network, N0, obtained after integration of a set of genes with the general PPI 
network is propagated to include interactions not only between proteins encoded by 
genes in the original gene list, but also those in the general network known to interact 
with the N0 nodes (N1 network) and interactions of the latter (N2 network) and so forth. 
Circles represent nodes (i.e protein of gene). Links between nodes represent protein-
protein interactions. (B) Changes in average degree upon propagation of the 
HMPV-induced gene network in the HsapiensPPI network. (C) Changes in average 
degree upon propagation of the interferon gamma-induced gene network in the 
HsapiensPPI network. (UpregHMPV12 denotes that the gene set used for this network 
where upregulated (≥3 times) in expression after 12 hr of HMPV infection; upregIFNG24 
denotes that the gene set used for this network where upregulated (≥3 times) in 
expression after 24 hr of interferon gamma treatment).
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2.  Downstream pathway gene predictions
 
2.1  Precepts of prediction of down-stream pathway genes
If a propagated network is found to be physically cohesive, it will be interesting to 
extract and examine the new nodes. For example; enrichment of the new nodes could 
be assessed in a benchmark set of genes in pathways downstream the original test 
nodes. The benchmark set of genes used in this study are those observed at later time 
points to be up-regulated in expression by the same stimulus used to trigger the 
original test set of genes. The enrichment terms are defined as follows. True positives 
(TP) are the nodes in the propagated network that are present in the benchmark set. 
False positives (FP) are the nodes in the propagated network that are not present in the 
benchmark set. False negatives (FN) are the benchmark nodes not present in the set of 
nodes of the propagated network. The sensitivity of prediction is calculated as the 
percentage of TP divided by the sum of TP and FN. The positive predictive value (PPV) 
of prediction is calculated as the percentage of TP divided by the sum of TP and FP. The 
p-value of prediction is represented as the empirical fraction of instances whereby 
amidst the nodes from 1000 random networks of the same size and global degree 
distribution as the propagated test network (i.e. randoms obtained using the PIE 
randomization approach) there are equal or greater number of TP nodes than that of 
the test TP nodes. 
2.2 Results of prediction of down-stream pathway genes
The one-step propagation of a PPI network at high fold change yields other networks 
that are still significant in terms of physical cohesiveness, and can therewith be regarded 
as biologically meaningful. In order to harness this property, nodes in cohesive 
propagated networks were queried in a benchmarked set of genes that are situated in 
pathways downstream of the response. This principle was applied to HMPV infection by 
using the sets of genes obtained at 5 infection time points as benchmarks.
We observed that the propagation of networks consisting of proteins whose genes are 
induced at an FC threshold of 3.0 by the HMPV virus at time points 12, 24 and 48 hrs led 
to significant (p<1.0e-3) prediction of genes induced at similar levels at the subsequent 
time points used (Table 1). For instance at the fold change of 3.0, 69 of the predicted 
nodes (amongst which were 23 nodes that were not over-expressed before) in the 
“HMPV12N1” network are indeed expressed at this fold change threshold at time point 
24 hr. The HMPV12N1 network was obtained after one- level propagation of the PPI 
network (i.e. HMPV12N0) of proteins encoded by genes that are up-regulated 12 hr post 
HMPV infection.  Overall, the sensitivity of prediction is 5-41 % and the positive predictive 
value is 5-11%. Intriguingly, there is a strong correlation between the PIE score of 
precursor networks and the predictability of genes in their propagated networks. For 
instance the correlation between the PIE score and sensitivity of predictions is 0.93 
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(p=0.066). These results demonstrate the usefulness of the PIE approach to assess the 
biological coherence of a set of genes and the potential to use general PPI networks in 
an exploratory manner to predict genes of relevance to a process being studied.
Table 1 -  Summary of gene expression prediction using PPI networks.
Scenario PN
(PIE score)
*PPV +SN TP TP
pvalue
NN
hmpv6N1
and
hmpv12N0
hmpv6N0
(1)
0.05 0.05 6 1.0e-03 0
hmpv12N1
and
hmpv24N0
hmpv12N0
(1.05)
0.11 0.29 69 <1.0e-03 23
hmpv24N1
and
hmpv48N0
hmpv24N0
(1.06)
0.1 0.33 170 <1.0e-03 59
hmpv48N1
and
hmpv72N0
hmpv48N0
(1.12)
0.1 0.41 257 <1.0e-03 48
*Pearson correlation between PPV and PIE score is 0.74 (p= 0.26) for the 4 data points. +Pearson correlation 
between SN and PIE score is 0.93 (p=0.066) for the 4 data points. (PN precursor network (i.e. the original 
network that was propagated to yield the predicted genes), PPV positive predictive value, SN sensitivity, TP 
number of true positives, NN number of the TP nodes that were not in PN)
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Supplementary Material to Chapter 4
Transcriptomic assessment of cellular response to intracellular 
pathogens reveals an iron-depletion profile
Iziah Edwin Sama, April Kartikasari, Arno Andeweg, Dorine Swinkels, Martijn Huynen
1. Iron Squelch profile from transcriptomics data
In addition to our in-house data, we further examined iron profiles using Squelch 
analysis of published microarray data sets obtained from NCBI gene-expression omnibus 
database (GEO) .The datasets are transcriptomics data from cells treated with human 
metapneumovirus (HMPV) for  6, 12, 24, 48, and 72 hours (GSE8961) [1];  Human respiratory 
syncytial virus (RSV) for 4 and 24 hours ( GSE3397) contributed by Huang et al, 2001. ; 
Measles virus (MV) for 3, 6, 12, and 24 hours (GSE980) [2] ;   Influenza A virus (Infa) for 24, 
48, 96, and 168 hours (GSE5289) [3] ; Chlamydia pneumonia  for 12, 24, 48 and  72 hours 
(GSE7246) [4];  E. coli  for 6 hours(GSE2232) [5] ; Pseudomonas aeruginosa   for 1.5 hours 
(GSE4485)  [6] ;  uv-irradiated airway-pathogens for 4 hours (GSE6802)  [7] ; LPS for 1 and 
4 hours (GSE1541)  [8]  and  Interferon gamma (IFNG) for 4 and 24 hours (GSE1815) [9] . 
The cell types used to generate the above-mentioned datasets were epithelial cells, 
except that of MV which were dendritic cells.
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Figure 1 -  Heatmap of genes that are perturbed in expression in virus-infected cells 
and that have “iron” in their description in Gene Ontology.  
Respectively, rsv6 and   rsv6uvd refer to data of 6 hours of live and uv-irradiated RSV 
infection, etc. RSV, respiratory syncytial virus; HMPV, human metapneumovirus; MV 
measles virus; PIV, parainfluenza virus; depletion, iron-depletion; overload, iron-overload. 
(red >=1.5 fold up-regulated; blue >=1.5 fold down-regulated; white not up to 1.5 fold 
perturbed relative to control cells.)
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Figure 2 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in A549 
cells after 6, 12, 24, 48 and 72 hours of HMPV 
infection.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or 
vice versa. There are 40 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes 
and at most 1/1.5 for down- regulated genes in the 
iron-depletion and overload models. A low p-value, 
indicates that the infection mimics iron-depletion. 
(Boxplot, random; Grey diamond, test). (hmpv6, 
hmpv12, hmpv24, hmpv48, hmpv72; respective   data 
of 6, 12, 24, 48 and 72 hours of HMPV infection.)
Figure 3 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in bronchial 
epithelial cells after 4 and 24 hours of RSV 
infection.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or 
vice versa. There are 35 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes 
and at most 1/1.5 for down- regulated genes in the 
iron-depletion and overload models. A low p-value, 
indicates that the infection mimics iron-depletion. 
(Boxplot, random. Grey diamond, test (RSV4hr, RSV24hr; 
respective data of 4, and 24 hours of RSV infection.)
Figure 4 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in monocyte 
derived dendritic cells after 3, 6, 12, and 24 
hours of MV infection.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or 
vice versa. There are 25 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes 
and at most 1/1.5 for down- regulated genes in the 
iron-depletion and overload models. A low p-value, 
indicates that the infection mimics iron-depletion. 
(Boxplot, random. Grey diamond, test). (MV3hr, MV6hr, 
MV12hr, MV24hr; respective data of 3, 6, 12 and 24 
hours of MV infection.)
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Figure 5 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in mice lung 
cells after 24, 48, 96 and 168 hours of influenza 
A infection.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or vice 
versa. There are only 14 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes and at 
most 1/1.5 for down-regulated genes in the iron-depletion 
and overload models. A low p-value, indicates that the 
infection mimics iron-depletion. (Boxplot, random. Grey 
diamond, test). (infa24hr, infa48hr, infa96hr, infa168hr; 
respective data of 24, 48, 96, and 168 hours of Influenza A 
virus infection. Human homologues of the mice genes 
were used for these analyses.)
Figure 6 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in bronchial 
epithelial cells after 4 hours of exposure with 
uv-irradiated airway pathogens.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or 
vice versa. There are 32 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes 
and at most 1/1.5 for down-regulated genes in the 
iron-depletion and overload models. A low p-value, 
indicates that the infection mimics iron-depletion. 
(pa4uvd, rsv4uvd, staph4uvd respectively refer to 
data of 4 hours of uv-irradiated Pseudomonas 
aeruginona, respiratory syncytial virus, and Staphylo-
coccus aureus  infection.)
Figure 7 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in human 
epithelial cells (HL cell line) after 12, 24, 48 and 
72 hours of Chlamydia pneumoniae infection.  
This involves genes that are up-regulated in iron- 
depletion but down-regulated in iron-overload, or 
vice versa. There are 44 such genes at a fold change 
threshold (FC) of at least 1.5 for up-regulated genes 
and at most 1/1.5 for down-regulated genes in the 
iron-depletion and overload models. A low p-value, 
indicates that the infection mimics iron-depletion. 
(cp12h, cp24h, cp48h, cp72h; respective data of 12, 
24, 48 and 72 hours of Chlamydia pneumoniae 
infection.)
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Figure 8 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in human 
bronchial epithelial cells after 8 and 24 hours 
of interferon gamma (IFNG) exposure.  
This involves genes that are up-regulated in 
iron-depletion but down-regulated in iron- 
overload, or vice versa. There are only 13 such 
genes at a fold change threshold (FC) of at least 
1.5 for up-regulated genes and at most 1/1.5 for 
down-regulated genes in the iron-depletion 
and overload models. The Squelch index 
(y-axis) reported is the sum of the log2 gene-
expression fold changes for the entire gene set. 
A low p-value indicates that IFNG mimics an 
iron-depletion profile. (Boxplot, random. Grey 
diamond, test). (IFNG8hr, IFNG24hr respective 
data of 8, or 24 hours of IFNG exposure to the 
epithelial cells.)
Figure 9 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in airway 
epithelial cells after 1.5 hours of Pseudomonas 
aeruginosa infection.  
This involves genes that are up-regulated in 
iron-depletion but down-regulated in iron- 
overload, or vice versa. There are 32 such genes 
at a fold change threshold (FC) of at least 1.5 for 
up-regulated genes and at most 1/1.5 for 
down-regulated genes in the iron-depletion 
and overload models. The Squelch index 
(y-axis) reported is the sum of the log2 gene-
expression fold changes for the entire gene set. 
A low p-value, indicates that the infection 
mimics iron-depletion. (Boxplot, random. Grey 
diamond, test). (Pa_90min and pa_rsma_90min, 
respectively refer to data of 90 minutes of 
pseudomonas and pseudomonas rsma mutant 
infection.)
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Figure 11 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in alveolar 
epithelial cells after 1 and 6 hours of LPS 
exposure.  
This involves genes that are up-regulated in 
iron-depletion but down-regulated in iron- 
overload, or vice versa. There are 27 such genes 
at a fold change threshold (FC) of at least 1.5 for 
up-regulated genes and at most 1/1.5 for 
down-regulated genes in the iron-depletion 
and overload models. The Squelch index 
(y-axis) reported is the sum of the log2 gene-
expression fold changes for the entire gene set. 
A low p-value indicates that LPS mimics 
iron-depletion profile. (Boxplot, random. Grey 
diamond, test). (LPS1h, LPS4h respective data of 
1 or  4 hour of LPS exposure to epithelial cells).
Figure 10 - Profiles from Iron Squelch analysis 
of genes perturbed in expression in intestinal 
epithelial cells after 6 hours of E. coli infection. 
This involves genes that are up-regulated in 
iron-depletion but down-regulated in iron- 
overload, or vice versa. There are 32 such genes 
at a fold change threshold (FC) of at least 1.5 for 
up-regulated genes and at most 1/1.5 for 
down-regulated genes in the iron-depletion 
and overload models. A low p-value, indicates 
that the infection mimics iron-depletion. (Boxplot, 
random. Grey diamond, test).  (Ecoli6hr, data of 
6 hours of E. coli infection).
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2.  Overrepresented transcription factor binding sites 
(TFBS) in genes perturbed in expression (fold change 
threshold 1.5) by iron treatment and virus infection
 
Table 1 -  TFBS overrepresented in promoter region of genes relatively 
upregulated in iron overload and infection (group 1 genes).
Matrix factor Raw_score P_value
MA0050 IRF1 8.82 0.009
M00258 ISRE 6.52 0.042
M00210 OCT-x 6.51 0.009
M00062 IRF-1 4.87 0.018
M00193 NF-1 4.82 0.025
M00158 COUP-TF,_HNF-4 3.91 0.042
MA0017 NR2F1 3.91 0.042
M00161 Oct-1 3.67 0.032
M00054 NF-kappaB 3.59 0.029
M00122 USF 3.45 0.012
MA0033 FOXL1 2.15 0.036
MA0119 Hox11-CTF1 1.74 0.034
M00201 C/EBP 1.14 0.039
M00121 USF 0.439 0.049
M00123 c-Myc:Max 0.245 0.025
Table 2 -  TFBS overrepresented in promoter region of genes relatively 
upregulated in iron depletion and infection (group 2 genes).
Matrix factor Raw_score P_value
M00216 TATA 21.4 0.001
M00500 STAT6 16.9 0.014
M00192 GR 14 0.008
M00152 SRF 13.2 0
MA0107 RELA 12.5 0
M00053 c-Rel 12 0
M00052 NF-kappaB_(p65) 11.9 0
M00499 STAT5A 11.6 0.039
MA0101 REL 11.4 0
193
Appendix 2
Table 2 -  Continued.
Matrix factor Raw_score P_value
M00194 NF-kappaB 11.4 0
M00054 NF-kappaB 11.3 0
M00159 C/EBP 11 0.006
M00195 Oct-1 10.6 0.028
M00291 Freac-3 9.54 0.002
M00215 SRF 9.3 0
M00486 Pax-2 8.02 0.027
M00498 STAT4 7.79 0.021
M00252 TATA 7.29 0.001
M00186 SRF 7 0
M00188 AP-1 6.35 0.005
M00051 NF-kappaB_(p50) 6.35 0.003
M00208 NF-kappaB 6.04 0.006
M00497 STAT3 5.98 0.014
M00173 AP-1 5.38 0.002
M00410 SOX-9 5.33 0.015
M00210 OCT-x 5.32 0.027
M00496 STAT1 5.19 0.026
M00172 AP-1 4.72 0.003
M00174 AP-1 4.4 0.011
MA0031 FOXD1 4.24 0.008
M00290 Freac-2 4.2 0.017
MA0083 SRF 3.6 0.001
MA0030 FOXF2 2.72 0.027
MA0105 NFKB1 2.68 0.045
M00203 GATA-X 2.41 0.016
M00135 Oct-1 1.33 0.046
MA0077 SOX9 0.744 0.021
M00248 Oct-1 0.737 0.043
M00128 GATA-1 0.388 0.036
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Table 3 -  TFBS overrepresented in promoter region of genes relatively 
downregulated in iron overload and infection (group 3 genes).
Matrix factor Raw_score P_value
M00196 Sp1 19.2 0.038
M00491 MAZR 12.2 0.004
M00008 Sp1 7.58 0.046
M00480 LUN-1 6.28 0.019
M00499 STAT5A 3.67 0.03
M00208 NF-kappaB 3.07 0.025
M00051 NF-kappaB_(p50) 3.05 0.015
MA0025 NFIL3 0.335 0.034
M00024 E2F 0.165 0.014
M00246 Egr-2 0.0704 0.024
Table 4 -  TFBS overrepresented in promoter region of genes relatively 
downregulated in iron depletion and infection (group 4 genes).
Matrix factor Raw_score P_value
M00209 NF-Y 7.45 0
M00287 NF-Y 5.13 0.011
M00143 BSAP 3.72 0.046
M00184 MyoD 3.38 0.039
M00185 NF-Y 3.23 0.003
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Figure 12 -  Graphical display of some TFBS overrepresented in promoter region of 
genes relatively upregulated in iron overload and infection (group 1 genes). 
Y-axis, TFBS scores. (Only a selection of factors is projected here in order to facilitate 
interpretation of the figure).
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Figure 13 -  Graphical display of some TFBS overrepresented in promoter region of genes 
relatively upregulated in iron depletion and infection (group 2 genes).   
Y-axis, TFBS scores ranging from 6-15. (Only a selection of factors are projected here in 
order to facilitate interpretation of the figure).
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Figure 14 -  Graphical display of some TFBS overrepresented in promoter region of genes 
relatively downregulated in iron overload and infection (group 3 genes).   
Y-axis, TFBS scores. (Only a selection of factors is projected here in order to facilitate 
interpretation of the figure).
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Table 5 -  Expression of the Transcription factors with over-represented binding 
sites in the promoter regions of genes in groups 1-4 above.
Factor Official 
Symbol
Entrez
geneID
Group Infection Iron 
Depletion
Iron 
Overload
Infection 
Detail
IRF1 IRF1 3659 1 + 0 + 0++++
OCT-x POU2F1 5451 1 + 0 0 0000+
IRF-1 IRF1 3659 1 + 0 + 0++++
NF-1 NFIC 4782 1 - 0 0 0000-
NF-1 NFIX 4784 1 + - 0 00+00
COUP-TF,_
HNF-4
NR2F1 7025 1 + 0 0 00+++
NR2F1 NR2F1 7025 1 + 0 0 00+++
Figure 15 -  Graphical display of some TFBS overrepresented in promoter region of genes 
relatively downregulated in iron depletion and infection (group 4 genes). 
 Y-axis, TFBS scores.
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Table 5 -  Continued.
Factor Official 
Symbol
Entrez
geneID
Group Infection Iron 
Depletion
Iron 
Overload
Infection 
Detail
Oct-1 POU2F1 5451 1 + 0 0 0000+
NF-
kappaB
NFKB1 4790 1 + 0 0 00+++
USF USF2 7392 1 - 0 0 000--
FOXL1 FOXL1 2300 1 + 0 0 000++
C/EBP CEBPB 1051 1 + 0 0 -0+++
C/EBP CEBPA 1050 1 - 0 + 00---
C/EBP CEBPE 1053 1 - 0 0 ---00
C/EBP CEBPD 1052 1 0 0 0 -00+0
C/EBP CEBPG 1054 1 + 0 0 +00++
c-Myc:Max MAX 4149 1 + 0 0 00+00
c-Myc:Max MYC 4609 1 + 0 0 000++
STAT6 STAT6 6778 2 + 0 0 00++0
GR NR3C1 2908 2 + 0 0 -00++
SRF SRF 6722 2 + 0 0 000++
RELA RELA 5970 2 + 0 0 -00++
c-Rel REL 5966 2 + 0 0 00+++
NF-
kappaB_
(p65)
RELA 5970 2 + 0 0 -00++
STAT5A STAT5A 6776 2 + 0 0 000++
REL REL 5966 2 + 0 0 00+++
NF-
kappaB
NFKB1 4790 2 + 0 0 00+++
C/EBP CEBPB 1051 2 + 0 0 -0+++
C/EBP CEBPA 1050 2 - 0 + 00---
C/EBP CEBPE 1053 2 - 0 0 ---00
C/EBP CEBPD 1052 2 0 0 0 -00+0
C/EBP CEBPG 1054 2 + 0 0 +00++
Oct-1 POU2F1 5451 2 + 0 0 0000+
Pax-2 PAX2 5076 2 + - 0 000+0
STAT4 STAT4 6775 2 + 0 0 +0000
AP-1 JUN 3725 2 + 0 0 +++++
AP-1 FOS 2353 2 + + - -0+++
AP-1 JUNB 3726 2 + 0 0 -0+++
AP-1 FOSB 2354 2 + 0 0 0++++
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Table 5 -  Continued.
Factor Official 
Symbol
Entrez
geneID
Group Infection Iron 
Depletion
Iron 
Overload
Infection 
Detail
NF-
kappaB_
(p50)
NFKB1 4790 2 + 0 0 00+++
STAT3 STAT3 6774 2 - 0 0 -0000
SOX-9 SOX9 6662 2 + 0 0 000+0
OCT-x POU2F1 5451 2 + 0 0 0000+
STAT1 STAT1 6772 2 + 0 0 +++++
FOXD1 FOXD1 2297 2 + 0 0 0000+
FOXF2 FOXF2 2295 2 - 0 0 0000-
NFKB1 NFKB1 4790 2 + 0 0 00+++
GATA-1 GATA1 2623 2 + 0 0 000++
GATA-X GATA1 2623 2 + 0 0 000++
SOX9 SOX9 6662 2 + 0 0 000+0
Freac-2 FOXF2 2295 2 - 0 0 0000-
SP1 SP1 6667 3 - 0 0 0000-
MAZR PATZ1 23598 3 - 0 0 -000-
STAT5A STAT5A 6776 3 + 0 0 000++
NF-
kappaB
NFKB1 4790 3 + 0 0 00+++
NF-
kappaB_
(p50)
NFKB1 4790 3 + 0 0 00+++
NFIL3 NFIL3 4783 3 + 0 - 0++++
E2F E2F1 1869 3 - 0 0 -00--
E2F E2F2 1870 3 - 0 0 --0--
E2F E2F4 1874 3 - 0 0 0-00-
E2F E2F7 144455 3 - 0 0 -00--
E2F E2F8 79733 3 0 0 0 -000+
Egr-2 EGR2 1959 3 + 0 0 0++++
NF-Y NFYA 4800 4 - 0 0 --000
NF-Y NFYB 4801 4 - 0 0 ----0
NF-Y NFYC 4802 4 - 0 0 0-000
BSAP PAX5 5079 4 + 0 0 0++++
MyoD MYOD1 4654 4 + 0 0 0000+
(+ : upregulated (FC>=1.5);  - : downregulated (FC<=1/1.5);  0 : FC threshold not met;  InfectionDetail : 6,12,24,48 
and 72 hour post HMPV infection. Data from [1])
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Figure 17 -  Time dependent down-regulation of transferrin receptor c (TFRC) and ferritin 
subunits FTH1 and FTL accompanied by up-regulation of interferon stimulating 
gene 20 (ISG20) gene expressions.   
A: HMPV and B: IFNG treatments of airway epithelial cells. (Y-axis: log2 relative fold 
change of gene expression (treatment to control), x: axis treatment (iron-overload, iron-
depletion, HMPV and IFNG) over time. (hmpv6, hmpv12 imply hmpv infection for 6, and 
12 hours etc. IFNG8hr implies IFNG administration for 8 hours, etc).
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Additional files
Additional file 1
Figure S1 -  Setup of culture and quality of monocyte-derived DCs. 
(A) Culture setup and harvest schedule for RNA isolations. (B) Purity of monocytes 
(upper histogram) and the expression of maturation markers CD80 and CD86 on the 
different DC populations (C) Mixed lymphocyte reaction with the various DC 
populations; ratio of DCs vs. PBLs is indicated on the x-axis. (D) Production of TNFα and 
IL8 by the different DC populations, as determined by ELISA. The white and black bars 
each represent data from two different donors.
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Additional file 2
Figure S2 -  Schematic overview of the miRNA expression screen in monocytes and 
DCs.
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Additional file 3
Table S1 -  MicroRNAs for which assays have been developed by Applied Biosystems, 
and of which expression levels were determined in monocytes and 
dendritic cells. Of a total of 157 miRNAs, 104 were expressed in DC and/or 
monocytes, whereas 53 were not detected in either cell type.
 (Table too large to place here but it is available with the article online)
Additional file 4
Table S2 -  Overview of over-represented TFBS motifs in promoter sequences of miRNAs 
that are upregulated in monocytes (A) or DCs(B).
Table S2A -  TFBS motifs over-represented (based on CLOVER; p < 0.05) in 
promoter sequences of miRNAs that are up-regulated in monocytes.
Matrix Factor Raw_score P_value
M00257 RREB-1 10 0.042
MA0081 SPIB 5.22 0.006
M00500 STAT6 4.98 0.029
M00532 RP58 3.47 0.013
M00070 Tal-1beta:ITF-2 3.38 0.003
MA0062 GABPA 2.7 0.031
M00483 ATF6 2.62 0
M00065 Tal-1beta:E47 2.43 0.012
M00025 Elk-1 1.78 0.04
M00066 Tal-1alpha:E47 1.6 0.028
MA0091 TAL1-TCF3 1.51 0.032
M00243 Egr-1 1.2 0.006
M00126 GATA-1 0.679 0.027
M00246 Egr-2 0.675 0.017
MA0083 SRF 0.646 0.016
M00186 SRF 0.4 0.036
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Table S2B -  TFBS motifs over-represented (based on CLOVER; p < 0.05) in 
promoter sequences of miRNAs that are up-regulated in DCs.
Matrix Factor Raw_score P_value
M00084 MZF1 17.3 0
M00491 MAZR 17 0
M00005 AP-4 14.5 0
M00083 MZF1 12.8 0
MA0073 RREB1 29 0.001
M00257 RREB-1 23 0.001
MA0057 ZNF42_5-13 9.27 0.002
MA0056 ZNF42_1-4 7.28 0.004
M00500 STAT6 8.21 0.006
MA0080 SPI1 4.84 0.006
MA0081 SPIB 6.61 0.013
M00184 MyoD 6.85 0.018
M00497 STAT3 2.73 0.018
M00002 E47 8.09 0.023
MA0095 YY1 0.938 0.024
M00196 Sp1 27.2 0.03
M00222 Hand1:E47 4.72 0.041
M00526 GCNF 0.0864 0.045
MA0055 Myf 9.14 0.047
208
Additional file 5
Figure S3
(A) Commonality of TFBSs in promoter regions of monocyte-expressed miRNAs. Shown 
on the x-axis are the high-scoring TFBSs (i.e. of instance score ≥ 6) that occur at least 
once in the 2 kb promoters of the miRNA up-regulated in monocytes. The y-axis shows 
the number of promoters that have the TFBS, at least once at this threshold. (B) The 
distribution of the number of common TFBS hits per number of common miRNA 
promoters as in A, for test and random sets of miRNA promoters. The values for random 
are the median values from 1000 random set of miRNA promoters of same size and 
length as those in the monocyte set. The score is the ratio of the sum of “the product of 
numbers on the x-axis and corresponding y-axis values” for the monocyte set relative to 
that of the random.  The p-value is the fraction of cases wherein this sum for random 
sets of miRNA promoters is greater than or equal to that of the DC set.
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Additional file 6
Figure S4
(A) TFBSs shared among the promoter regions of miRNAs up-regulated in monocytes. 
Shown on the x-axis are high-scoring TFBSs filtered at a motif instance score threshold 
of at least 6 and at a 10th percentile evolutionary conservation score that occur at least 
once in the promoters of miRNAs up-regulated in DCs. The y-axis shows the number of 
promoters that have the TFBS at least once at these thresholds.  (B) The distribution of 
the number of common TFBS hits per number of common miRNA promoters as in A, for 
test and random sets of miRNA promoters. The values for random are the median values 
from 1000 random set of miRNA promoters of same size and length as those in the 
monocyte set. The score is the ratio of the sum of all occurrences of all TFBS for the 
monocyte set relative to that of the random sets. The p-value is estimated from the 
number of instances wherein this sum of “the product of number of TFBSs and the 
number of miRNA promoters” of 1000 random sets of miRNA promoters is greater than 
or equal to that of the monocyte set.
210
Additional file 7
Table S3 -  Library of TFBS motif for which the cognate TFs are expressed (presence = 1) 
or not expressed (absence = 1) in DCs. 
 (Table too large to place here but it is available with the article online)
Additional file 8
Figure S5
Correlation of the number of expressed TFs with the number of promoters of miRNAs 
that are over-expressed in DCs. The TFs used are those of high-scoring TFBSs (i.e. of 
instance score >= 6) that are also highly conserved (10th percentile of PhastCons scores) 
and occur at least once in the 2 kb promoters of the miRNA up-regulated in DCs (left 
plot), and a random set of miRNAs (right plot). The original number of miRNA promoters 
that share at least one TFBS was 12 for both DCs and the random set of promoters (i.e 
the number of promoters of miRNAs that were over-expressed in DCs). Due to the high 
conservation threshold used, the maximum number of miRNA promoters that share at 
least one TFBS became smaller (6 for the test set and 3 for the random set). The 
correlations were calculated using the Pearson correlation as implemented in R.
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Additional file 9
Table S4 -  Gene ontology analysis of the expressed and not-expressed TFs of predicted 
binding sites in the promoters of miRNA. 
 (Table too large to place here but it is available with the article online)
Additional file 10
Table S5 -  The 421 target genes that are predicted by TargetScan for the DC-over-
expressed miRNAs.
 (Table too large to place here but it is available with the article online)
Additional file 11
Table S6 -  The 2300 target genes that are predicted by PicTar for the DC-over- 
expressed miRNAs.
 (Table too large to place here but it is available with the article online)
Additional file 12
Table S7 -  The 282 target genes that are predicted by TargetScan for the Monocyte-
over-expressed miRNAs.
 (Table too large to place here but it is available with the article online)
Additional file 13
Table S8 -  The 1591 target genes that are predicted by PicTar for the Monocyte-
over-expressed miRNAs.
 (Table too large to place here but it is available with the article online)
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Additional file 14
Figure S6
Venn diagram showing the intersection of target genes. (A) Intersection of target genes 
of the miRNAs that are over-expressed in DCs, using  PicTar (DC.pic), and TargetScan (DC.
tar). (B) Similar to A, but for monocytes. (C) Intersections of the common targets found 
by PicTar and TargetScan for DC miRNAs (DC.pic.tar),  the common targets for monocyte 
miRNAs (mono.pic.tar), and the dataset of Lehtonen et al .2007 (Leh.) of genes that are 
regulated in DCs relative to monocytes during DC differentiation. (D-F) Intersection of 
common target genes from DC miRNAs, monocyte miRNAs, and genes that were 
up-regulated (upreg) or down-regulated (downreg), in DCs relative to monocytes in the 
data set of Lehtonen et al.2007. Figure D, E, F represent respectively the data sets at time 
points 3, 6 and 24 hr of DC differentiation from monocytes. (Differential gene relations 
(DC/monocyte) were selected at a fold change of at least 2. The PicTar score used >=0.4, 
TargetScan context score <=-0.4 . Comparisons were done at the level of RefSeq DNA ID 
and the elements in the intersections with the upreg and downreg datasets are 
provided in Table S11 with gene symbols attached.
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Additional file 15
Table S9 -  Target genes that are down-regulated in DCs relative to monocytes and 
that were predicted using PicTar or Targetscan, to be targets of miRNAs 
that are over-expressed in DCs relative to monocytes.
Table S9A -  Target genes that are down-regulated in DCs relative to Monocytes 
and that were predicted using PicTar to be targets of miRNAs that  
are over-expressed in DCs relative to Monocytes.
relative expression (DC/
monocyte) of target 
gene in the dataset of 
Lehtonen et al 2007
Affy_HGU133A
ID
RefSeqDNA
ID
HGNC 
symbol
t3hr t6hr t24hr DC
miRNA
Pictar 
score
219534_x_at NM_000076 CDKN1C -4.85 -6.35 -7.15 hsa-miR-221 3.78
216894_x_at NM_000076 CDKN1C -2.8 -5.4 -6.75 hsa-miR-221 3.78
216248_s_at NM_006186 NR4A2 -2.7 -4.6 -6.45 hsa-miR-34a 3.81
204621_s_at NM_006186 NR4A2 -2.5 -4.1 -6.2 hsa-miR-34a 3.81
213182_x_at NM_000076 CDKN1C -3.45 -5.8 -5.8 hsa-miR-221 3.78
204622_x_at NM_006186 NR4A2 -2.25 -3.9 -5.3 hsa-miR-34a 3.81
201939_at NM_006622 PLK2 -2.55 -3.15 -5.15 hsa-miR-342 2.61
220266_s_at NM_004235 KLF4 -3.75 -5.1 -5 hsa-miR-135a 2.65
220266_s_at NM_004235 KLF4 -3.75 -5.1 -5 hsa-miR-34a 3.33
221841_s_at NM_004235 KLF4 -3 -4.75 -4.8 hsa-miR-135a 2.65
221841_s_at NM_004235 KLF4 -3 -4.75 -4.8 hsa-miR-34a 3.33
221920_s_at NM_016612 SLC25A37 -1.45 -2.75 -4.55 hsa-miR-221 3.72
208078_s_at NM_173354 SIK1 -3.15 -3.6 -4.15 hsa-miR-137 7.41
219480_at NM_005985 SNAI1 -1.85 -2.65 -4.1 hsa-miR-125a 2.74
219480_at NM_005985 SNAI1 -1.85 -2.65 -4.1 hsa-miR-125b 2.74
206115_at NM_004430 EGR3 -2.1 -3.65 -3.8 hsa-let-7e 1.41
203036_s_at NM_014751 MTSS1 -4 -3.9 -3.7 hsa-miR-135a 1.92
205214_at NM_004226 STK17B -1.85 -2.45 -3.45 hsa-miR-221 3.83
221986_s_at NM_017644 KLHL24 -1.5 -2.45 -3.4 hsa-let-7e 4.03
201015_s_at NM_002230 JUP -2.1 -2.1 -3.35 hsa-miR-125a 2.91
201015_s_at NM_002230 JUP -2.1 -2.1 -3.35 hsa-miR-125b 2.91
201015_s_at NM_021991 JUP -2.1 -2.1 -3.35 hsa-miR-125a 3.19
201015_s_at NM_021991 JUP -2.1 -2.1 -3.35 hsa-miR-125b 3.19
207433_at NM_000572 IL10 -2.35 -1.9 -3.2 hsa-let-7e 2.56
221763_at NM_004241 JMJD1C -1.45 -2.8 -3.15 hsa-miR-34a 4.07
213348_at NM_000076 CDKN1C -2.55 -4 -3.05 hsa-miR-221 3.78
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relative expression (DC/
monocyte) of target 
gene in the dataset of 
Lehtonen et al 2007
Affy_HGU133A
ID
RefSeqDNA
ID
HGNC 
symbol
t3hr t6hr t24hr DC
miRNA
Pictar 
score
202149_at NM_006403 NEDD9 -2.25 -2.85 -3.05 hsa-miR-125a 2.4
202149_at NM_006403 NEDD9 -2.25 -2.85 -3.05 hsa-miR-125b 2.4
202150_s_at NM_006403 NEDD9 -2.2 -2.9 -2.95 hsa-miR-125a 2.4
202150_s_at NM_006403 NEDD9 -2.2 -2.9 -2.95 hsa-miR-125b 2.4
219132_at NM_021255 PELI2 -1.5 -2.55 -2.95 hsa-miR-125a 1.64
219132_at NM_021255 PELI2 -1.5 -2.55 -2.95 hsa-miR-125b 1.64
219132_at NM_021255 PELI2 -1.5 -2.55 -2.95 hsa-miR-135a 6.31
202932_at NM_005433 YES1 -1.25 -1.9 -2.65 hsa-miR-125a 3.06
202932_at NM_005433 YES1 -1.25 -1.9 -2.65 hsa-miR-125b 3.06
203547_at NM_000616 CD4 -1.05 -2.15 -2.6 hsa-miR-221 2.55
220319_s_at NM_013262 MYLIP -1.9 -2.75 -2.5 hsa-miR-221 2.11
218738_s_at NM_016271 RNF138 -1.55 -1.1 -2.3 hsa-miR-135a 2.84
218738_s_at NM_016271 RNF138 -1.55 -1.1 -2.3 hsa-miR-137 4.15
218738_s_at NM_198128 RNF138 -1.55 -1.1 -2.3 hsa-miR-135a 2.84
218738_s_at NM_198128 RNF138 -1.55 -1.1 -2.3 hsa-miR-137 4.15
201751_at NM_014876 JOSD1 -1.15 -1.6 -2.15 hsa-miR-135a 2.53
202933_s_at NM_005433 YES1 -1.7 -2.6 -2.15 hsa-miR-125a 3.06
202933_s_at NM_005433 YES1 -1.7 -2.6 -2.15 hsa-miR-125b 3.06
212689_s_at NM_018433 KDM3A -1.55 -1.75 -2 hsa-let-7e 3.05
210360_s_at NM_014751 MTSS1 -1.7 -1.95 -2 hsa-miR-135a 1.92
217964_at NM_017775 TTC19 -1.6 -2.1 -1.95 hsa-miR-34a 7.04
209189_at NM_005252 FOS -2.9 -2.45 -1.8 hsa-miR-221 3.38
218205_s_at NM_199054 MKNK2 -2.2 -1.75 -1.8 hsa-miR-125a 4.84
218205_s_at NM_199054 MKNK2 -2.2 -1.75 -1.8 hsa-miR-125b 4.84
202191_s_at NM_003644 GAS7 -1.6 -2.4 -1.75 hsa-let-7e 2.11
202191_s_at NM_003644 GAS7 -1.6 -2.4 -1.75 hsa-miR-135a 3.71
202191_s_at NM_201433 GAS7 -1.6 -2.4 -1.75 hsa-let-7e 2.11
202191_s_at NM_201433 GAS7 -1.6 -2.4 -1.75 hsa-miR-135a 3.71
202192_s_at NM_003644 GAS7 -1.75 -2.1 -1.75 hsa-let-7e 2.11
202192_s_at NM_003644 GAS7 -1.75 -2.1 -1.75 hsa-miR-135a 3.71
202192_s_at NM_201433 GAS7 -1.75 -2.1 -1.75 hsa-let-7e 2.11
202192_s_at NM_201433 GAS7 -1.75 -2.1 -1.75 hsa-miR-135a 3.71
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Table S9A -  Continued.
relative expression (DC/
monocyte) of target 
gene in the dataset of 
Lehtonen et al 2007
Affy_HGU133A
ID
RefSeqDNA
ID
HGNC 
symbol
t3hr t6hr t24hr DC
miRNA
Pictar 
score
221985_at NM_017644 KLHL24 -1.05 -1.8 -1.65 hsa-let-7e 4.03
204650_s_at NM_006051 APBB3 -1.25 -1.8 -1.6 hsa-let-7e 3.29
204650_s_at NM_133172 APBB3 -1.25 -1.8 -1.6 hsa-let-7e 3.29
204650_s_at NM_133173 APBB3 -1.25 -1.8 -1.6 hsa-let-7e 3.29
204650_s_at NM_133174 APBB3 -1.25 -1.8 -1.6 hsa-let-7e 3.29
203003_at NM_005920 MEF2D -1.45 -1.75 -1.6 hsa-let-7e 2.62
203003_at NM_005920 MEF2D -1.45 -1.75 -1.6 hsa-miR-125a 1.91
203003_at NM_005920 MEF2D -1.45 -1.75 -1.6 hsa-miR-125b 1.91
210359_at NM_014751 MTSS1 -1.7 -1.75 -1.55 hsa-miR-135a 1.92
212430_at NM_017495 RBM38 -2.45 -2.05 -1.55 hsa-let-7e 2.77
212430_at NM_017495 RBM38 -2.45 -2.05 -1.55 hsa-miR-125a 3.5
212430_at NM_017495 RBM38 -2.45 -2.05 -1.55 hsa-miR-125b 3.5
202769_at NM_004354 CCNG2 -1.15 -1.25 -1.4 hsa-miR-135a 3.17
202769_at NM_004354 CCNG2 -1.15 -1.25 -1.4 hsa-miR-137 2.62
202770_s_at NM_004354 CCNG2 -1.65 -1.2 -1.4 hsa-miR-135a 3.17
202770_s_at NM_004354 CCNG2 -1.65 -1.2 -1.4 hsa-miR-137 2.62
211559_s_at NM_004354 CCNG2 -1.35 -1.2 -1.4 hsa-miR-135a 3.17
211559_s_at NM_004354 CCNG2 -1.35 -1.2 -1.4 hsa-miR-137 2.62
210872_x_at NM_003644 GAS7 -1.1 -1.75 -1.4 hsa-let-7e 2.11
210872_x_at NM_003644 GAS7 -1.1 -1.75 -1.4 hsa-miR-135a 3.71
210872_x_at NM_201432 GAS7 -1.1 -1.75 -1.4 hsa-let-7e 2.11
210872_x_at NM_201432 GAS7 -1.1 -1.75 -1.4 hsa-miR-135a 3.71
210872_x_at NM_201433 GAS7 -1.1 -1.75 -1.4 hsa-let-7e 2.11
210872_x_at NM_201433 GAS7 -1.1 -1.75 -1.4 hsa-miR-135a 3.71
201416_at NM_003107 SOX4 -1.4 -1.15 -1.4 hsa-miR-221 1.37
201416_at NM_003107 SOX4 -1.4 -1.15 -1.4 hsa-miR-34a 2.18
204897_at NM_000958 PTGER4 -1.6 -1.9 -1.35 hsa-miR-342 2.18
201557_at NM_014232 VAMP2 -1.1 -1.15 -1.15 hsa-miR-34a 8.66
201417_at NM_003107 SOX4 -1.7 -1.85 -1.05 hsa-miR-221 1.37
201417_at NM_003107 SOX4 -1.7 -1.85 -1.05 hsa-miR-34a 2.18
202723_s_at NM_002015 FOXO1 -1.75 -1.55 -1 hsa-miR-135a 1.6
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Table S9B -  Target genes that are down-regulated in DCs relative to Monocytes 
and that were predicted using TargetScan to be targets of miRNAs  
that are over-expressed in DCs relative to Monocytes.
Affy_HGU133A
ID
RefSeqDNA 
ID
HGNC 
symbol
t3hr t6hr t24hr DC
miRNA
context 
score
211840_s_at NM_001104631 PDE4D -2.4 -5.4 -5.05 hsa-miR-342-3p -0.6764
208078_s_at NM_173354 SIK1 -3.15 -3.6 -4.15 hsa-miR-137 -0.563
204491_at NM_001104631 PDE4D -2.35 -3 -3.35 hsa-miR-342-3p -0.6764
219132_at NM_021255 PELI2 -1.5 -2.55 -2.95 hsa-miR-135a -0.695
220319_s_at NM_013262 MYLIP -1.9 -2.75 -2.5 hsa-miR-221 -0.46
218738_s_at NM_016271 RNF138 -1.55 -1.1 -2.3 hsa-miR-137 -0.522
210836_x_at NM_001104631 PDE4D -2 -2.4 -2.05 hsa-miR-342-3p -0.6764
212443_at NM_015175 NBEAL2 -1.35 -1.55 -1.55 hsa-miR-125b -0.411
209020_at NM_016470 C20orf111 -1.35 -1.2 -1.4 hsa-miR-342-3p -0.424
202769_at NM_004354 CCNG2 -1.15 -1.25 -1.4 hsa-miR-137 -0.465
202770_s_at NM_004354 CCNG2 -1.65 -1.2 -1.4 hsa-miR-137 -0.465
211559_s_at NM_004354 CCNG2 -1.35 -1.2 -1.4 hsa-miR-137 -0.465
210837_s_at NM_001104631 PDE4D -2.05 -2.95 -1.4 hsa-miR-342-3p -0.6764
213022_s_at NM_007124 UTRN -2.3 -1.4 -1.2 hsa-miR-135a -0.577
202723_s_at NM_002015 FOXO1 -1.75 -1.55 -1 hsa-miR-135a -0.54
Additional file 16
Table S10 -  Target genes that are down-regulated in monocytes relative to DCs and 
that were predicted using PicTar or Targetscan, to be targets of miRNAs 
that are over-expressed in monocytes relative to DCs.
Table S10A -  Target genes that are down-regulated in monocytes relative to DCs 
and that were predicted using PicTar to be targets of miRNAs that are 
over-expressed in monocytes relative to DCs.
Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
relative expression 
(DC/monocyte) of 
target gene in the 
dataset of Lehtonen  
et al 2007
monocyte-
miRNA
Pictar
score
t3hr t6hr t24hr
211839_s_at NM_000757 CSF1 6.6 7.4 7.8 hsa-miR-130a 4.22
210557_x_at NM_172211 CSF1 6.05 6.7 6.85 hsa-miR-130a 4.22
208510_s_at NM_138712 PPARG 7.85 7.65 6.45 hsa-miR-130a 4.28
208510_s_at NM_138711 PPARG 7.85 7.65 6.45 hsa-miR-130a 4.28
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Table S10A -  Continued.
Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
relative expression 
(DC/monocyte) of 
target gene in the 
dataset of Lehtonen  
et al 2007
monocyte-
miRNA
Pictar
score
t3hr t6hr t24hr
208510_s_at NM_015869 PPARG 7.85 7.65 6.45 hsa-miR-130a 4.27
208510_s_at NM_005037 PPARG 7.85 7.65 6.45 hsa-miR-130a 4.27
212298_at NM_003873 NRP1 4.95 6.4 6.2 hsa-miR-130a 2
207082_at NM_000757 CSF1 3.6 5.2 6 hsa-miR-130a 4.22
212765_at NM_203459 CAMSAP1L1 2.3 3.95 3.65 hsa-miR-16 2.23
212765_at NM_203459 CAMSAP1L1 2.3 3.95 3.65 hsa-miR-15b 2.23
201266_at NM_182743 TXNRD1 3 3.6 3.2 hsa-miR-199b 2.37
201266_at NM_182743 TXNRD1 3 3.6 3.2 hsa-miR-199a 2.37
201266_at NM_182742 TXNRD1 3 3.6 3.2 hsa-miR-199b 2.37
201266_at NM_182742 TXNRD1 3 3.6 3.2 hsa-miR-199a 2.37
201266_at NM_182729 TXNRD1 3 3.6 3.2 hsa-miR-199b 2.37
201266_at NM_182729 TXNRD1 3 3.6 3.2 hsa-miR-199a 2.37
201266_at NM_003330 TXNRD1 3 3.6 3.2 hsa-miR-199b 2.37
201266_at NM_003330 TXNRD1 3 3.6 3.2 hsa-miR-199a 2.37
217196_s_at NM_203459 CAMSAP1L1 2.3 3.55 3.1 hsa-miR-16 2.23
217196_s_at NM_203459 CAMSAP1L1 2.3 3.55 3.1 hsa-miR-15b 2.23
204401_at NM_002250 KCNN4 1.45 1.75 3 hsa-miR-16 4.31
204401_at NM_002250 KCNN4 1.45 1.75 3 hsa-miR-15b 4.31
200900_s_at NM_002355 M6PR 1.25 2.35 2.85 hsa-miR-199b 3.95
200900_s_at NM_002355 M6PR 1.25 2.35 2.85 hsa-miR-199a 3.95
200900_s_at NM_002355 M6PR 1.25 2.35 2.85 hsa-miR-130a 3.67
207233_s_at NM_198178 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_198178 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
207233_s_at NM_198177 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_198177 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
207233_s_at NM_198159 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_198159 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
207233_s_at NM_198158 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_198158 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
207233_s_at NM_006722 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_006722 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
207233_s_at NM_000248 MITF 1.5 2.5 2.8 hsa-miR-199b 2.45
207233_s_at NM_000248 MITF 1.5 2.5 2.8 hsa-miR-199a 2.45
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Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
relative expression 
(DC/monocyte) of 
target gene in the 
dataset of Lehtonen  
et al 2007
monocyte-
miRNA
Pictar
score
t3hr t6hr t24hr
200961_at NM_012248 SEPHS2 1.2 2 2.55 hsa-miR-150 2.88
203795_s_at NM_020993 BCL7A 2.4 2.6 2.35 hsa-miR-130a 1.99
214179_s_at NM_003204 NFE2L1 1.05 1.95 2.1 hsa-miR-199b 7.63
214179_s_at NM_003204 NFE2L1 1.05 1.95 2.1 hsa-miR-199a 7.63
214179_s_at NM_003204 NFE2L1 1.05 1.95 2.1 hsa-miR-16 3.05
214179_s_at NM_003204 NFE2L1 1.05 1.95 2.1 hsa-miR-15b 3.05
201024_x_at NM_015904 EIF5B 1.05 1.95 2.1 hsa-miR-199b 4.16
210896_s_at NM_032468 ASPH 3 1.45 2 hsa-miR-16 2.45
210896_s_at NM_032468 ASPH 3 1.45 2 hsa-miR-15b 2.45
210896_s_at NM_032466 ASPH 3 1.45 2 hsa-miR-16 2.46
210896_s_at NM_032466 ASPH 3 1.45 2 hsa-miR-15b 2.46
203935_at NM_001105 ACVR1 3.3 3 1.95 hsa-miR-130a 6.52
209455_at NM_033644 FBXW11 1.95 1.55 1.9 hsa-miR-199b 2.21
209455_at NM_033644 FBXW11 1.95 1.55 1.9 hsa-miR-199a 2.21
209455_at NM_033644 FBXW11 1.95 1.55 1.9 hsa-miR-150 1.97
209455_at NM_012300 FBXW11 1.95 1.55 1.9 hsa-miR-199b 2.21
209455_at NM_012300 FBXW11 1.95 1.55 1.9 hsa-miR-199a 2.21
209455_at NM_012300 FBXW11 1.95 1.55 1.9 hsa-miR-150 1.97
217993_s_at NM_182796 MAT2B 1.05 1.3 1.85 hsa-miR-130a 2.7
217993_s_at NM_013283 MAT2B 1.05 1.3 1.85 hsa-miR-130a 2.7
200614_at NM_004859 CLTC 1.6 1.9 1.85 hsa-miR-130a 2.29
200020_at NM_007375 TARDBP 1.6 2 1.7 hsa-miR-130a 2.02
201176_s_at NM_001655 ARCN1 1.2 1.65 1.7 hsa-miR-199b 3.25
201176_s_at NM_001655 ARCN1 1.2 1.65 1.7 hsa-miR-199a 3.25
201176_s_at NM_001655 ARCN1 1.2 1.65 1.7 hsa-miR-16 4.32
201176_s_at NM_001655 ARCN1 1.2 1.65 1.7 hsa-miR-15b 4.32
218242_s_at NM_017635 SUV420H1 1.25 1.8 1.65 hsa-miR-130a 2.12
218761_at NM_017610 RNF111 1.05 1.65 1.45 hsa-miR-16 2.29
218761_at NM_017610 RNF111 1.05 1.65 1.45 hsa-miR-15b 2.29
205479_s_at NM_002658 PLAU 1.5 2.5 1.45 hsa-miR-199b 4.42
205479_s_at NM_002658 PLAU 1.5 2.5 1.45 hsa-miR-199a 4.42
221568_s_at NM_018362 LIN7C 1.05 1.65 1.45 hsa-miR-199b 4.79
221568_s_at NM_018362 LIN7C 1.05 1.65 1.45 hsa-miR-199a 4.79
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Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
relative expression 
(DC/monocyte) of 
target gene in the 
dataset of Lehtonen  
et al 2007
monocyte-
miRNA
Pictar
score
t3hr t6hr t24hr
201089_at NM_001693 ATP6V1B2 1.75 1.75 1.45 hsa-miR-130a 2.02
217939_s_at NM_203437 AFTPH 1.15 1.25 1.45 hsa-miR-199b 3.46
217939_s_at NM_203437 AFTPH 1.15 1.25 1.45 hsa-miR-199a 3.46
217939_s_at NM_017657 AFTPH 1.15 1.25 1.45 hsa-miR-199b 3.46
217939_s_at NM_017657 AFTPH 1.15 1.25 1.45 hsa-miR-199a 3.46
217939_s_at NM_001002243 AFTPH 1.15 1.25 1.45 hsa-miR-199b 3.46
217939_s_at NM_001002243 AFTPH 1.15 1.25 1.45 hsa-miR-199a 3.46
205327_s_at NM_001616 ACVR2A 1.05 1.25 1.45 hsa-miR-16 8.44
205327_s_at NM_001616 ACVR2A 1.05 1.25 1.45 hsa-miR-15b 8.44
216199_s_at NM_006724 MAP3K4 2 2.45 1.4 hsa-miR-16 3.15
216199_s_at NM_006724 MAP3K4 2 2.45 1.4 hsa-miR-15b 3.15
216199_s_at NM_005922 MAP3K4 2 2.45 1.4 hsa-miR-16 3.15
216199_s_at NM_005922 MAP3K4 2 2.45 1.4 hsa-miR-15b 3.15
212297_at NM_024524 ATP13A3 1.95 2.1 1.35 hsa-miR-16 3.1
212297_at NM_024524 ATP13A3 1.95 2.1 1.35 hsa-miR-15b 3.1
219496_at NM_023016 ANKRD57 4.05 3.4 1.35 hsa-miR-16 2.12
219496_at NM_023016 ANKRD57 4.05 3.4 1.35 hsa-miR-15b 2.12
209238_at NM_004177 STX3 1.05 1.25 1.3 hsa-miR-130a 3.08
211668_s_at NM_002658 PLAU 1.45 2.4 1.25 hsa-miR-199b 4.42
211668_s_at NM_002658 PLAU 1.45 2.4 1.25 hsa-miR-199a 4.42
202370_s_at NM_022845 CBFB 1.2 1.3 1.2 hsa-miR-130a 3.06
202370_s_at NM_001755 CBFB 1.2 1.3 1.2 hsa-miR-130a 3.01
218056_at NM_016561 BFAR 1.05 1.65 1.2 hsa-miR-16 2.9
218056_at NM_016561 BFAR 1.05 1.65 1.2 hsa-miR-15b 2.9
201998_at NM_173217 ST6GAL1 1.3 1.6 1.15 hsa-miR-199b 4.39
201998_at NM_173217 ST6GAL1 1.3 1.6 1.15 hsa-miR-199a 4.49
201998_at NM_173216 ST6GAL1 1.3 1.6 1.15 hsa-miR-199b 4.39
201998_at NM_173216 ST6GAL1 1.3 1.6 1.15 hsa-miR-199a 4.49
201998_at NM_003032 ST6GAL1 1.3 1.6 1.15 hsa-miR-199b 4.39
201998_at NM_003032 ST6GAL1 1.3 1.6 1.15 hsa-miR-199a 4.49
209341_s_at NM_001556 IKBKB 1.2 1.85 1.1 hsa-miR-199b 3.74
209341_s_at NM_001556 IKBKB 1.2 1.85 1.1 hsa-miR-199a 3.74
207719_x_at NM_014812 CEP170 1.95 1.2 1.1 hsa-miR-130a 2.8
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Table S10A -  Continued.
Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
relative expression 
(DC/monocyte) of 
target gene in the 
dataset of Lehtonen  
et al 2007
monocyte-
miRNA
Pictar
score
t3hr t6hr t24hr
204089_x_at NM_006724 MAP3K4 1.95 2.65 1 hsa-miR-16 3.15
204089_x_at NM_006724 MAP3K4 1.95 2.65 1 hsa-miR-15b 3.15
204089_x_at NM_005922 MAP3K4 1.95 2.65 1 hsa-miR-16 3.15
204089_x_at NM_005922 MAP3K4 1.95 2.65 1 hsa-miR-15b 3.15
Table S10B -  Target genes that are down-regulated in monocytes relative to DCs 
and that were predicted using TargetScan to be targets of miRNAs 
that are over-expressed in monocytes relative to DCs.
Affy_HGU133A
ID
Refseq DNA
ID
HGNC
symbol
t3hr t6hr t24hr monocyte-
miRNA
Context 
score
209921_at NM_014331 SLC7A11 5.2 5.1 4.5 hsa-miR-199a-3p -0.503
217678_at NM_014331 SLC7A11 4.75 4.8 4.15 hsa-miR-199a-3p -0.503
212158_at NM_002998 SDC2 2.2 3.8 4.05 hsa-miR-199a-3p -0.486
212157_at NM_002998 SDC2 1.3 3.7 4.05 hsa-miR-199a-3p -0.486
212154_at NM_002998 SDC2 1.75 4.1 3.9 hsa-miR-199a-3p -0.486
207528_s_at NM_014331 SLC7A11 5.15 5.65 3.45 hsa-miR-199a-3p -0.503
204032_at NM_003567 BCAR3 2.7 2.45 2.65 hsa-miR-199a-3p -0.825
201972_at NM_001690 ATP6V1A 1.65 1.85 2.2 hsa-miR-199a-3p -0.558
201971_s_at NM_001690 ATP6V1A 1.35 2.45 2.1 hsa-miR-199a-3p -0.558
222262_s_at NM_018638 ETNK1 1.35 2.25 2 hsa-miR-16 -0.52
222262_s_at NM_018638 ETNK1 1.35 2.25 2 hsa-miR-199a-3p -0.66
219017_at NM_018638 ETNK1 2 2.55 2 hsa-miR-16 -0.52
219017_at NM_018638 ETNK1 2 2.55 2 hsa-miR-199a-3p -0.66
212888_at NM_030621 DICER1 1.1 2.3 1.75 hsa-miR-130a -0.579
205327_s_at NM_001616 ACVR2A 1.05 1.25 1.45 hsa-miR-199a-3p -0.546
216199_s_at NM_005922 MAP3K4 2 2.45 1.4 hsa-miR-199a-3p -0.51
200915_x_at NM_182926 KTN1 1.6 1.45 1.4 hsa-miR-199a-3p -0.425
213229_at NM_030621 DICER1 1.15 2.4 1.3 hsa-miR-130a -0.579
214709_s_at NM_182926 KTN1 1.55 1.5 1.1 hsa-miR-199a-3p -0.425
204089_x_at NM_005922 MAP3K4 1.95 2.65 1 hsa-miR-199a-3p -0.51
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Table S11 -  Elements in the Venn diagram intersection of Figure S6D to S6F.
Refseq ID Gene symbol
Common 6 elements in "DC.pic.tar" and "Downreg24" (same at 3 and 6hr)
NM_021255 PELI2
NM_016271 RNF138
NM_013262 MYLIP
NM_173354 SIK1
NM_002015 FOXO1
NM_004354 CCNG2
Common 2 elements in "Mono.pic.tar" and "Upreg24"(same at 3 and 6hr)
NM_005922 MAP3K4
NM_001616 ACVR2A
Common 9 elements in "DC.pic.tar" and "Upreg24"(same at 3 and 6hr)
NM_016644 PRR16
NM_003901 SGPL1
NM_007375 TARDBP
NM_003615 SLC4A7
NM_000248 MITF
NM_016040 TMED5
NM_014290 TDRD7
NM_003888 ALDH1A2
NM_032804 ADO
Common 3 elements in "Mono.pic.tar" and "Downreg24"(same at 3 and 6hr)
NM_003453 ZMYM2
NM_205768 ZNF238
NM_014456 PDCD4
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